<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Microorganisms</journal-id><journal-id journal-id-type="iso-abbrev">Microorganisms</journal-id><journal-id journal-id-type="publisher-id">microorganisms</journal-id><journal-title-group><journal-title>Microorganisms</journal-title></journal-title-group><issn pub-type="epub">2076-2607</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6560413</article-id><article-id pub-id-type="doi">10.3390/microorganisms7050133</article-id><article-id pub-id-type="publisher-id">microorganisms-07-00133</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Arthritogenic Alphaviruses: A Worldwide Emerging Threat?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Levi</surname><given-names>Laura I.</given-names></name><xref ref-type="aff" rid="af1-microorganisms-07-00133">1</xref><xref ref-type="aff" rid="af2-microorganisms-07-00133">2</xref></contrib><contrib contrib-type="author"><name><surname>Vignuzzi</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="af1-microorganisms-07-00133">1</xref><xref rid="c1-microorganisms-07-00133" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-microorganisms-07-00133"><label>1</label>Populations Virales et Pathogen&#x000e8;se, Institut Pasteur, CNRS UMR 3569, 75015 Paris, France; <email>laura.levi@pasteur.fr</email></aff><aff id="af2-microorganisms-07-00133"><label>2</label>Ecole doctorale BioSPC, Universit&#x000e9; Paris Diderot, Sorbonne Paris Cit&#x000e9;, 75013 Paris, France</aff><author-notes><corresp id="c1-microorganisms-07-00133"><label>*</label>Correspondence: <email>marco.vignuzzi@pasteur.fr</email>; Tel.: +33-1-45-68-82-42</corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2019</year></pub-date><volume>7</volume><issue>5</issue><elocation-id>133</elocation-id><history><date date-type="received"><day>24</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>10</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Arthritogenic alphaviruses are responsible for a dengue-like syndrome associated with severe debilitating polyarthralgia that can persist for months or years and impact life quality. Chikungunya virus is the most well-known member of this family since it was responsible for two worldwide epidemics with millions of cases in the last 15 years. However, other arthritogenic alphaviruses that are as of yet restrained to specific territories are the cause of neglected tropical diseases: O&#x02019;nyong&#x02019;nyong virus in Sub-Saharan Africa, Mayaro virus in Latin America, and Ross River virus in Australia and the Pacific island countries and territories. This review evaluates their emerging potential in light of the current knowledge for each of them and in comparison to chikungunya virus.</p></abstract><kwd-group><kwd>alphaviruses</kwd><kwd>chikungunya virus</kwd><kwd>Mayaro virus</kwd><kwd>O&#x02019;nyong&#x02019;nyong virus</kwd><kwd>Ross River virus</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-microorganisms-07-00133"><title>1. Introduction</title><p>Alphaviruses are a genus of enveloped positive-stranded RNA viruses belonging to the <italic>Togaviridae</italic> family. As arboviruses, they circulate between an invertebrate vector (mosquitoes) and a vertebrate host. They are distributed worldwide and are separated into two groups: the New World alphaviruses responsible for disease with neurological involvement and the Old World alphaviruses (or Semliki forest virus group) that have a rheumatic tropism. The latter, also called arthritogenic alphaviruses, notably include chikungunya virus (CHIKV), now widely distributed, O&#x02019;nyong&#x02019;nyong virus (ONNV) located in Sub-Saharan Africa, Mayaro virus (MAYV) in Latin America, and Ross River virus (RRV) in Australia and the Pacific island countries and territories [<xref rid="B1-microorganisms-07-00133" ref-type="bibr">1</xref>] (<xref rid="microorganisms-07-00133-t001" ref-type="table">Table 1</xref>).</p><p>CHIKV emergence in the Indian Ocean islands in 2005&#x02013;2006 [<xref rid="B2-microorganisms-07-00133" ref-type="bibr">2</xref>,<xref rid="B3-microorganisms-07-00133" ref-type="bibr">3</xref>] and throughout the Caribbean states and the Americas in 2013&#x02013;2014 [<xref rid="B4-microorganisms-07-00133" ref-type="bibr">4</xref>] has raised awareness of the threat that other alphaviruses represent. While ONNV, MAYV, and RRV are currently responsible for smaller, local epidemics, the risk of dissemination worldwide is real, promoted by international trade and travel, globalization, and climate change.</p><p>In this work, we review the current knowledge on CHIKV and compare it to these three less-described alphaviruses (ONNV, MAYV, and RRV) circulating in three distinct continents, to try to understand their emergence potential in the near future.</p></sec><sec id="sec2-microorganisms-07-00133"><title>2. Historical Description and Main Epidemics</title><sec id="sec2dot1-microorganisms-07-00133"><title>2.1. Chikungunya Virus</title><p>Robinson first described chikungunya fever in 1955, after an epidemic of dengue-like fever with extremely severe joint pain in Southern Tanganyika (now Tanzania) in 1952&#x02013;1953 [<xref rid="B7-microorganisms-07-00133" ref-type="bibr">7</xref>]. Its name comes from the Kimakonde language meaning &#x0201c;that which bends up&#x0201d; describing this particular clinical manifestation.</p><p>Three main chikungunya virus genotypes, named after their original geographical distribution, are described: the West African, the East-Central-Southern African (ECSA, including Indian Ocean lineage), and the Asian genotypes (that include the Caribbean strains) [<xref rid="B8-microorganisms-07-00133" ref-type="bibr">8</xref>,<xref rid="B9-microorganisms-07-00133" ref-type="bibr">9</xref>]. Before 2000, chikungunya virus had been circulating mainly in Sub-Saharan Africa (Zimbabwe [<xref rid="B10-microorganisms-07-00133" ref-type="bibr">10</xref>,<xref rid="B11-microorganisms-07-00133" ref-type="bibr">11</xref>], Nigeria [<xref rid="B12-microorganisms-07-00133" ref-type="bibr">12</xref>], Angola [<xref rid="B13-microorganisms-07-00133" ref-type="bibr">13</xref>], South Africa [<xref rid="B14-microorganisms-07-00133" ref-type="bibr">14</xref>], Democratic Republic of Congo [<xref rid="B15-microorganisms-07-00133" ref-type="bibr">15</xref>,<xref rid="B16-microorganisms-07-00133" ref-type="bibr">16</xref>], Senegal [<xref rid="B17-microorganisms-07-00133" ref-type="bibr">17</xref>,<xref rid="B18-microorganisms-07-00133" ref-type="bibr">18</xref>]) and South-East Asia (India [<xref rid="B19-microorganisms-07-00133" ref-type="bibr">19</xref>,<xref rid="B20-microorganisms-07-00133" ref-type="bibr">20</xref>,<xref rid="B21-microorganisms-07-00133" ref-type="bibr">21</xref>,<xref rid="B22-microorganisms-07-00133" ref-type="bibr">22</xref>], Sri-Lanka [<xref rid="B21-microorganisms-07-00133" ref-type="bibr">21</xref>], Vietnam [<xref rid="B23-microorganisms-07-00133" ref-type="bibr">23</xref>], Thailand [<xref rid="B24-microorganisms-07-00133" ref-type="bibr">24</xref>], Malaysia [<xref rid="B25-microorganisms-07-00133" ref-type="bibr">25</xref>], Indonesia [<xref rid="B26-microorganisms-07-00133" ref-type="bibr">26</xref>,<xref rid="B27-microorganisms-07-00133" ref-type="bibr">27</xref>]) where numerous local outbreaks have been reported. Since then, two worldwide epidemics occurred that pushed chikungunya virus into the spotlight.</p><p>The first epidemic, caused by the Indian Ocean lineage, started in coastal Kenya in august 2004 with an attack rate of over 50% [<xref rid="B2-microorganisms-07-00133" ref-type="bibr">2</xref>] and rapidly disseminated to the Comoros islands in December 2004&#x02013;March 2005 [<xref rid="B28-microorganisms-07-00133" ref-type="bibr">28</xref>], and from there to Mayotte, Mauritius, La Reunion, and the Seychelles [<xref rid="B29-microorganisms-07-00133" ref-type="bibr">29</xref>], infecting hundreds of thousands of people at the end of 2005 through the beginning of 2006. Because La Reunion Island is a French territory with a developed public health infrastructure and surveillance system, the epidemic gathered more global attention after making the headlines. It also disseminated through India and South-East Asia, and into southern Europe because of air travel, causing altogether approximately six million cases in more than 40 countries [<xref rid="B2-microorganisms-07-00133" ref-type="bibr">2</xref>,<xref rid="B3-microorganisms-07-00133" ref-type="bibr">3</xref>].</p><p>In December 2013, the Asian genotype was responsible for the second major outbreak that started in Saint Martin Island in the Caribbean Sea [<xref rid="B30-microorganisms-07-00133" ref-type="bibr">30</xref>,<xref rid="B31-microorganisms-07-00133" ref-type="bibr">31</xref>]. From there, it disseminated throughout the American continent, causing more than two million cases in 50 countries [<xref rid="B4-microorganisms-07-00133" ref-type="bibr">4</xref>].</p><p>A particular and recent concern about CHIKV is its potential to cause outbreaks in temperate regions where the Asian tiger mosquito, <italic>Aedes albopictus</italic>, has recently established, enabling local epidemics, such as in Italy in 2007 [<xref rid="B32-microorganisms-07-00133" ref-type="bibr">32</xref>] and 2017 [<xref rid="B33-microorganisms-07-00133" ref-type="bibr">33</xref>,<xref rid="B34-microorganisms-07-00133" ref-type="bibr">34</xref>,<xref rid="B35-microorganisms-07-00133" ref-type="bibr">35</xref>] and in France in 2010 [<xref rid="B36-microorganisms-07-00133" ref-type="bibr">36</xref>] and 2017 [<xref rid="B37-microorganisms-07-00133" ref-type="bibr">37</xref>].</p></sec><sec id="sec2dot2-microorganisms-07-00133"><title>2.2. O&#x02019;nyong&#x02019;nyong Virus</title><p>Although genetically distinct from CHIKV, ONNV is its most closely related relative [<xref rid="B8-microorganisms-07-00133" ref-type="bibr">8</xref>]. Similar to CHIKV, it can cause large-scale epidemics in Africa, but infection by ONNV has never been reported outside of this continent. The first described ONNV outbreak took place during the first half of 1959 in north-western Uganda (Gulu), before it crossed the border to Belgian Congo and Sudan, causing close to 750,000 cases [<xref rid="B38-microorganisms-07-00133" ref-type="bibr">38</xref>]. This epidemic lasted until 1962, spreading from eastern to western Africa and permitting the first isolation of the virus in human serum [<xref rid="B39-microorganisms-07-00133" ref-type="bibr">39</xref>]. In 1984&#x02013;1985, it caused another outbreak in Ivory Coast [<xref rid="B40-microorganisms-07-00133" ref-type="bibr">40</xref>], and although it was then called Igbo-Ora virus, it is now clear that it was in fact a lineage of ONNV [<xref rid="B8-microorganisms-07-00133" ref-type="bibr">8</xref>,<xref rid="B41-microorganisms-07-00133" ref-type="bibr">41</xref>]. A third epidemic took place in southern Uganda in 1996&#x02013;1997 with 40&#x02013;80% of the population infected [<xref rid="B42-microorganisms-07-00133" ref-type="bibr">42</xref>,<xref rid="B43-microorganisms-07-00133" ref-type="bibr">43</xref>]. More recently (2003), an outbreak in a Liberian refugee camp was reported in Ivory Coast [<xref rid="B44-microorganisms-07-00133" ref-type="bibr">44</xref>].</p></sec><sec id="sec2dot3-microorganisms-07-00133"><title>2.3. Mayaro Virus</title><p>MAYV was first described in Trinidad where it caused mild to moderate short febrile illness in five humans in 1954 [<xref rid="B45-microorganisms-07-00133" ref-type="bibr">45</xref>]. In 1959, it caused an epidemic among colonists in the Bolivian rain forest under the name of Uruma virus, which has since been proven to be MAYV [<xref rid="B46-microorganisms-07-00133" ref-type="bibr">46</xref>]. Since then, it has been responsible for several small outbreaks or sporadic cases in rural areas around tropical forests in South and Central America (Brazil [<xref rid="B47-microorganisms-07-00133" ref-type="bibr">47</xref>,<xref rid="B48-microorganisms-07-00133" ref-type="bibr">48</xref>,<xref rid="B49-microorganisms-07-00133" ref-type="bibr">49</xref>,<xref rid="B50-microorganisms-07-00133" ref-type="bibr">50</xref>,<xref rid="B51-microorganisms-07-00133" ref-type="bibr">51</xref>], Bolivia [<xref rid="B52-microorganisms-07-00133" ref-type="bibr">52</xref>], Ecuador [<xref rid="B53-microorganisms-07-00133" ref-type="bibr">53</xref>], Venezuela [<xref rid="B54-microorganisms-07-00133" ref-type="bibr">54</xref>,<xref rid="B55-microorganisms-07-00133" ref-type="bibr">55</xref>], Peru [<xref rid="B56-microorganisms-07-00133" ref-type="bibr">56</xref>,<xref rid="B57-microorganisms-07-00133" ref-type="bibr">57</xref>], French Guyana [<xref rid="B58-microorganisms-07-00133" ref-type="bibr">58</xref>], Suriname [<xref rid="B59-microorganisms-07-00133" ref-type="bibr">59</xref>], Mexico [<xref rid="B60-microorganisms-07-00133" ref-type="bibr">60</xref>], Haiti [<xref rid="B61-microorganisms-07-00133" ref-type="bibr">61</xref>]).</p></sec><sec id="sec2dot4-microorganisms-07-00133"><title>2.4. Ross River Virus</title><p>Epidemic polyarthritis has been described since 1886 in rural Australia [<xref rid="B62-microorganisms-07-00133" ref-type="bibr">62</xref>,<xref rid="B63-microorganisms-07-00133" ref-type="bibr">63</xref>]. The virus responsible for this was first isolated in 1959 from infected mosquitoes along the Ross River in Queensland, Australia [<xref rid="B64-microorganisms-07-00133" ref-type="bibr">64</xref>]. Because patients suffering from epidemic polyarthritis had antibodies against RRV, it was thought to be the agent responsible for the disease [<xref rid="B65-microorganisms-07-00133" ref-type="bibr">65</xref>,<xref rid="B66-microorganisms-07-00133" ref-type="bibr">66</xref>]. In 1971, it was first isolated from an aboriginal boy in Australia [<xref rid="B67-microorganisms-07-00133" ref-type="bibr">67</xref>], confirming this hypothesis. Since then, frequent RRV outbreaks have been reported in Australia [<xref rid="B68-microorganisms-07-00133" ref-type="bibr">68</xref>,<xref rid="B69-microorganisms-07-00133" ref-type="bibr">69</xref>,<xref rid="B70-microorganisms-07-00133" ref-type="bibr">70</xref>] with close to 5000 cases/year [<xref rid="B71-microorganisms-07-00133" ref-type="bibr">71</xref>]. RRV also circulates in the Pacific island countries and territories [<xref rid="B72-microorganisms-07-00133" ref-type="bibr">72</xref>] since it was introduced in 1979&#x02013;1980, causing an epidemic with over 500,000 cases and spectacular attack rates in Fiji (90%), the Cook Islands (69%), American Samoa (44%), and New Caledonia (33%) [<xref rid="B73-microorganisms-07-00133" ref-type="bibr">73</xref>,<xref rid="B74-microorganisms-07-00133" ref-type="bibr">74</xref>,<xref rid="B75-microorganisms-07-00133" ref-type="bibr">75</xref>].</p></sec></sec><sec id="sec3-microorganisms-07-00133"><title>3. Sylvatic Versus Urban Cycle</title><sec id="sec3dot1-microorganisms-07-00133"><title>3.1. Chikungunya Virus</title><p>Between outbreaks, CHIKV circulates in a sylvatic cycle where non-human primates are the main host [<xref rid="B76-microorganisms-07-00133" ref-type="bibr">76</xref>,<xref rid="B77-microorganisms-07-00133" ref-type="bibr">77</xref>,<xref rid="B78-microorganisms-07-00133" ref-type="bibr">78</xref>,<xref rid="B79-microorganisms-07-00133" ref-type="bibr">79</xref>,<xref rid="B80-microorganisms-07-00133" ref-type="bibr">80</xref>], and sylvatic <italic>Aedes</italic> mosquitoes (such as <italic>Aedes africanus</italic> [<xref rid="B78-microorganisms-07-00133" ref-type="bibr">78</xref>], <italic>Aedes furcifer-taylori</italic>, <italic>Ae. luteocephalus</italic>, <italic>Ae. Dalzieli</italic> [<xref rid="B18-microorganisms-07-00133" ref-type="bibr">18</xref>], etc.) are the main vector. Even though these mosquitoes are not particularly anthropophilic, sporadic human cases can originate from that cycle if a human is bitten by an infected mosquito in a rural area. While the western African lineage has never switched to an urban cycle, both the Asian and the ECSA lineages are able to circulate in urban cycles between humans (that become the amplifying host) [<xref rid="B81-microorganisms-07-00133" ref-type="bibr">81</xref>] and anthropophilic urban mosquitoes (<italic>Aedes aegypti</italic> and <italic>Aedes albopictus</italic>) [<xref rid="B7-microorganisms-07-00133" ref-type="bibr">7</xref>,<xref rid="B38-microorganisms-07-00133" ref-type="bibr">38</xref>,<xref rid="B82-microorganisms-07-00133" ref-type="bibr">82</xref>]. Interestingly, while <italic>Aedes aegypti</italic> is usually the main vector of CHIKV in African urban cycles, <italic>Aedes albopictus</italic> (widely present on La Reunion Island in the Indian Ocean) was the vector responsible for the transmission during the epidemic that bore its name. Indeed, a single mutation, A226V in the E1 glycoprotein, favored the infection and dissemination of the virus in the new <italic>Aedes albopictus</italic> vector [<xref rid="B83-microorganisms-07-00133" ref-type="bibr">83</xref>,<xref rid="B84-microorganisms-07-00133" ref-type="bibr">84</xref>,<xref rid="B85-microorganisms-07-00133" ref-type="bibr">85</xref>]. Interestingly, this same A226V mutation appeared independently in India, Sri Lanka, Cameroon, and Gabon in settings where <italic>Aedes albopictus</italic> was suspected to be the vector of the disease. This convergent evolution illustrates the ease with which the virus evolves to improve its transmissibility [<xref rid="B4-microorganisms-07-00133" ref-type="bibr">4</xref>].</p></sec><sec id="sec3dot2-microorganisms-07-00133"><title>3.2. O&#x02019;nyong&#x02019;nyong Virus</title><p>Mainly circulating in an enzootic cycle, the vertebrate host of ONNV is not clearly defined. Nevertheless, forest buffalos, mandrills, and duikers were positive for ONNV in a serosurvey in the Congo basin [<xref rid="B86-microorganisms-07-00133" ref-type="bibr">86</xref>]. <italic>Anopheles funestus</italic> and more rarely <italic>Anopheles gambiae</italic> are the main vectors [<xref rid="B38-microorganisms-07-00133" ref-type="bibr">38</xref>,<xref rid="B87-microorganisms-07-00133" ref-type="bibr">87</xref>,<xref rid="B88-microorganisms-07-00133" ref-type="bibr">88</xref>,<xref rid="B89-microorganisms-07-00133" ref-type="bibr">89</xref>]. Experimentally, ONNV can infect <italic>Aedes aegypti</italic> and disseminate to their salivary glands [<xref rid="B90-microorganisms-07-00133" ref-type="bibr">90</xref>], but <italic>Aedes</italic> mosquitoes have not yet been demonstrated to be carriers in the wild. More likely, as for CHIKV, it switches to an urban cycle where humans are the amplifying host during bigger outbreaks.</p></sec><sec id="sec3dot3-microorganisms-07-00133"><title>3.3. Mayaro Virus</title><p>MAYV is circulating in an enzootic cycle between non-human primates [<xref rid="B58-microorganisms-07-00133" ref-type="bibr">58</xref>,<xref rid="B91-microorganisms-07-00133" ref-type="bibr">91</xref>,<xref rid="B92-microorganisms-07-00133" ref-type="bibr">92</xref>,<xref rid="B93-microorganisms-07-00133" ref-type="bibr">93</xref>,<xref rid="B94-microorganisms-07-00133" ref-type="bibr">94</xref>] (or more rarely, small mammals [<xref rid="B92-microorganisms-07-00133" ref-type="bibr">92</xref>] or birds [<xref rid="B95-microorganisms-07-00133" ref-type="bibr">95</xref>]) and forest mosquitoes including <italic>Haemagogus</italic> sp. [<xref rid="B49-microorganisms-07-00133" ref-type="bibr">49</xref>,<xref rid="B91-microorganisms-07-00133" ref-type="bibr">91</xref>], <italic>Mansonia</italic> sp. [<xref rid="B96-microorganisms-07-00133" ref-type="bibr">96</xref>], and <italic>Psophora</italic> sp. [<xref rid="B5-microorganisms-07-00133" ref-type="bibr">5</xref>,<xref rid="B6-microorganisms-07-00133" ref-type="bibr">6</xref>]. Nonetheless, two studies found pools of <italic>Aedes aegypti</italic> positive for MAYV [<xref rid="B6-microorganisms-07-00133" ref-type="bibr">6</xref>,<xref rid="B97-microorganisms-07-00133" ref-type="bibr">97</xref>], and experimental work confirms that they might be efficient vectors for the disease, as well as <italic>Aedes albopictus</italic> [<xref rid="B98-microorganisms-07-00133" ref-type="bibr">98</xref>,<xref rid="B99-microorganisms-07-00133" ref-type="bibr">99</xref>,<xref rid="B100-microorganisms-07-00133" ref-type="bibr">100</xref>,<xref rid="B101-microorganisms-07-00133" ref-type="bibr">101</xref>,<xref rid="B102-microorganisms-07-00133" ref-type="bibr">102</xref>]. This raises the possibility of MAYV circulating in an urban setting. Furthermore, in an experimental setting, four <italic>Anopheles</italic> species (two North American species, one African, and one Southeast Asian) were able to get infected and to transmit MAYV, adding other potent MAYV vectors distributed worldwide to the list [<xref rid="B101-microorganisms-07-00133" ref-type="bibr">101</xref>].</p></sec><sec id="sec3dot4-microorganisms-07-00133"><title>3.4. Ross River Virus</title><p>While twenty-one vertebrate hosts have been described for RRV [<xref rid="B103-microorganisms-07-00133" ref-type="bibr">103</xref>], marsupials are considered to be the most important reservoir [<xref rid="B104-microorganisms-07-00133" ref-type="bibr">104</xref>,<xref rid="B105-microorganisms-07-00133" ref-type="bibr">105</xref>,<xref rid="B106-microorganisms-07-00133" ref-type="bibr">106</xref>], even though proof is scarce [<xref rid="B107-microorganisms-07-00133" ref-type="bibr">107</xref>], and some locations such as the islands of Samoa have circulation of RRV without the presence of marsupials [<xref rid="B108-microorganisms-07-00133" ref-type="bibr">108</xref>]. Horses or cattle also play a role [<xref rid="B105-microorganisms-07-00133" ref-type="bibr">105</xref>,<xref rid="B109-microorganisms-07-00133" ref-type="bibr">109</xref>], and humans are the main host during outbreaks [<xref rid="B106-microorganisms-07-00133" ref-type="bibr">106</xref>]. Different species of mosquitoes seem to play a role in the RRV cycle. <italic>Aedes vigilax</italic> are the most common ones in coastal and subcoastal areas and <italic>Culex annulirostris</italic> in both rural and urban settings, but <italic>Aedes notoscriptus</italic>, <italic>Aedes funereus</italic>, <italic>Aedes camptorhynchus</italic>, and <italic>Ochlerotatus camptorhynchus</italic> are also incriminated [<xref rid="B69-microorganisms-07-00133" ref-type="bibr">69</xref>,<xref rid="B70-microorganisms-07-00133" ref-type="bibr">70</xref>,<xref rid="B110-microorganisms-07-00133" ref-type="bibr">110</xref>]. Experimentally, <italic>Aedes aegypti</italic> and <italic>albopictus</italic> are efficient vectors [<xref rid="B111-microorganisms-07-00133" ref-type="bibr">111</xref>,<xref rid="B112-microorganisms-07-00133" ref-type="bibr">112</xref>,<xref rid="B113-microorganisms-07-00133" ref-type="bibr">113</xref>,<xref rid="B114-microorganisms-07-00133" ref-type="bibr">114</xref>], but it has never been reported to happen in the wild.</p></sec></sec><sec id="sec4-microorganisms-07-00133"><title>4. Clinical Description</title><p>Contrary to what has been reported for most flaviviruses (for which asymptomatic cases can reach up to 94% [<xref rid="B115-microorganisms-07-00133" ref-type="bibr">115</xref>,<xref rid="B116-microorganisms-07-00133" ref-type="bibr">116</xref>]), most alphavirus infections are symptomatic with rates ranging from 72&#x02013;97% for CHIKV [<xref rid="B30-microorganisms-07-00133" ref-type="bibr">30</xref>,<xref rid="B117-microorganisms-07-00133" ref-type="bibr">117</xref>,<xref rid="B118-microorganisms-07-00133" ref-type="bibr">118</xref>,<xref rid="B119-microorganisms-07-00133" ref-type="bibr">119</xref>,<xref rid="B120-microorganisms-07-00133" ref-type="bibr">120</xref>] (only one study reporting an unusually low symptomatic infection rate of 18% [<xref rid="B121-microorganisms-07-00133" ref-type="bibr">121</xref>]), 64&#x02013;86% for ONN [<xref rid="B42-microorganisms-07-00133" ref-type="bibr">42</xref>,<xref rid="B122-microorganisms-07-00133" ref-type="bibr">122</xref>,<xref rid="B123-microorganisms-07-00133" ref-type="bibr">123</xref>,<xref rid="B124-microorganisms-07-00133" ref-type="bibr">124</xref>], 64&#x02013;80% for MAYV [<xref rid="B48-microorganisms-07-00133" ref-type="bibr">48</xref>,<xref rid="B56-microorganisms-07-00133" ref-type="bibr">56</xref>], and 25&#x02013;76% for RRV [<xref rid="B73-microorganisms-07-00133" ref-type="bibr">73</xref>,<xref rid="B125-microorganisms-07-00133" ref-type="bibr">125</xref>,<xref rid="B126-microorganisms-07-00133" ref-type="bibr">126</xref>,<xref rid="B127-microorganisms-07-00133" ref-type="bibr">127</xref>]. Rheumatic disease is the main clinical manifestation compared to other arboviral infections that are responsible for a flu-like syndrome. They all follow roughly the same timeline (<xref ref-type="fig" rid="microorganisms-07-00133-f001">Figure 1</xref>) and share the same major symptoms (<xref rid="microorganisms-07-00133-t002" ref-type="table">Table 2</xref>). The severity of these infections, however, is difficult to compare between viruses because of considerable variability in absolute numbers and methods of clinical study (<xref ref-type="fig" rid="microorganisms-07-00133-f002">Figure 2</xref>). </p><sec id="sec4dot1-microorganisms-07-00133"><title>4.1. Acute Phase</title><p>Following a 2.5-day incubation period (range of 2&#x02013;12 days) [<xref rid="B7-microorganisms-07-00133" ref-type="bibr">7</xref>,<xref rid="B162-microorganisms-07-00133" ref-type="bibr">162</xref>], the acute phase of CHIKV infection is characterized by a brutal onset of symptoms typically associated with fever, very severe polyarthralgia (&#x0201c;frightening in its severity&#x0201d; as first described by Robinson [<xref rid="B7-microorganisms-07-00133" ref-type="bibr">7</xref>]) with possible synovitis, and a delayed rash that is often pruriginous while rarely bullous [<xref rid="B128-microorganisms-07-00133" ref-type="bibr">128</xref>,<xref rid="B163-microorganisms-07-00133" ref-type="bibr">163</xref>,<xref rid="B164-microorganisms-07-00133" ref-type="bibr">164</xref>]. Less well-known, but commonly associated manifestations include headaches, gastrointestinal symptoms, and more rarely conjunctival hyperemia or lymphadenopathy. While in the earliest descriptions of the disease the hemorrhagic, severe or lethal cases were questioned because of co-circulation with dengue fever [<xref rid="B19-microorganisms-07-00133" ref-type="bibr">19</xref>,<xref rid="B129-microorganisms-07-00133" ref-type="bibr">129</xref>,<xref rid="B165-microorganisms-07-00133" ref-type="bibr">165</xref>,<xref rid="B166-microorganisms-07-00133" ref-type="bibr">166</xref>], it is now clearly established that CHIKV infection can carry potentially lethal neurologic and cardiologic involvement [<xref rid="B150-microorganisms-07-00133" ref-type="bibr">150</xref>,<xref rid="B152-microorganisms-07-00133" ref-type="bibr">152</xref>,<xref rid="B153-microorganisms-07-00133" ref-type="bibr">153</xref>] or be directly or indirectly linked to death, particularly in older patients with numerous comorbidities [<xref rid="B128-microorganisms-07-00133" ref-type="bibr">128</xref>,<xref rid="B150-microorganisms-07-00133" ref-type="bibr">150</xref>,<xref rid="B156-microorganisms-07-00133" ref-type="bibr">156</xref>,<xref rid="B167-microorganisms-07-00133" ref-type="bibr">167</xref>] or in neonates [<xref rid="B156-microorganisms-07-00133" ref-type="bibr">156</xref>,<xref rid="B157-microorganisms-07-00133" ref-type="bibr">157</xref>]. Overall, the global mortality rate is estimated at 0.01&#x02013;0.1% [<xref rid="B32-microorganisms-07-00133" ref-type="bibr">32</xref>,<xref rid="B81-microorganisms-07-00133" ref-type="bibr">81</xref>,<xref rid="B119-microorganisms-07-00133" ref-type="bibr">119</xref>,<xref rid="B156-microorganisms-07-00133" ref-type="bibr">156</xref>].</p><p>The ONNV fever acute phase follows an eight-day or more incubation period [<xref rid="B122-microorganisms-07-00133" ref-type="bibr">122</xref>]. It is characterized by the triad of fever, polyarthralgia, and lymphadenopathy. This last sign is more specific to ONNV infection and is mostly located in the cervical region. Skin rash is associated a few days later and is often itchy. Other reported complications include headaches, gastrointestinal symptoms, and eye involvement [<xref rid="B44-microorganisms-07-00133" ref-type="bibr">44</xref>,<xref rid="B122-microorganisms-07-00133" ref-type="bibr">122</xref>,<xref rid="B141-microorganisms-07-00133" ref-type="bibr">141</xref>]. Bleeding gums and epistaxis have been reported for one patient each [<xref rid="B141-microorganisms-07-00133" ref-type="bibr">141</xref>]. To our knowledge, no mortality linked to ONNV infection has been described.</p><p>After less than a week of incubation [<xref rid="B47-microorganisms-07-00133" ref-type="bibr">47</xref>], MAYV infection causes brutal fever associated with arthromyalgia (sometimes with swollen joints). Headaches, retro-orbital pain, and gastrointestinal symptoms are frequent [<xref rid="B47-microorganisms-07-00133" ref-type="bibr">47</xref>,<xref rid="B49-microorganisms-07-00133" ref-type="bibr">49</xref>,<xref rid="B50-microorganisms-07-00133" ref-type="bibr">50</xref>,<xref rid="B51-microorganisms-07-00133" ref-type="bibr">51</xref>,<xref rid="B56-microorganisms-07-00133" ref-type="bibr">56</xref>,<xref rid="B142-microorganisms-07-00133" ref-type="bibr">142</xref>,<xref rid="B143-microorganisms-07-00133" ref-type="bibr">143</xref>,<xref rid="B144-microorganisms-07-00133" ref-type="bibr">144</xref>,<xref rid="B145-microorganisms-07-00133" ref-type="bibr">145</xref>]. This acute phase usually lasts two to five days [<xref rid="B49-microorganisms-07-00133" ref-type="bibr">49</xref>]. Three independent studies reported benign hemorrhagic signs in a total of seven patients (bleeding gums, epistaxis, petechiae) [<xref rid="B56-microorganisms-07-00133" ref-type="bibr">56</xref>,<xref rid="B60-microorganisms-07-00133" ref-type="bibr">60</xref>,<xref rid="B142-microorganisms-07-00133" ref-type="bibr">142</xref>]. Only one patient with heavy comorbidities was reported to have died following MAYV infection, without certainty about the cause of death [<xref rid="B60-microorganisms-07-00133" ref-type="bibr">60</xref>].</p><p>From traveler data, the incubation time of RRV infection is estimated to be 7&#x02013;9 days [<xref rid="B168-microorganisms-07-00133" ref-type="bibr">168</xref>] (ranging between three and 21 days [<xref rid="B75-microorganisms-07-00133" ref-type="bibr">75</xref>,<xref rid="B169-microorganisms-07-00133" ref-type="bibr">169</xref>]). Fever polyarthralgia and rash are, as is the case for the other rheumatic alphaviruses, typical, occurring during the acute phase [<xref rid="B125-microorganisms-07-00133" ref-type="bibr">125</xref>,<xref rid="B146-microorganisms-07-00133" ref-type="bibr">146</xref>,<xref rid="B147-microorganisms-07-00133" ref-type="bibr">147</xref>,<xref rid="B148-microorganisms-07-00133" ref-type="bibr">148</xref>,<xref rid="B149-microorganisms-07-00133" ref-type="bibr">149</xref>]. If only nausea is reported in the main cohorts or retrospective studies, gastrointestinal symptoms are often mentioned in case reports [<xref rid="B72-microorganisms-07-00133" ref-type="bibr">72</xref>,<xref rid="B170-microorganisms-07-00133" ref-type="bibr">170</xref>]. Severe forms of infection include glomerulonephritis [<xref rid="B158-microorganisms-07-00133" ref-type="bibr">158</xref>] and encephalitis [<xref rid="B159-microorganisms-07-00133" ref-type="bibr">159</xref>,<xref rid="B160-microorganisms-07-00133" ref-type="bibr">160</xref>,<xref rid="B161-microorganisms-07-00133" ref-type="bibr">161</xref>], but to our knowledge, no lethality has been reported.</p></sec><sec id="sec4dot2-microorganisms-07-00133"><title>4.2. Chronic Phase</title><p>With over 40 clinical studies to date, the chronic joint pain (i.e., persisting after 12 weeks of onset of symptoms) is very well described and represents the major burden of CHIKV infection because it can be responsible for very heavy and long term incapacity [<xref rid="B130-microorganisms-07-00133" ref-type="bibr">130</xref>]. A recent meta-analysis estimated that 43% of patients after three months and 21% after one year still experience symptoms linked to CHIKV. This rate seems to depend on which CHIKV strain is involved [<xref rid="B171-microorganisms-07-00133" ref-type="bibr">171</xref>]. In a recent prospective cohort of La Reunion Island patients [<xref rid="B172-microorganisms-07-00133" ref-type="bibr">172</xref>], chronic joint pain concerned up to 83% of patients at 32 months and was accompanied by asthenia and depression [<xref rid="B173-microorganisms-07-00133" ref-type="bibr">173</xref>]. As the virus has never been isolated from chronic swollen joints, it is thought that CHIKV acute infection might trigger host autoimmunity [<xref rid="B172-microorganisms-07-00133" ref-type="bibr">172</xref>,<xref rid="B174-microorganisms-07-00133" ref-type="bibr">174</xref>,<xref rid="B175-microorganisms-07-00133" ref-type="bibr">175</xref>]. However, it is important to differentiate chronic inflammatory rheumatism causing erosive arthritis [<xref rid="B131-microorganisms-07-00133" ref-type="bibr">131</xref>] and for which the differential diagnosis is rheumatoid arthritis, from musculoskeletal disorder. Indeed, whereas the latter is only treated with pain killers possibly associated with steroids, the former requires a heavier treatment including methotrexate [<xref rid="B176-microorganisms-07-00133" ref-type="bibr">176</xref>].</p><p>At the opposite end of the spectrum, accounts of ONNV chronic manifestations are scarce. While Shore et al. mentioned joint pain associated with residual weakness and depression in some patients in 1965 [<xref rid="B122-microorganisms-07-00133" ref-type="bibr">122</xref>], other studies either report &#x0201c;no recurrent fever case&#x0201d; [<xref rid="B141-microorganisms-07-00133" ref-type="bibr">141</xref>] or do not mention chronicity [<xref rid="B44-microorganisms-07-00133" ref-type="bibr">44</xref>].</p><p>For MAYV, recurrent arthralgia has been reported in one patient [<xref rid="B177-microorganisms-07-00133" ref-type="bibr">177</xref>], and some case reports have mentioned arthralgia lasting over 5&#x02013;12 months after MAYV infection [<xref rid="B178-microorganisms-07-00133" ref-type="bibr">178</xref>,<xref rid="B179-microorganisms-07-00133" ref-type="bibr">179</xref>,<xref rid="B180-microorganisms-07-00133" ref-type="bibr">180</xref>,<xref rid="B181-microorganisms-07-00133" ref-type="bibr">181</xref>]. In 2013, one Peruvian prospective study of 13 patients confirmed these data and evaluated chronic arthralgia and headache to be present in 57% and 31% of patients 12 months after infection [<xref rid="B143-microorganisms-07-00133" ref-type="bibr">143</xref>].</p><p>As for CHIKV, there is great heterogeneity between studies concerning chronic joint pain after RRV infection. Two studies reported them in 52.5% of patients at one year and 57% of patients at three years [<xref rid="B146-microorganisms-07-00133" ref-type="bibr">146</xref>,<xref rid="B147-microorganisms-07-00133" ref-type="bibr">147</xref>]. Two other studies reported progressive resolution of symptoms in 3&#x02013;6 months [<xref rid="B149-microorganisms-07-00133" ref-type="bibr">149</xref>] or a prevalence of chronic arthralgia in only 2% of patients with no other conditions than RRV infection [<xref rid="B148-microorganisms-07-00133" ref-type="bibr">148</xref>]. This last study, apart from insisting on the difficulty of differentiating post-infectious chronic arthralgia from differential diagnosis, also implied a higher prevalence of chronic joint pain in the elderly, that also present with more comorbidities (even though this was not discussed in the paper). Although there is no human data available, in vitro and in vivo data suggest that post-RRV infection arthritis may be erosive [<xref rid="B182-microorganisms-07-00133" ref-type="bibr">182</xref>,<xref rid="B183-microorganisms-07-00133" ref-type="bibr">183</xref>].</p></sec></sec><sec id="sec5-microorganisms-07-00133"><title>5. Laboratory Features</title><sec id="sec5dot1-microorganisms-07-00133"><title>5.1. Standard Blood Test</title><p>For CHIKV, standard biological tests usually show lymphopenia, more rarely associated with a moderate thrombocytopenia. Hypocalcemia is detected in more than half of the cases, and a mild rhabdomyolysis with moderately elevated creatinine kinase and transaminases (ASAT &#x0003e; ALAT) might be observed [<xref rid="B128-microorganisms-07-00133" ref-type="bibr">128</xref>,<xref rid="B132-microorganisms-07-00133" ref-type="bibr">132</xref>,<xref rid="B133-microorganisms-07-00133" ref-type="bibr">133</xref>,<xref rid="B134-microorganisms-07-00133" ref-type="bibr">134</xref>]. Very few data are available for the other three viruses, but leucopenia and thrombopenia have also been described for MAYV.</p></sec><sec id="sec5dot2-microorganisms-07-00133"><title>5.2. Positive Diagnosis</title><p>Viremia usually rises a few days before onset of symptoms. RT-PCR or virus isolation permit direct diagnosis; however, most of the time, RT-PCR can no longer detect virus seven days after onset of symptoms for CHIKV [<xref rid="B32-microorganisms-07-00133" ref-type="bibr">32</xref>,<xref rid="B184-microorganisms-07-00133" ref-type="bibr">184</xref>] (even though one patient had a positive RT-PCR 17 days after [<xref rid="B185-microorganisms-07-00133" ref-type="bibr">185</xref>]) and for MAYV [<xref rid="B186-microorganisms-07-00133" ref-type="bibr">186</xref>], and virus isolation is positive for an even shorter time [<xref rid="B187-microorganisms-07-00133" ref-type="bibr">187</xref>]. This diagnostic tool is particularly useful because test specificity is very good between, and within, viral families, as specific assays exist for each virus [<xref rid="B186-microorganisms-07-00133" ref-type="bibr">186</xref>,<xref rid="B188-microorganisms-07-00133" ref-type="bibr">188</xref>,<xref rid="B189-microorganisms-07-00133" ref-type="bibr">189</xref>,<xref rid="B190-microorganisms-07-00133" ref-type="bibr">190</xref>].</p><p>Indirect diagnosis is achieved by serological tests to detect IgM and IgG. The antibodies arise later than viremia, but are long lasting in comparison. Indeed, as it has been shown for CHIKV, IgM can arise as soon as two days after onset of symptoms and is usually positive after a week [<xref rid="B184-microorganisms-07-00133" ref-type="bibr">184</xref>,<xref rid="B191-microorganisms-07-00133" ref-type="bibr">191</xref>]. IgM levels usually wane after three months [<xref rid="B191-microorganisms-07-00133" ref-type="bibr">191</xref>], but in some cases can persist more than six months [<xref rid="B128-microorganisms-07-00133" ref-type="bibr">128</xref>,<xref rid="B192-microorganisms-07-00133" ref-type="bibr">192</xref>]. IgG usually appears after 7&#x02013;14 days of the onset of illness and is long lasting [<xref rid="B184-microorganisms-07-00133" ref-type="bibr">184</xref>,<xref rid="B191-microorganisms-07-00133" ref-type="bibr">191</xref>]. Whatever the commercial or in-house serological test used (most often by enzymatic immune assay or hemagglutination inhibition), two samples per patient, taken at least 10 days apart, are needed to show the appearance of IgM and/or IgG or disappearance of IgM.</p><p>The main pitfall of serological methods is the cross-reactivity among alphaviruses that complicates identifying which of the arthritogenic alphaviruses is involved, especially in regions where they co-circulate. For this reason, the plaque-reduction neutralizing test (PRNT) remains a gold standard for diagnostics [<xref rid="B193-microorganisms-07-00133" ref-type="bibr">193</xref>,<xref rid="B194-microorganisms-07-00133" ref-type="bibr">194</xref>].</p></sec></sec><sec id="sec6-microorganisms-07-00133"><title>6. Treatment</title><sec id="sec6dot1-microorganisms-07-00133"><title>6.1. Prevention</title><p>Because an efficient curative treatment does not exist, prevention measures are crucial to avoiding or limiting epidemics caused by these arboviruses. These include general measures to avoid mosquito bites and vaccination.</p><sec id="sec6dot1dot1-microorganisms-07-00133"><title>6.1.1. Public Health Measures: Surveillance and Vector Control</title><p>Public health response measures are essential to prevent and control any alphavirus outbreak. During disease-free periods, ongoing mosquito surveillance (e.g., population densities, distribution) has shown its effectiveness for predicting RRV epidemics in Australia [<xref rid="B195-microorganisms-07-00133" ref-type="bibr">195</xref>]. Early detection of outbreaks is also favored by notification of cases, something that is mandatory for RRV in Australia and CHIKV in many other countries, leading to the early detection and increased surveillance of outbreaks [<xref rid="B71-microorganisms-07-00133" ref-type="bibr">71</xref>,<xref rid="B196-microorganisms-07-00133" ref-type="bibr">196</xref>,<xref rid="B197-microorganisms-07-00133" ref-type="bibr">197</xref>,<xref rid="B198-microorganisms-07-00133" ref-type="bibr">198</xref>,<xref rid="B199-microorganisms-07-00133" ref-type="bibr">199</xref>]. As soon as detection occurs, intervention in mosquito habitats, using a combination of larvicides, adulticides, and removal of breeding sites, may be the best strategy [<xref rid="B198-microorganisms-07-00133" ref-type="bibr">198</xref>,<xref rid="B200-microorganisms-07-00133" ref-type="bibr">200</xref>,<xref rid="B201-microorganisms-07-00133" ref-type="bibr">201</xref>,<xref rid="B202-microorganisms-07-00133" ref-type="bibr">202</xref>]. Geovisualization tools might also help locate the source of infection to better target it [<xref rid="B203-microorganisms-07-00133" ref-type="bibr">203</xref>]. Public outreach to educate individuals on how to avoid mosquito bites (e.g., protective clothing, mosquito repellents, and impregnated bed nets) is also common, but its effectiveness is still not clearly demonstrated [<xref rid="B200-microorganisms-07-00133" ref-type="bibr">200</xref>].</p></sec><sec id="sec6dot1dot2-microorganisms-07-00133"><title>6.1.2. Vaccination</title><p>Because CHIKV infection produces a life-lasting protection against a second infection and due to the limited antigenic variability of the virus, one might think that a CHIKV vaccine should be relatively easy to produce, or at least easier so than a dengue virus vaccine [<xref rid="B204-microorganisms-07-00133" ref-type="bibr">204</xref>]. Nevertheless, there are still no licensed CHIKV vaccines available, although many candidates have been tested including live-attenuated vaccines [<xref rid="B205-microorganisms-07-00133" ref-type="bibr">205</xref>,<xref rid="B206-microorganisms-07-00133" ref-type="bibr">206</xref>], recombinant virus vaccines (measles virus [<xref rid="B207-microorganisms-07-00133" ref-type="bibr">207</xref>,<xref rid="B208-microorganisms-07-00133" ref-type="bibr">208</xref>,<xref rid="B209-microorganisms-07-00133" ref-type="bibr">209</xref>], vesicular stomatitis virus [<xref rid="B210-microorganisms-07-00133" ref-type="bibr">210</xref>,<xref rid="B211-microorganisms-07-00133" ref-type="bibr">211</xref>]), inactivated vaccines [<xref rid="B212-microorganisms-07-00133" ref-type="bibr">212</xref>,<xref rid="B213-microorganisms-07-00133" ref-type="bibr">213</xref>], virus-like particles (VLPs) [<xref rid="B214-microorganisms-07-00133" ref-type="bibr">214</xref>,<xref rid="B215-microorganisms-07-00133" ref-type="bibr">215</xref>,<xref rid="B216-microorganisms-07-00133" ref-type="bibr">216</xref>], DNA- [<xref rid="B217-microorganisms-07-00133" ref-type="bibr">217</xref>,<xref rid="B218-microorganisms-07-00133" ref-type="bibr">218</xref>] or mRNA-based vaccines [<xref rid="B219-microorganisms-07-00133" ref-type="bibr">219</xref>], and subunit formulations of CHIKV [<xref rid="B220-microorganisms-07-00133" ref-type="bibr">220</xref>].</p><p>Two candidates are currently in Phase II clinical trials. The first one is a recombinant measles virus encoding the CHIKV structural proteins. The first results of the Phase II trial are very encouraging with all vaccines fully immunized after two injections (regardless of the individual&#x02019;s immunological status against measles virus) and excellent safety and tolerability [<xref rid="B209-microorganisms-07-00133" ref-type="bibr">209</xref>]. The second candidate is a VLP vaccine containing CHIKV structural proteins that is immunogenic and protective against a challenge infection in mice and rhesus macaques [<xref rid="B214-microorganisms-07-00133" ref-type="bibr">214</xref>]. A Phase I clinical trial confirmed immunogenicity in humans after two injections and the absence of serious adverse events [<xref rid="B221-microorganisms-07-00133" ref-type="bibr">221</xref>,<xref rid="B222-microorganisms-07-00133" ref-type="bibr">222</xref>]; a Phase II trial is currently underway.</p><p>While it still needs to be unequivocally demonstrated, a number of studies suggest that protection against one strain of CHIKV protects against all others [<xref rid="B223-microorganisms-07-00133" ref-type="bibr">223</xref>,<xref rid="B224-microorganisms-07-00133" ref-type="bibr">224</xref>,<xref rid="B225-microorganisms-07-00133" ref-type="bibr">225</xref>,<xref rid="B226-microorganisms-07-00133" ref-type="bibr">226</xref>]. Interestingly, Partidos et al. showed that passive monoclonal antibodies after immunization of mice with a CHIKV vaccine protect against ONNV infection (the closest related alphavirus) in AG129 mice [<xref rid="B227-microorganisms-07-00133" ref-type="bibr">227</xref>]. Because there are no vaccine candidates for ONN, a broad-spectrum CHIKV vaccine is of particular interest; that should also be evaluated for MAYV and RRV.</p><p>Three vaccine candidates have been tested for MAYV. The first one was a formalin-inactivated vaccine with moderate efficiency in mice [<xref rid="B228-microorganisms-07-00133" ref-type="bibr">228</xref>]. More recently, a live attenuated vaccine and a DNA vaccine showed good immunogenicity and protection after a lethal challenge in mice [<xref rid="B229-microorganisms-07-00133" ref-type="bibr">229</xref>,<xref rid="B230-microorganisms-07-00133" ref-type="bibr">230</xref>].</p><p>Since RRV has been a public health issue for some time now in Australia, vaccine research there has led to several candidates in preclinical studies [<xref rid="B231-microorganisms-07-00133" ref-type="bibr">231</xref>,<xref rid="B232-microorganisms-07-00133" ref-type="bibr">232</xref>,<xref rid="B233-microorganisms-07-00133" ref-type="bibr">233</xref>,<xref rid="B234-microorganisms-07-00133" ref-type="bibr">234</xref>], and formalin-inactivated vaccines have successfully passed Phase I, II, and III clinical trials [<xref rid="B235-microorganisms-07-00133" ref-type="bibr">235</xref>,<xref rid="B236-microorganisms-07-00133" ref-type="bibr">236</xref>]. However, this vaccine is not commercialized, and no RRV vaccine is currently available, highlighting the importance of public/private partnerships to invest in vaccine licensure [<xref rid="B237-microorganisms-07-00133" ref-type="bibr">237</xref>].</p></sec></sec><sec id="sec6dot2-microorganisms-07-00133"><title>6.2. Symptomatic and Curative Treatments</title><p>Symptomatic treatment with antalgics, such as paracetamol, and steroidal or non-steroidal anti-inflammatory drugs remains the main driver of action available [<xref rid="B148-microorganisms-07-00133" ref-type="bibr">148</xref>,<xref rid="B238-microorganisms-07-00133" ref-type="bibr">238</xref>,<xref rid="B239-microorganisms-07-00133" ref-type="bibr">239</xref>]. As discussed above, in case of chronic inflammatory rheumatism, methotrexate treatment might be necessary [<xref rid="B176-microorganisms-07-00133" ref-type="bibr">176</xref>].</p><p>Several studies have searched for efficient antiviral molecules that have a broad-spectrum activity inhibiting all arthritogenic alphaviruses [<xref rid="B240-microorganisms-07-00133" ref-type="bibr">240</xref>,<xref rid="B241-microorganisms-07-00133" ref-type="bibr">241</xref>,<xref rid="B242-microorganisms-07-00133" ref-type="bibr">242</xref>,<xref rid="B243-microorganisms-07-00133" ref-type="bibr">243</xref>,<xref rid="B244-microorganisms-07-00133" ref-type="bibr">244</xref>,<xref rid="B245-microorganisms-07-00133" ref-type="bibr">245</xref>,<xref rid="B246-microorganisms-07-00133" ref-type="bibr">246</xref>]; however, despite a long list of antivirals efficient in vitro or in vivo, no treatment is currently available [<xref rid="B247-microorganisms-07-00133" ref-type="bibr">247</xref>]. Indeed, all clinical trials conducted until now have either failed, such as for chloroquine [<xref rid="B248-microorganisms-07-00133" ref-type="bibr">248</xref>,<xref rid="B249-microorganisms-07-00133" ref-type="bibr">249</xref>], or have been inconclusive because of small test groups, such as for ribavirin [<xref rid="B250-microorganisms-07-00133" ref-type="bibr">250</xref>]. Pentosan polysulfate has shown efficiency against cartilage damage in mice both with CHIKV and RRV, and a Phase II trial is now ongoing [<xref rid="B251-microorganisms-07-00133" ref-type="bibr">251</xref>].</p><p>Another approach is to use hyper-immune intravenous anti-CHIKV immunoglobulins to prevent CHIKV infection in neonates, who often develop very severe forms of the disease. Indeed, after a conclusive study in neonate mice [<xref rid="B252-microorganisms-07-00133" ref-type="bibr">252</xref>], a Phase II trial is currently in progress [<xref rid="B253-microorganisms-07-00133" ref-type="bibr">253</xref>].</p></sec></sec><sec sec-type="discussion" id="sec7-microorganisms-07-00133"><title>7. Discussion</title><p>With two worldwide epidemics causing close to 10 million cases all together during the 21<sup>st</sup> Century, chikungunya virus is undoubtedly a re-emerged disease threatening both tropical and temperate regions [<xref rid="B2-microorganisms-07-00133" ref-type="bibr">2</xref>,<xref rid="B3-microorganisms-07-00133" ref-type="bibr">3</xref>,<xref rid="B4-microorganisms-07-00133" ref-type="bibr">4</xref>]. While it was a neglected tropical disease until the early 2000s, it has since gathered considerable interest as the number of publications through the years illustrates (<xref ref-type="fig" rid="microorganisms-07-00133-f002">Figure 2</xref>). In contrast, ONN, MAYV, and RRV are still understudied, even though specialists consider them as a Sword of Damocles. Indeed, some reviews raise the question of a possible emergence in the near future [<xref rid="B186-microorganisms-07-00133" ref-type="bibr">186</xref>,<xref rid="B254-microorganisms-07-00133" ref-type="bibr">254</xref>,<xref rid="B255-microorganisms-07-00133" ref-type="bibr">255</xref>,<xref rid="B256-microorganisms-07-00133" ref-type="bibr">256</xref>,<xref rid="B257-microorganisms-07-00133" ref-type="bibr">257</xref>], especially for ONNV, which is known to have caused a large African outbreak with a hundred thousand cases in 1959&#x02013;1962 [<xref rid="B38-microorganisms-07-00133" ref-type="bibr">38</xref>].</p><p>One of the prerequisites to imagining a worldwide outbreak of any of these alphaviruses is a wide distribution of their mosquito vector. Indeed, no circulation of the disease would occur in a region free from competent mosquitoes. Interestingly, none of these four alphaviruses shares the same vector (<xref rid="microorganisms-07-00133-t001" ref-type="table">Table 1</xref>), and they are currently more geographically restrained than the CHIKV vector: <italic>Anopheles</italic> sp. for ONNV in Africa and the Middle East, <italic>Haemagogus</italic> sp., <italic>Mansonia</italic> sp., and <italic>Psophora</italic> sp. for MAYV in America. and <italic>Aedes vigilax</italic> and <italic>Culex annulirostris</italic> for RRV in Oceania and South-East Asia [<xref rid="B258-microorganisms-07-00133" ref-type="bibr">258</xref>]. However, globalization, travel, migration, trade, or climatic change might be leading forces of the redistribution of these mosquitoes. Indeed, climate and weather patterns are important factors in the occurrence of epidemics, which have become the focus of many modeling studies. For example, natural climatic and weather trends influenced RRV&#x02019;s pattern of infection, especially hydrological features [<xref rid="B125-microorganisms-07-00133" ref-type="bibr">125</xref>,<xref rid="B259-microorganisms-07-00133" ref-type="bibr">259</xref>] and temperatures [<xref rid="B260-microorganisms-07-00133" ref-type="bibr">260</xref>,<xref rid="B261-microorganisms-07-00133" ref-type="bibr">261</xref>,<xref rid="B262-microorganisms-07-00133" ref-type="bibr">262</xref>]; and a modeling study predicts that global warming might lead to the presence of MAYV across all of the Brazilian territory [<xref rid="B263-microorganisms-07-00133" ref-type="bibr">263</xref>].</p><p>Furthermore, <italic>Aedes aegypti</italic> and/or <italic>albopictus</italic> have been proven to be competent vectors in experimental settings for ONNV, MAYV, and RRV [<xref rid="B6-microorganisms-07-00133" ref-type="bibr">6</xref>,<xref rid="B90-microorganisms-07-00133" ref-type="bibr">90</xref>,<xref rid="B97-microorganisms-07-00133" ref-type="bibr">97</xref>,<xref rid="B98-microorganisms-07-00133" ref-type="bibr">98</xref>,<xref rid="B99-microorganisms-07-00133" ref-type="bibr">99</xref>,<xref rid="B100-microorganisms-07-00133" ref-type="bibr">100</xref>,<xref rid="B102-microorganisms-07-00133" ref-type="bibr">102</xref>,<xref rid="B111-microorganisms-07-00133" ref-type="bibr">111</xref>,<xref rid="B112-microorganisms-07-00133" ref-type="bibr">112</xref>,<xref rid="B113-microorganisms-07-00133" ref-type="bibr">113</xref>,<xref rid="B114-microorganisms-07-00133" ref-type="bibr">114</xref>]. While this does not mean it is currently happening in the wild, these observations are a warning of what could occur in the future, particular if vector populations expand and overlap and further adaptation to new vectors occurs. Public health services should keep this on their radar, especially because alphaviruses are single-stranded RNA viruses that are known to evolve rapidly [<xref rid="B264-microorganisms-07-00133" ref-type="bibr">264</xref>]. One point mutation or one recombination event might favor infection of <italic>Aedes aegypti</italic> and/or <italic>albopictus</italic> compared to the original vector and trigger a worldwide epidemic, as has happened for CHIKV (during the La Reunion epidemic with the A226V mutation [<xref rid="B83-microorganisms-07-00133" ref-type="bibr">83</xref>,<xref rid="B84-microorganisms-07-00133" ref-type="bibr">84</xref>,<xref rid="B85-microorganisms-07-00133" ref-type="bibr">85</xref>] and during the American outbreak with a duplication of the 3&#x02019;UTR [<xref rid="B265-microorganisms-07-00133" ref-type="bibr">265</xref>]). Because these vectors are widely distributed anthropophilic mosquitoes, the risk of initiating an urban cycle could be high, and further enabled by high viremia in humans.</p><p>On the other hand, the real risk and the severity of an outbreak are difficult to anticipate because little is known about ONNV, MAYV, and RRV. While a surveillance system has been well established in Australia for RRV (as it is a main health problem in a developed country), under-surveillance of ONNV and MAYV is an issue, as well as the low number of clinical studies. Thus, many open questions remain concerning possible under-the-radar outbreaks, the true incidence of the diseases, or their clinical manifestations: What is the real risk of chronicity? Can severe cases occur and which types? Can these infections be directly or indirectly lethal? Since CHIKV is more of a global concern, fundamental knowledge on alphaviruses in general is expanding, and many of these publications also tested their hypothesis on the related ONNV, MAYV, or RRV. As an example, recent findings on the still obscure entry pathway of alphaviruses identified Mxra8 as an entry mediator, not only for CHIKV, but also for ONNV, MAYV, and RRV [<xref rid="B266-microorganisms-07-00133" ref-type="bibr">266</xref>].</p><p>Another potential pitfall, if an epidemic were to happen, is the speed of identifying which virus is responsible. Indeed, despite some virus-specific trends such as lymphadenopathy for ONNV, arthritogenic alphaviruses share very similar clinical manifestations that are also common to other arboviruses or other infectious diseases. Because they co-circulate in many geographical areas, an etiological diagnosis without biological testing seems impossible. Moreover, many cases of arbovirus co-infections have been reported, adding a layer of complexity to this problem [<xref rid="B19-microorganisms-07-00133" ref-type="bibr">19</xref>,<xref rid="B129-microorganisms-07-00133" ref-type="bibr">129</xref>,<xref rid="B165-microorganisms-07-00133" ref-type="bibr">165</xref>,<xref rid="B166-microorganisms-07-00133" ref-type="bibr">166</xref>,<xref rid="B267-microorganisms-07-00133" ref-type="bibr">267</xref>,<xref rid="B268-microorganisms-07-00133" ref-type="bibr">268</xref>,<xref rid="B269-microorganisms-07-00133" ref-type="bibr">269</xref>]. As a further complication, these viruses currently circulate in remote rural areas with low access to health care facilities, including laboratories. Fortunately, many tests are now better adapted to the field [<xref rid="B270-microorganisms-07-00133" ref-type="bibr">270</xref>,<xref rid="B271-microorganisms-07-00133" ref-type="bibr">271</xref>,<xref rid="B272-microorganisms-07-00133" ref-type="bibr">272</xref>], particularly for indirect diagnosis, but also with sequencing technology, such as MinION [<xref rid="B273-microorganisms-07-00133" ref-type="bibr">273</xref>]. Regardless, cross-reactivity remains a main limitation in biological diagnostics, especially for immunological tests [<xref rid="B274-microorganisms-07-00133" ref-type="bibr">274</xref>,<xref rid="B275-microorganisms-07-00133" ref-type="bibr">275</xref>,<xref rid="B276-microorganisms-07-00133" ref-type="bibr">276</xref>]. Hence, the closer alphaviruses are phylogenetically, the more cross-reactivity exists [<xref rid="B194-microorganisms-07-00133" ref-type="bibr">194</xref>]. In response, considerable effort is made on developing technologies to avoid cross-reactivity both in direct [<xref rid="B271-microorganisms-07-00133" ref-type="bibr">271</xref>,<xref rid="B277-microorganisms-07-00133" ref-type="bibr">277</xref>] and indirect diagnosis [<xref rid="B194-microorganisms-07-00133" ref-type="bibr">194</xref>,<xref rid="B278-microorganisms-07-00133" ref-type="bibr">278</xref>].</p><p>Despite the problems stemming from cross-reactivity, it could be a major help in vaccine design, allowing broad-spectrum protection across all arthritogenic alphaviruses. Indeed, broad neutralizing antibodies against CHIKV can neutralize MAYV and ONNV by inhibiting entry and egress [<xref rid="B227-microorganisms-07-00133" ref-type="bibr">227</xref>,<xref rid="B279-microorganisms-07-00133" ref-type="bibr">279</xref>]. While no licensed vaccine exists for any of these viruses, several candidates have gone or are currently going through clinical trials for CHIKV and RRV, and it is reasonable to expect a CHIKV vaccine in the years to come. The immunity triggered by this vaccine would then need to be evaluated on other alphaviruses to validate its potent broad-spectrum activity. Strengthening the collective commitment of national and international actors and public/private partnerships will be necessary to develop and license vaccines [<xref rid="B237-microorganisms-07-00133" ref-type="bibr">237</xref>] and to avoid what had happened for RRV: an efficient and safe vaccine that went through Phase I, II, and III clinical trials [<xref rid="B235-microorganisms-07-00133" ref-type="bibr">235</xref>,<xref rid="B236-microorganisms-07-00133" ref-type="bibr">236</xref>], yet is still not licensed.</p><p>In conclusion, enriched by lessons learned from recent CHIKV outbreaks, it is undeniable that ONN, MAYV, or RRV represent emerging threats favored by climatic changes, globalization, travel, migration, and trade. Surveillance is key for detecting any unusual activity of these diseases, so that preventive measures can be taken as soon as possible to tackle a starting epidemic. Hopefully, the availability of a CHIKV vaccine might enable a broad-spectrum activity on all arthritogenic viruses that would be key for future prevention.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors want to thank Djoshkun Shengjuler for helpful discussions. This work was funded by a PhD fellowship from the Defense Innovation Agency (AID) (L.I.L.) and by the DARPA PREEMPT program managed by Jim Gimlett and administered through DARPA Cooperative Agreement HR001118S0017-PREEMPT-BAA-PA-008 (the content of the information does not necessarily reflect the position or the policy of the U.S. government, and no official endorsement should be inferred).</p></ack><notes><title>Author Contributions</title><p>Conceptualization, L.I.L. and M.V.; writing, original draft preparation, L.I.L.; writing, review and editing L.I.L. and M.V; supervision, M.V.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-microorganisms-07-00133"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suhrbier</surname><given-names>A.</given-names></name><name><surname>Jaffar-Bandjee</surname><given-names>M.-C.</given-names></name><name><surname>Gasque</surname><given-names>P.</given-names></name></person-group><article-title>Arthritogenic alphaviruses&#x02014;An overview</article-title><source>Nat. Rev. Rheumatol.</source><year>2012</year><volume>8</volume><fpage>420</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1038/nrrheum.2012.64</pub-id><?supplied-pmid 22565316?><pub-id pub-id-type="pmid">22565316</pub-id></element-citation></ref><ref id="B2-microorganisms-07-00133"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chretien</surname><given-names>J.-P.</given-names></name><name><surname>Anyamba</surname><given-names>A.</given-names></name><name><surname>Bedno</surname><given-names>S.A.</given-names></name><name><surname>Breiman</surname><given-names>R.F.</given-names></name><name><surname>Sang</surname><given-names>R.</given-names></name><name><surname>Sergon</surname><given-names>K.</given-names></name><name><surname>Powers</surname><given-names>A.M.</given-names></name><name><surname>Onyango</surname><given-names>C.O.</given-names></name><name><surname>Small</surname><given-names>J.</given-names></name><name><surname>Tucker</surname><given-names>C.J.</given-names></name><etal/></person-group><article-title>Drought-associated chikungunya emergence along coastal east africa</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2007</year><volume>76</volume><fpage>405</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2007.76.405</pub-id><pub-id pub-id-type="pmid">17360859</pub-id></element-citation></ref><ref id="B3-microorganisms-07-00133"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>S.C.</given-names></name><name><surname>Osorio</surname><given-names>J.E.</given-names></name><name><surname>Livengood</surname><given-names>J.A.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Stinchcomb</surname><given-names>D.T.</given-names></name></person-group><article-title>Chikungunya virus and prospects for a vaccine</article-title><source>Expert Rev. Vaccines</source><year>2012</year><volume>11</volume><fpage>1087</fpage><lpage>1101</lpage><pub-id pub-id-type="doi">10.1586/erv.12.84</pub-id><pub-id pub-id-type="pmid">23151166</pub-id></element-citation></ref><ref id="B4-microorganisms-07-00133"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vignuzzi</surname><given-names>M.</given-names></name><name><surname>Higgs</surname><given-names>S.</given-names></name></person-group><article-title>The Bridges and Blockades to Evolutionary Convergence on the Road to Predicting Chikungunya Virus Evolution</article-title><source>Annu. Rev. Virol.</source><year>2017</year><volume>4</volume><fpage>181</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1146/annurev-virology-101416-041757</pub-id><pub-id pub-id-type="pmid">28961411</pub-id></element-citation></ref><ref id="B5-microorganisms-07-00133"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groot</surname><given-names>H.</given-names></name><name><surname>Morales</surname><given-names>A.</given-names></name><name><surname>Vidales</surname><given-names>H.</given-names></name></person-group><article-title>VIRUS ISOLATIONS FROM FOREST MOSQUITOES IN SAN VICENTE</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1961</year><volume>6</volume><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1961.10.397</pub-id></element-citation></ref><ref id="B6-microorganisms-07-00133"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname><given-names>O.P.</given-names></name><name><surname>Cardoso</surname><given-names>B.F.</given-names></name><name><surname>Ribeiro</surname><given-names>A.L.M.</given-names></name><name><surname>dos Santos</surname><given-names>F.A.L.</given-names></name><name><surname>Slhessarenko</surname><given-names>R.D.</given-names></name></person-group><article-title>Mayaro virus and dengue virus 1 and 4 natural infection in culicids from Cuiab&#x000e1;, state of Mato Grosso, Brazil</article-title><source>Mem. Inst. Oswaldo Cruz</source><year>2016</year><volume>111</volume><fpage>20</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1590/0074-02760150270</pub-id><pub-id pub-id-type="pmid">26784852</pub-id></element-citation></ref><ref id="B7-microorganisms-07-00133"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>M.C.</given-names></name></person-group><article-title>An epidemic of virus disease in southern province, tanganyika territory, in 1952-1953</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1955</year><volume>49</volume><fpage>28</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(55)90080-8</pub-id><pub-id pub-id-type="pmid">14373834</pub-id></element-citation></ref><ref id="B8-microorganisms-07-00133"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powers</surname><given-names>A.M.</given-names></name><name><surname>Tesh</surname><given-names>R.B.</given-names></name><name><surname>Brault</surname><given-names>A.C.</given-names></name><name><surname>Weaver</surname><given-names>S.C.</given-names></name></person-group><article-title>Re-emergence of chikungunya and O&#x02019;nyong&#x02019;nyong viruses: Evidence for distinct geographical lineages and distant evolutionary relationships</article-title><source>J. Gen. Virol.</source><year>2000</year><volume>81</volume><fpage>471</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-81-2-471</pub-id><pub-id pub-id-type="pmid">10644846</pub-id></element-citation></ref><ref id="B9-microorganisms-07-00133"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volk</surname><given-names>S.M.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Tsetsarkin</surname><given-names>K.A.</given-names></name><name><surname>Adams</surname><given-names>A.P.</given-names></name><name><surname>Garcia</surname><given-names>T.I.</given-names></name><name><surname>Sall</surname><given-names>A.A.</given-names></name><name><surname>Nasar</surname><given-names>F.</given-names></name><name><surname>Schuh</surname><given-names>A.J.</given-names></name><name><surname>Holmes</surname><given-names>E.C.</given-names></name><name><surname>Higgs</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Genome-Scale Phylogenetic Analyses of Chikungunya Virus Reveal Independent Emergences of Recent Epidemics and Various Evolutionary Rates</article-title><source>J. Virol.</source><year>2010</year><volume>84</volume><fpage>6497</fpage><lpage>6504</lpage><pub-id pub-id-type="doi">10.1128/JVI.01603-09</pub-id><?supplied-pmid 20410280?><pub-id pub-id-type="pmid">20410280</pub-id></element-citation></ref><ref id="B10-microorganisms-07-00133"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodger</surname><given-names>L.M.</given-names></name></person-group><article-title>An outbreak of suspected Chikungunya fever in Northern Rhodesia</article-title><source>S. Afr. Med. J.</source><year>1961</year><volume>35</volume><fpage>126</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">13742532</pub-id></element-citation></ref><ref id="B11-microorganisms-07-00133"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntosh</surname><given-names>B.M.</given-names></name><name><surname>Harwin</surname><given-names>R.M.</given-names></name><name><surname>Paterson</surname><given-names>H.E.</given-names></name><name><surname>Westwater</surname><given-names>M.L.</given-names></name></person-group><article-title>An Epidemic of Chikungunya in South-Eastern Southern Rhodesia</article-title><source>Cent. Afr. J. Med.</source><year>1963</year><volume>9</volume><fpage>351</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">14061785</pub-id></element-citation></ref><ref id="B12-microorganisms-07-00133"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomori</surname><given-names>O.</given-names></name><name><surname>Fagbami</surname><given-names>A.</given-names></name><name><surname>Fabiyi</surname><given-names>A.</given-names></name></person-group><article-title>The 1974 epidemic of Chikungunya fever in children in Ibadan</article-title><source>Trop. Geogr. Med.</source><year>1975</year><volume>27</volume><fpage>413</fpage><lpage>417</lpage><pub-id pub-id-type="pmid">1216323</pub-id></element-citation></ref><ref id="B13-microorganisms-07-00133"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filipe</surname><given-names>A.F.</given-names></name><name><surname>Pinto</surname><given-names>M.R.</given-names></name></person-group><article-title>Arbovirus studies in Luanda, Angola. 2. Virological and serological studies during an outbreak of dengue-like disease caused by the Chikungunya virus</article-title><source>Bull. World Health Organ.</source><year>1973</year><volume>49</volume><fpage>37</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">4545155</pub-id></element-citation></ref><ref id="B14-microorganisms-07-00133"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fourie</surname><given-names>E.D.</given-names></name><name><surname>Morrison</surname><given-names>J.G.</given-names></name></person-group><article-title>Rheumatoid arthritic syndrome after chikungunya fever</article-title><source>S. Afr. Med. J.</source><year>1979</year><volume>56</volume><fpage>130</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">494034</pub-id></element-citation></ref><ref id="B15-microorganisms-07-00133"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muyembe-Tamfum</surname><given-names>J.J.</given-names></name><name><surname>Peyrefitte</surname><given-names>C.N.</given-names></name><name><surname>Yogolelo</surname><given-names>R.</given-names></name><name><surname>Mathina Basisya</surname><given-names>E.</given-names></name><name><surname>Koyange</surname><given-names>D.</given-names></name><name><surname>Pukuta</surname><given-names>E.</given-names></name><name><surname>Mashako</surname><given-names>M.</given-names></name><name><surname>Tolou</surname><given-names>H.</given-names></name><name><surname>Durand</surname><given-names>J.P.</given-names></name></person-group><article-title>[Epidemic of Chikungunya virus in 1999 and 200 in the Democratic Republic of the Congo]</article-title><source>Med. Trop. Rev. Corps Sante Colon.</source><year>2003</year><volume>63</volume><fpage>637</fpage><lpage>638</lpage></element-citation></ref><ref id="B16-microorganisms-07-00133"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastorino</surname><given-names>B.</given-names></name><name><surname>Muyembe-Tamfum</surname><given-names>J.J.</given-names></name><name><surname>Bessaud</surname><given-names>M.</given-names></name><name><surname>Tock</surname><given-names>F.</given-names></name><name><surname>Tolou</surname><given-names>H.</given-names></name><name><surname>Durand</surname><given-names>J.P.</given-names></name><name><surname>Peyrefitte</surname><given-names>C.N.</given-names></name></person-group><article-title>Epidemic resurgence of Chikungunya virus in democratic Republic of the Congo: Identification of a new central African strain</article-title><source>J. Med. Virol.</source><year>2004</year><volume>74</volume><fpage>277</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1002/jmv.20168</pub-id><pub-id pub-id-type="pmid">15332277</pub-id></element-citation></ref><ref id="B17-microorganisms-07-00133"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saluzzo</surname><given-names>J.F.</given-names></name><name><surname>Cornet</surname><given-names>M.</given-names></name><name><surname>Digoutte</surname><given-names>J.P.</given-names></name></person-group><article-title>[Outbreak of a Chikungunya virus epidemic in western Senegal in 1982]</article-title><source>Dakar Med.</source><year>1983</year><volume>28</volume><fpage>497</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">6323109</pub-id></element-citation></ref><ref id="B18-microorganisms-07-00133"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diallo</surname><given-names>M.</given-names></name><name><surname>Thonnon</surname><given-names>J.</given-names></name><name><surname>Traore-Lamizana</surname><given-names>M.</given-names></name><name><surname>Fontenille</surname><given-names>D.</given-names></name></person-group><article-title>Vectors of Chikungunya virus in Senegal: Current data and transmission cycles</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1999</year><volume>60</volume><fpage>281</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1999.60.281</pub-id><pub-id pub-id-type="pmid">10072152</pub-id></element-citation></ref><ref id="B19-microorganisms-07-00133"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>J.K.</given-names></name><name><surname>Chatterjee</surname><given-names>S.N.</given-names></name><name><surname>Chakravarti</surname><given-names>S.K.</given-names></name><name><surname>Mitra</surname><given-names>A.C.</given-names></name></person-group><article-title>Chikungunya Virus Infection with Haemorrhagic Manifestations</article-title><source>Indian J. Med. Res.</source><year>1965</year><volume>53</volume><fpage>921</fpage><lpage>925</lpage><pub-id pub-id-type="pmid">5849867</pub-id></element-citation></ref><ref id="B20-microorganisms-07-00133"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>K.V.</given-names></name><name><surname>Gibbs</surname><given-names>C.J.</given-names></name><name><surname>Banerjee</surname><given-names>G.</given-names></name></person-group><article-title>Virological investigation of the epidemic of haemorrhagic fever in calcutta: Isolation of three strains of chikungunya virus</article-title><source>Indian J. Med. Res.</source><year>1964</year><volume>52</volume><fpage>676</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">14195507</pub-id></element-citation></ref><ref id="B21-microorganisms-07-00133"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munasinghe</surname><given-names>D.R.</given-names></name><name><surname>Amarasekera</surname><given-names>P.J.</given-names></name><name><surname>Fernando</surname><given-names>C.F.O.</given-names></name></person-group><article-title>An epidemic of dengue-like fever in Ceylon (chikungunya)&#x02014;A clinical and haematological study</article-title><source>Ceylon Med. J.</source><year>1966</year><volume>11</volume><fpage>129</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">5984948</pub-id></element-citation></ref><ref id="B22-microorganisms-07-00133"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhuri</surname><given-names>R.N.</given-names></name><name><surname>Chatterjea</surname><given-names>J.B.</given-names></name><name><surname>Saha</surname><given-names>T.K.</given-names></name><name><surname>Chaudhuri</surname><given-names>A.D.</given-names></name></person-group><article-title>clinical and haematological observations on a recent outbreak of dengue-like fever in calcutta with or without haemorrhagic manifestations</article-title><source>J. Indian Med. Assoc.</source><year>1964</year><volume>43</volume><fpage>579</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">14254275</pub-id></element-citation></ref><ref id="B23-microorganisms-07-00133"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vu-Qui-Dai</surname></name><name><surname>Kim-Thoa</surname><given-names>N.T.</given-names></name></person-group><article-title>[Hemorrhagic fever in Vietnam in 1964-1965. Serologic study with a brief clinica and epidemiologic note]</article-title><source>Bull. Soc. Pathol. Exot. Fil.</source><year>1967</year><volume>60</volume><fpage>21</fpage><lpage>33</lpage></element-citation></ref><ref id="B24-microorganisms-07-00133"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thaikruea</surname><given-names>L.</given-names></name><name><surname>Charearnsook</surname><given-names>O.</given-names></name><name><surname>Reanphumkarnkit</surname><given-names>S.</given-names></name><name><surname>Dissomboon</surname><given-names>P.</given-names></name><name><surname>Phonjan</surname><given-names>R.</given-names></name><name><surname>Ratchbud</surname><given-names>S.</given-names></name><name><surname>Kounsang</surname><given-names>Y.</given-names></name><name><surname>Buranapiyawong</surname><given-names>D.</given-names></name></person-group><article-title>Chikungunya in Thailand: A re-emerging disease?</article-title><source>Southeast Asian J. Trop. Med. Public Health</source><year>1997</year><volume>28</volume><fpage>359</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">9444021</pub-id></element-citation></ref><ref id="B25-microorganisms-07-00133"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>S.</given-names></name><name><surname>Chua</surname><given-names>K.</given-names></name><name><surname>Hooi</surname><given-names>P.</given-names></name><name><surname>Rahimah</surname><given-names>M.</given-names></name><name><surname>Kumari</surname><given-names>S.</given-names></name><name><surname>Tharmaratnam</surname><given-names>M.</given-names></name><name><surname>Chuah</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>D.</given-names></name><name><surname>Sampson</surname><given-names>I.</given-names></name></person-group><article-title>Chikungunya infection&#x02014;An emerging disease in malaysia</article-title><source>Southeast Asian J. Trop. Med. Public Health</source><year>2001</year><volume>32</volume><fpage>5</fpage></element-citation></ref><ref id="B26-microorganisms-07-00133"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>K.R.</given-names></name><name><surname>Tan</surname><given-names>R.</given-names></name><name><surname>Istary</surname><given-names>Y.</given-names></name><name><surname>Suharyono</surname><given-names>W.</given-names></name><name><surname>Sutaryo</surname></name><name><surname>Widjaja</surname><given-names>S.</given-names></name><name><surname>Ma&#x02019;Roef</surname><given-names>C.</given-names></name><name><surname>Listiyaningsih</surname><given-names>E.</given-names></name><name><surname>Kosasih</surname><given-names>H.</given-names></name><name><surname>Hueston</surname><given-names>L.</given-names></name><etal/></person-group><article-title>A serological study of Chikungunya virus transmission in Yogyakarta, Indonesia: Evidence for the first outbreak since 1982</article-title><source>Southeast Asian J. Trop. Med. Public Health</source><year>2004</year><volume>35</volume><fpage>408</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">15691147</pub-id></element-citation></ref><ref id="B27-microorganisms-07-00133"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laras</surname><given-names>K.</given-names></name><name><surname>Sukri</surname><given-names>N.C.</given-names></name><name><surname>Larasati</surname><given-names>R.P.</given-names></name><name><surname>Bangs</surname><given-names>M.J.</given-names></name><name><surname>Kosim</surname><given-names>R.</given-names></name><name><surname>Djauzi</surname></name><name><surname>Wandra</surname><given-names>T.</given-names></name><name><surname>Master</surname><given-names>J.</given-names></name><name><surname>Kosasih</surname><given-names>H.</given-names></name><name><surname>Hartati</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Tracking the re-emergence of epidemic chikungunya virus in Indonesia</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>2005</year><volume>99</volume><fpage>128</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.trstmh.2004.03.013</pub-id><pub-id pub-id-type="pmid">15693148</pub-id></element-citation></ref><ref id="B28-microorganisms-07-00133"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>F.</given-names></name><name><surname>Tolou</surname><given-names>H.</given-names></name><name><surname>Jeandel</surname><given-names>P.</given-names></name></person-group><article-title>Chikungunya, l&#x02019;&#x000e9;pid&#x000e9;mie que l&#x02019;on n&#x02019;attendait pas</article-title><source>Rev. M&#x000e9;decine Interne</source><year>2006</year><volume>27</volume><fpage>437</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1016/j.revmed.2006.03.028</pub-id></element-citation></ref><ref id="B29-microorganisms-07-00133"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pialoux</surname><given-names>G.</given-names></name><name><surname>Ga&#x000fc;z&#x000e8;re</surname><given-names>B.-A.</given-names></name><name><surname>Strobel</surname><given-names>M.</given-names></name></person-group><article-title>Infection &#x000e0; virus Chikungunya: Revue g&#x000e9;n&#x000e9;rale par temps d&#x02019;&#x000e9;pid&#x000e9;mie</article-title><source>M&#x000e9;decine Mal. Infect.</source><year>2006</year><volume>36</volume><fpage>253</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.medmal.2006.04.002</pub-id></element-citation></ref><ref id="B30-microorganisms-07-00133"><label>30.</label><element-citation publication-type="gov"><person-group person-group-type="author"><name><surname>Staples</surname><given-names>J.E.</given-names></name><name><surname>Fischer</surname><given-names>M.</given-names></name></person-group><article-title>Chikungunya Virus in the Americas&#x02014;What a Vectorborne Pathogen Can Do</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.nejm.org/doi/10.1056/NEJMp1407698?url_ver=Z39.88-2003&#x00026;rfr_id=ori%3Arid%3Acrossref.org&#x00026;rfr_dat=cr_pub%3Dwww.ncbi.nlm.nih.gov">https://www.nejm.org/doi/10.1056/NEJMp1407698?url_ver=Z39.88-2003&#x00026;rfr_id=ori%3Arid%3Acrossref.org&#x00026;rfr_dat=cr_pub%3Dwww.ncbi.nlm.nih.gov</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-03-14">(accessed on 14 March 2019)</date-in-citation></element-citation></ref><ref id="B31-microorganisms-07-00133"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassadou</surname><given-names>S.</given-names></name><name><surname>Boucau</surname><given-names>S.</given-names></name><name><surname>Petit-Sinturel</surname><given-names>M.</given-names></name><name><surname>Huc</surname><given-names>P.</given-names></name><name><surname>Leparc-Goffart</surname><given-names>I.</given-names></name><name><surname>Ledrans</surname><given-names>M.</given-names></name></person-group><article-title>Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013</article-title><source>Eurosurveillance</source><year>2014</year><volume>19</volume><fpage>20752</fpage><pub-id pub-id-type="doi">10.2807/1560-7917.ES2014.19.13.20752</pub-id><pub-id pub-id-type="pmid">24721536</pub-id></element-citation></ref><ref id="B32-microorganisms-07-00133"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezza</surname><given-names>G.</given-names></name><name><surname>Nicoletti</surname><given-names>L.</given-names></name><name><surname>Angelini</surname><given-names>R.</given-names></name><name><surname>Romi</surname><given-names>R.</given-names></name><name><surname>Finarelli</surname><given-names>A.C.</given-names></name><name><surname>Panning</surname><given-names>M.</given-names></name><name><surname>Cordioli</surname><given-names>P.</given-names></name><name><surname>Fortuna</surname><given-names>C.</given-names></name><name><surname>Boros</surname><given-names>S.</given-names></name><name><surname>Magurano</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Infection with chikungunya virus in Italy: An outbreak in a temperate region</article-title><source>Lancet Lond. Engl.</source><year>2007</year><volume>370</volume><fpage>1840</fpage><lpage>1846</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(07)61779-6</pub-id></element-citation></ref><ref id="B33-microorganisms-07-00133"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manica</surname><given-names>M.</given-names></name><name><surname>Guzzetta</surname><given-names>G.</given-names></name><name><surname>Poletti</surname><given-names>P.</given-names></name><name><surname>Filipponi</surname><given-names>F.</given-names></name><name><surname>Solimini</surname><given-names>A.</given-names></name><name><surname>Caputo</surname><given-names>B.</given-names></name><name><surname>Della Torre</surname><given-names>A.</given-names></name><name><surname>Ros&#x000e0;</surname><given-names>R.</given-names></name><name><surname>Merler</surname><given-names>S.</given-names></name></person-group><article-title>Transmission dynamics of the ongoing chikungunya outbreak in Central Italy: From coastal areas to the metropolitan city of Rome, summer 2017</article-title><source>Eurosurveillance</source><year>2017</year><volume>22</volume><fpage>17-00685</fpage><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2017.22.44.17-00685</pub-id></element-citation></ref><ref id="B34-microorganisms-07-00133"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venturi</surname><given-names>G.</given-names></name><name><surname>Di Luca</surname><given-names>M.</given-names></name><name><surname>Fortuna</surname><given-names>C.</given-names></name><name><surname>Remoli</surname><given-names>M.E.</given-names></name><name><surname>Riccardo</surname><given-names>F.</given-names></name><name><surname>Severini</surname><given-names>F.</given-names></name><name><surname>Toma</surname><given-names>L.</given-names></name><name><surname>Del Manso</surname><given-names>M.</given-names></name><name><surname>Benedetti</surname><given-names>E.</given-names></name><name><surname>Caporali</surname><given-names>M.G.</given-names></name><etal/></person-group><article-title>Detection of a chikungunya outbreak in Central Italy, August to September 2017</article-title><source>Eurosurveillance</source><year>2017</year><volume>22</volume><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2017.22.39.17-00646</pub-id><?supplied-pmid 29019306?><pub-id pub-id-type="pmid">29019306</pub-id></element-citation></ref><ref id="B35-microorganisms-07-00133"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angelini</surname><given-names>R.</given-names></name><name><surname>Finarelli</surname><given-names>A.C.</given-names></name><name><surname>Angelini</surname><given-names>P.</given-names></name><name><surname>Po</surname><given-names>C.</given-names></name><name><surname>Petropulacos</surname><given-names>K.</given-names></name><name><surname>Silvi</surname><given-names>G.</given-names></name><name><surname>Macini</surname><given-names>P.</given-names></name><name><surname>Fortuna</surname><given-names>C.</given-names></name><name><surname>Venturi</surname><given-names>G.</given-names></name><name><surname>Magurano</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Chikungunya in north-eastern Italy: A summing up of the outbreak</article-title><source>Eurosurveillance</source><year>2007</year><volume>12</volume><fpage>E071122.2</fpage><pub-id pub-id-type="doi">10.2807/esw.12.47.03313-en</pub-id></element-citation></ref><ref id="B36-microorganisms-07-00133"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delisle</surname><given-names>E.</given-names></name><name><surname>Rousseau</surname><given-names>C.</given-names></name><name><surname>Broche</surname><given-names>B.</given-names></name><name><surname>Leparc-Goffart</surname><given-names>I.</given-names></name><name><surname>L&#x02019;Ambert</surname><given-names>G.</given-names></name><name><surname>Cochet</surname><given-names>A.</given-names></name><name><surname>Prat</surname><given-names>C.</given-names></name><name><surname>Foulongne</surname><given-names>V.</given-names></name><name><surname>Ferre</surname><given-names>J.B.</given-names></name><name><surname>Catelinois</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Chikungunya outbreak in Montpellier, France, September to October 2014</article-title><source>Eurosurveillance</source><year>2015</year><volume>20</volume><pub-id pub-id-type="doi">10.2807/1560-7917.ES2015.20.17.21108</pub-id></element-citation></ref><ref id="B37-microorganisms-07-00133"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calba</surname><given-names>C.</given-names></name><name><surname>Guerbois-Galla</surname><given-names>M.</given-names></name><name><surname>Franke</surname><given-names>F.</given-names></name><name><surname>Jeannin</surname><given-names>C.</given-names></name><name><surname>Auzet-Caillaud</surname><given-names>M.</given-names></name><name><surname>Grard</surname><given-names>G.</given-names></name><name><surname>Pigaglio</surname><given-names>L.</given-names></name><name><surname>Decoppet</surname><given-names>A.</given-names></name><name><surname>Weicherding</surname><given-names>J.</given-names></name><name><surname>Savaill</surname><given-names>M.-C.</given-names></name><etal/></person-group><article-title>Preliminary report of an autochthonous chikungunya outbreak in France, July to September 2017</article-title><source>Eurosurveillance</source><year>2017</year><volume>22</volume><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2017.22.39.17-00647</pub-id></element-citation></ref><ref id="B38-microorganisms-07-00133"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddow</surname><given-names>A.J.</given-names></name><name><surname>Davies</surname><given-names>C.W.</given-names></name><name><surname>Walker</surname><given-names>A.J.</given-names></name></person-group><article-title>O&#x02019;nyong&#x02019;nyong fever: An epidemic virus disease in East Africa 1. Introduction</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1960</year><volume>54</volume><fpage>517</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(60)90025-0</pub-id></element-citation></ref><ref id="B39-microorganisms-07-00133"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>M.C.</given-names></name><name><surname>Woodall</surname><given-names>J.P.</given-names></name></person-group><article-title>O&#x02019;nyong&#x02019;nyong fever: An epidemic virus disease in East Africa. II. Isolation and some properties of the virus</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1961</year><volume>55</volume><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(61)90017-7</pub-id><pub-id pub-id-type="pmid">13785469</pub-id></element-citation></ref><ref id="B40-microorganisms-07-00133"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lhuillier</surname><given-names>M.</given-names></name><name><surname>Cunin</surname><given-names>P.</given-names></name><name><surname>Mazzariol</surname><given-names>M.J.</given-names></name><name><surname>Monteny</surname><given-names>N.</given-names></name><name><surname>Cordellier</surname><given-names>R.</given-names></name><name><surname>Bouchite</surname><given-names>B.</given-names></name></person-group><article-title>[A rural epidemic of Igbo Ora virus (with interhuman transmission) in the Ivory Coast 1984-1985]</article-title><source>Bull. Soc. Pathol. Exot. Fil.</source><year>1988</year><volume>81</volume><fpage>386</fpage><lpage>395</lpage></element-citation></ref><ref id="B41-microorganisms-07-00133"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanciotti</surname><given-names>R.S.</given-names></name><name><surname>Ludwig</surname><given-names>M.L.</given-names></name><name><surname>Rwaguma</surname><given-names>E.B.</given-names></name><name><surname>Lutwama</surname><given-names>J.J.</given-names></name><name><surname>Kram</surname><given-names>T.M.</given-names></name><name><surname>Karabatsos</surname><given-names>N.</given-names></name><name><surname>Cropp</surname><given-names>B.C.</given-names></name><name><surname>Miller</surname><given-names>B.R.</given-names></name></person-group><article-title>Emergence of epidemic O&#x02019;nyong&#x02019;nyong fever in Uganda after a 35-year absence: Genetic characterization of the virus</article-title><source>Virology</source><year>1998</year><volume>252</volume><fpage>258</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1006/viro.1998.9437</pub-id><pub-id pub-id-type="pmid">9875334</pub-id></element-citation></ref><ref id="B42-microorganisms-07-00133"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>E.J.</given-names></name><name><surname>Rwaguma</surname><given-names>E.B.</given-names></name><name><surname>Kawamata</surname><given-names>J.</given-names></name><name><surname>Kiwanuka</surname><given-names>N.</given-names></name><name><surname>Lutwama</surname><given-names>J.J.</given-names></name><name><surname>Ssengooba</surname><given-names>F.P.</given-names></name><name><surname>Lamunu</surname><given-names>M.</given-names></name><name><surname>Najjemba</surname><given-names>R.</given-names></name><name><surname>Were</surname><given-names>W.A.</given-names></name><name><surname>Bagambisa</surname><given-names>G.</given-names></name><etal/></person-group><article-title>O&#x02019;nyong&#x02019;nyong fever in south-central Uganda, 1996-1997: Description of the epidemic and results of a household-based seroprevalence survey</article-title><source>J. Infect. Dis.</source><year>1999</year><volume>180</volume><fpage>1436</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1086/315073</pub-id><pub-id pub-id-type="pmid">10515801</pub-id></element-citation></ref><ref id="B43-microorganisms-07-00133"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rwaguma</surname><given-names>E.B.</given-names></name><name><surname>Lutwama</surname><given-names>J.J.</given-names></name><name><surname>Sempala</surname><given-names>S.D.</given-names></name><name><surname>Kiwanuka</surname><given-names>N.</given-names></name><name><surname>Kamugisha</surname><given-names>J.</given-names></name><name><surname>Okware</surname><given-names>S.</given-names></name><name><surname>Bagambisa</surname><given-names>G.</given-names></name><name><surname>Lanciotti</surname><given-names>R.</given-names></name><name><surname>Roehrig</surname><given-names>J.T.</given-names></name><name><surname>Gubler</surname><given-names>D.J.</given-names></name></person-group><article-title>Emergence of epidemic O&#x02019;nyong&#x02019;nyong fever in southwestern Uganda, after an absence of 35 years</article-title><source>Emerg. Infect. Dis.</source><year>1997</year><volume>3</volume><fpage>77</fpage><pub-id pub-id-type="doi">10.3201/eid0301.970112</pub-id></element-citation></ref><ref id="B44-microorganisms-07-00133"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Posey</surname><given-names>D.L.</given-names></name><name><surname>O&#x02019;rourke</surname><given-names>T.</given-names></name><name><surname>Roehrig</surname><given-names>J.T.</given-names></name><name><surname>Lanciotti</surname><given-names>R.S.</given-names></name><name><surname>Weinberg</surname><given-names>M.</given-names></name><name><surname>Maloney</surname><given-names>S.</given-names></name></person-group><article-title>O&#x02019;nyong&#x02019;nyong fever in West Africa</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2005</year><volume>73</volume><fpage>32</fpage><pub-id pub-id-type="doi">10.4269/ajtmh.2005.73.1.0730032</pub-id></element-citation></ref><ref id="B45-microorganisms-07-00133"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>C.R.</given-names></name><name><surname>Downs</surname><given-names>W.G.</given-names></name><name><surname>Wattley</surname><given-names>G.H.</given-names></name><name><surname>Ahin</surname><given-names>N.W.</given-names></name><name><surname>Reese</surname><given-names>A.A.</given-names></name></person-group><article-title>Mayaro virus: A new human disease agent. II. Isolation from blood of patients in Trinidad, B.W.I</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1957</year><volume>6</volume><fpage>1012</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1957.6.1012</pub-id><pub-id pub-id-type="pmid">13487973</pub-id></element-citation></ref><ref id="B46-microorganisms-07-00133"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>J.R.</given-names></name><name><surname>Gajdusek</surname><given-names>D.C.</given-names></name><name><surname>Schaffer</surname><given-names>M.</given-names></name><name><surname>Gorrie</surname><given-names>R.H.</given-names></name></person-group><article-title>Epidemic jungle fever among Okinawan colonists in the Bolivian rain forest. II. Isolation and characterization of Uruma virus, a newly recognized human pathogen</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1959</year><volume>8</volume><fpage>479</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1959.8.479</pub-id><pub-id pub-id-type="pmid">13670375</pub-id></element-citation></ref><ref id="B47-microorganisms-07-00133"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Causey</surname><given-names>O.R.</given-names></name><name><surname>Maroja</surname><given-names>O.M.</given-names></name></person-group><article-title>Mayaro Virus: A New Human Disease Agent</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1957</year><volume>6</volume><fpage>1017</fpage><lpage>1023</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1957.6.1017</pub-id><pub-id pub-id-type="pmid">13487974</pub-id></element-citation></ref><ref id="B48-microorganisms-07-00133"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeDuc</surname><given-names>J.W.</given-names></name><name><surname>Pinheiro</surname><given-names>F.P.</given-names></name><name><surname>Travassos da Rosa</surname><given-names>A.P.</given-names></name></person-group><article-title>An outbreak of Mayaro virus disease in Belterra, Brazil. II. Epidemiology</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1981</year><volume>30</volume><fpage>682</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1981.30.682</pub-id><pub-id pub-id-type="pmid">6266264</pub-id></element-citation></ref><ref id="B49-microorganisms-07-00133"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinheiro</surname><given-names>F.P.</given-names></name><name><surname>Freitas</surname><given-names>R.B.</given-names></name><name><surname>Travassos da Rosa</surname><given-names>J.F.</given-names></name><name><surname>Gabbay</surname><given-names>Y.B.</given-names></name><name><surname>Mello</surname><given-names>W.A.</given-names></name><name><surname>LeDuc</surname><given-names>J.W.</given-names></name></person-group><article-title>An outbreak of Mayaro virus disease in Belterra, Brazil. I. Clinical and virological findings</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1981</year><volume>30</volume><fpage>674</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1981.30.674</pub-id><pub-id pub-id-type="pmid">6266263</pub-id></element-citation></ref><ref id="B50-microorganisms-07-00133"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azevedo</surname><given-names>R.S.S.</given-names></name><name><surname>Silva</surname><given-names>E.V.P.</given-names></name><name><surname>Carvalho</surname><given-names>V.L.</given-names></name><name><surname>Rodrigues</surname><given-names>S.G.</given-names></name><name><surname>Nunes-Neto</surname><given-names>J.P.</given-names></name><name><surname>Monteiro</surname><given-names>H.</given-names></name><name><surname>Peixoto</surname><given-names>V.S.</given-names></name><name><surname>Chiang</surname><given-names>J.O.</given-names></name><name><surname>Nunes</surname><given-names>M.R.T.</given-names></name><name><surname>Vasconcelos</surname><given-names>P.F.C.</given-names></name></person-group><article-title>Mayaro fever virus, Brazilian Amazon</article-title><source>Emerg. Infect. Dis.</source><year>2009</year><volume>15</volume><fpage>1830</fpage><lpage>1832</lpage><pub-id pub-id-type="doi">10.3201/eid1511.090461</pub-id><pub-id pub-id-type="pmid">19891877</pub-id></element-citation></ref><ref id="B51-microorganisms-07-00133"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunini</surname><given-names>S.</given-names></name><name><surname>Fran&#x000e7;a</surname><given-names>D.D.S.</given-names></name><name><surname>Silva</surname><given-names>J.B.</given-names></name><name><surname>Silva</surname><given-names>L.N.</given-names></name><name><surname>Silva</surname><given-names>F.P.A.</given-names></name><name><surname>Spadoni</surname><given-names>M.</given-names></name><name><surname>Rezza</surname><given-names>G.</given-names></name></person-group><article-title>High Frequency of Mayaro Virus IgM among Febrile Patients, Central Brazil</article-title><source>Emerg. Infect. Dis.</source><year>2017</year><volume>23</volume><fpage>1025</fpage><lpage>1026</lpage><pub-id pub-id-type="doi">10.3201/eid2306.160929</pub-id><pub-id pub-id-type="pmid">28518022</pub-id></element-citation></ref><ref id="B52-microorganisms-07-00133"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaeffer</surname><given-names>M.</given-names></name><name><surname>Gajdusek</surname><given-names>D.C.</given-names></name><name><surname>Lema</surname><given-names>A.B.</given-names></name><name><surname>Eichenwald</surname><given-names>H.</given-names></name></person-group><article-title>Epidemic jungle fevers among Okinawan colonists in the Bolivian rain forest. I. Epidemiology</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1959</year><volume>8</volume><fpage>372</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1959.8.372</pub-id><pub-id pub-id-type="pmid">13661542</pub-id></element-citation></ref><ref id="B53-microorganisms-07-00133"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izurieta</surname><given-names>R.O.</given-names></name><name><surname>Macaluso</surname><given-names>M.</given-names></name><name><surname>Watts</surname><given-names>D.M.</given-names></name><name><surname>Tesh</surname><given-names>R.B.</given-names></name><name><surname>Guerra</surname><given-names>B.</given-names></name><name><surname>Cruz</surname><given-names>L.M.</given-names></name><name><surname>Galwankar</surname><given-names>S.</given-names></name><name><surname>Vermund</surname><given-names>S.H.</given-names></name></person-group><article-title>Hunting in the Rainforest and Mayaro Virus Infection: An emerging Alphavirus in Ecuador</article-title><source>J. Glob. Infect. Dis.</source><year>2011</year><volume>3</volume><fpage>317</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.4103/0974-777X.91049</pub-id><pub-id pub-id-type="pmid">22223990</pub-id></element-citation></ref><ref id="B54-microorganisms-07-00133"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auguste</surname><given-names>A.J.</given-names></name><name><surname>Liria</surname><given-names>J.</given-names></name><name><surname>Forrester</surname><given-names>N.L.</given-names></name><name><surname>Giambalvo</surname><given-names>D.</given-names></name><name><surname>Moncada</surname><given-names>M.</given-names></name><name><surname>Long</surname><given-names>K.C.</given-names></name><name><surname>Mor&#x000f3;n</surname><given-names>D.</given-names></name><name><surname>de Manzione</surname><given-names>N.</given-names></name><name><surname>Tesh</surname><given-names>R.B.</given-names></name><name><surname>Halsey</surname><given-names>E.S.</given-names></name><etal/></person-group><article-title>Evolutionary and Ecological Characterization of Mayaro Virus Strains Isolated during an Outbreak, Venezuela, 2010</article-title><source>Emerg. Infect. Dis.</source><year>2015</year><volume>21</volume><fpage>1742</fpage><lpage>1750</lpage><pub-id pub-id-type="doi">10.3201/eid2110.141660</pub-id><pub-id pub-id-type="pmid">26401714</pub-id></element-citation></ref><ref id="B55-microorganisms-07-00133"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>J.R.</given-names></name><name><surname>Russell</surname><given-names>K.L.</given-names></name><name><surname>Vasquez</surname><given-names>C.</given-names></name><name><surname>Barrera</surname><given-names>R.</given-names></name><name><surname>Tesh</surname><given-names>R.B.</given-names></name><name><surname>Salas</surname><given-names>R.</given-names></name><name><surname>Watts</surname><given-names>D.M.</given-names></name></person-group><article-title>Family cluster of Mayaro fever, Venezuela</article-title><source>Emerg. Infect. Dis.</source><year>2004</year><volume>10</volume><fpage>1304</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.3201/eid1007.030860</pub-id><pub-id pub-id-type="pmid">15324555</pub-id></element-citation></ref><ref id="B56-microorganisms-07-00133"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesh</surname><given-names>R.B.</given-names></name><name><surname>Watts</surname><given-names>D.M.</given-names></name><name><surname>Russell</surname><given-names>K.L.</given-names></name><name><surname>Damodaran</surname><given-names>C.</given-names></name><name><surname>Calampa</surname><given-names>C.</given-names></name><name><surname>Cabezas</surname><given-names>C.</given-names></name><name><surname>Ramirez</surname><given-names>G.</given-names></name><name><surname>Vasquez</surname><given-names>B.</given-names></name><name><surname>Hayes</surname><given-names>C.G.</given-names></name><name><surname>Rossi</surname><given-names>C.A.</given-names></name><etal/></person-group><article-title>Mayaro Virus Disease: An Emerging Mosquito-Borne Zoonosis in Tropical South America</article-title><source>Clin. Infect. Dis.</source><year>1999</year><volume>28</volume><fpage>67</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1086/515070</pub-id><pub-id pub-id-type="pmid">10028074</pub-id></element-citation></ref><ref id="B57-microorganisms-07-00133"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumayr</surname><given-names>A.</given-names></name><name><surname>Gabriel</surname><given-names>M.</given-names></name><name><surname>Fritz</surname><given-names>J.</given-names></name><name><surname>G&#x000fc;nther</surname><given-names>S.</given-names></name><name><surname>Hatz</surname><given-names>C.</given-names></name><name><surname>Schmidt-Chanasit</surname><given-names>J.</given-names></name><name><surname>Blum</surname><given-names>J.</given-names></name></person-group><article-title>Mayaro virus infection in traveler returning from Amazon Basin, northern Peru</article-title><source>Emerg. Infect. Dis.</source><year>2012</year><volume>18</volume><fpage>695</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.3201/eid1804.111717</pub-id><pub-id pub-id-type="pmid">22469145</pub-id></element-citation></ref><ref id="B58-microorganisms-07-00133"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talarmin</surname><given-names>A.</given-names></name><name><surname>Chandler</surname><given-names>L.J.</given-names></name><name><surname>Kazanji</surname><given-names>M.</given-names></name><name><surname>de Thoisy</surname><given-names>B.</given-names></name><name><surname>Debon</surname><given-names>P.</given-names></name><name><surname>Lelarge</surname><given-names>J.</given-names></name><name><surname>Labeau</surname><given-names>B.</given-names></name><name><surname>Bourreau</surname><given-names>E.</given-names></name><name><surname>Vi&#x000e9;</surname><given-names>J.C.</given-names></name><name><surname>Shope</surname><given-names>R.E.</given-names></name><etal/></person-group><article-title>Mayaro virus fever in French Guiana: Isolation, identification, and seroprevalence</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1998</year><volume>59</volume><fpage>452</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1998.59.452</pub-id><pub-id pub-id-type="pmid">9749643</pub-id></element-citation></ref><ref id="B59-microorganisms-07-00133"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metselaar</surname><given-names>D.</given-names></name></person-group><article-title>Isolation of arboviruses of group A and group C in Surinam</article-title><source>Trop. Geogr. Med.</source><year>1966</year><volume>18</volume><fpage>137</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">5962842</pub-id></element-citation></ref><ref id="B60-microorganisms-07-00133"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarrete-Espinosa</surname><given-names>J.</given-names></name><name><surname>G&#x000f3;mez-Dant&#x000e9;s</surname><given-names>H.</given-names></name></person-group><article-title>[Arbovirus causing hemorrhagic fever at IMSS]</article-title><source>Rev. Medica Inst. Mex. Seguro Soc.</source><year>2006</year><volume>44</volume><fpage>347</fpage><lpage>353</lpage></element-citation></ref><ref id="B61-microorganisms-07-00133"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lednicky</surname><given-names>J.</given-names></name><name><surname>De Rochars</surname><given-names>V.M.B.</given-names></name><name><surname>Elbadry</surname><given-names>M.</given-names></name><name><surname>Loeb</surname><given-names>J.</given-names></name><name><surname>Telisma</surname><given-names>T.</given-names></name><name><surname>Chavannes</surname><given-names>S.</given-names></name><name><surname>Anilis</surname><given-names>G.</given-names></name><name><surname>Cella</surname><given-names>E.</given-names></name><name><surname>Ciccozzi</surname><given-names>M.</given-names></name><name><surname>Okech</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Mayaro Virus in Child with Acute Febrile Illness, Haiti, 2015</article-title><source>Emerg. Infect. Dis.</source><year>2016</year><volume>22</volume><fpage>2000</fpage><lpage>2002</lpage><pub-id pub-id-type="doi">10.3201/eid2211.161015</pub-id><pub-id pub-id-type="pmid">27767924</pub-id></element-citation></ref><ref id="B62-microorganisms-07-00133"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>J.</given-names></name></person-group><article-title>On a outbreak of Dengue fever</article-title><source>Aust. Med. J.</source><year>1886</year><volume>8</volume><fpage>291</fpage><lpage>293</lpage></element-citation></ref><ref id="B63-microorganisms-07-00133"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolstenholme</surname><given-names>J.</given-names></name></person-group><article-title>Ross River virus disease&#x02014;The first recorded outbreak?</article-title><source>Aust. N. Z. J. Med.</source><year>1993</year><volume>23</volume><fpage>417</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1111/j.1445-5994.1993.tb01455.x</pub-id><pub-id pub-id-type="pmid">8240164</pub-id></element-citation></ref><ref id="B64-microorganisms-07-00133"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>R.</given-names></name><name><surname>Carley</surname><given-names>J.G.</given-names></name><name><surname>Mackerras</surname><given-names>M.J.</given-names></name><name><surname>Marks</surname><given-names>E.N.</given-names></name></person-group><article-title>Studies of arthropod-borne virus infections in Queensland. III. Isolation and characterization of virus strains from wild-caught mosquitoes in North Queensland</article-title><source>Aust. J. Exp. Biol. Med. Sci.</source><year>1963</year><volume>41</volume><fpage>17</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1038/icb.1963.2</pub-id><pub-id pub-id-type="pmid">14028387</pub-id></element-citation></ref><ref id="B65-microorganisms-07-00133"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>R.L.</given-names></name><name><surname>Gorman</surname><given-names>B.M.</given-names></name><name><surname>Whitehead</surname><given-names>R.H.</given-names></name><name><surname>Carley</surname><given-names>J.G.</given-names></name></person-group><article-title>Studies of epidemic polyarthritis: The significance of three group a arboviruses isolated from mosquitoes in queensland</article-title><source>Australas. Ann. Med.</source><year>1964</year><volume>13</volume><fpage>322</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1111/imj.1964.13.4.322</pub-id><pub-id pub-id-type="pmid">14237809</pub-id></element-citation></ref><ref id="B66-microorganisms-07-00133"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>R.L.</given-names></name><name><surname>Barrett</surname><given-names>E.J.</given-names></name><name><surname>Gorman</surname><given-names>B.M.</given-names></name><name><surname>Whitehead</surname><given-names>R.H.</given-names></name></person-group><article-title>Epidemic polyarthritis in Eastern Australia, 1959-1970</article-title><source>Med. J. Aust.</source><year>1971</year><volume>1</volume><fpage>5</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">5100546</pub-id></element-citation></ref><ref id="B67-microorganisms-07-00133"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>R.L.</given-names></name><name><surname>Carley</surname><given-names>J.G.</given-names></name><name><surname>Best</surname><given-names>J.C.</given-names></name></person-group><article-title>Isolation of Ross River virus from man</article-title><source>Med. J. Aust.</source><year>1972</year><volume>1</volume><fpage>1083</fpage><lpage>1084</lpage><pub-id pub-id-type="pmid">5040017</pub-id></element-citation></ref><ref id="B68-microorganisms-07-00133"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>K.</given-names></name><name><surname>Whelan</surname><given-names>P.</given-names></name><name><surname>Patel</surname><given-names>M.</given-names></name><name><surname>Currie</surname><given-names>B.</given-names></name></person-group><article-title>An outbreak of epidemic polyarthritis (Ross River virus disease) in the Northern Territory during the 1990-1991 wet season</article-title><source>Med. J. Aust.</source><year>1993</year><volume>158</volume><fpage>522</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">8098129</pub-id></element-citation></ref><ref id="B69-microorganisms-07-00133"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>S.A.</given-names></name><name><surname>Fanning</surname><given-names>I.D.</given-names></name><name><surname>Phillips</surname><given-names>D.A.</given-names></name><name><surname>Standfast</surname><given-names>H.A.</given-names></name><name><surname>Mcginn</surname><given-names>D.</given-names></name><name><surname>Kay</surname><given-names>B.H.</given-names></name></person-group><article-title>Ross River Virus in Mosquitoes (Diptera: Culicidae) During the 1994 Epidemic Around Brisbane, Australia</article-title><source>J. Med. Entomol.</source><year>1997</year><volume>34</volume><fpage>156</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1093/jmedent/34.2.156</pub-id><pub-id pub-id-type="pmid">9103757</pub-id></element-citation></ref><ref id="B70-microorganisms-07-00133"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>G.</given-names></name><name><surname>Doggett</surname><given-names>S.</given-names></name><name><surname>Seeman</surname><given-names>O.</given-names></name><name><surname>Russell</surname><given-names>R.C.</given-names></name><name><surname>Clancy</surname><given-names>J.</given-names></name><name><surname>Haniotis</surname><given-names>J.</given-names></name></person-group><article-title>Ross River virus and its vectors in Sorell Municipal Area, south-eastern Tasmania, January to March 2002</article-title><source>Commun. Dis. Intell.</source><year>2004</year><volume>28</volume><fpage>261</fpage><lpage>266</lpage></element-citation></ref><ref id="B71-microorganisms-07-00133"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knope</surname><given-names>K.</given-names></name><name><surname>Muller</surname><given-names>M.</given-names></name><name><surname>Kurucz</surname><given-names>N.</given-names></name><name><surname>Doggett</surname><given-names>S.</given-names></name><name><surname>Feldman</surname><given-names>R.</given-names></name><name><surname>Johansen</surname><given-names>C.</given-names></name><name><surname>Hobby</surname><given-names>M.</given-names></name><name><surname>Bennett</surname><given-names>S.</given-names></name><name><surname>Lynch</surname><given-names>S.</given-names></name><name><surname>Sly</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Arboviral diseases and malaria in Australia, 2013-14: Annual report of the National Arbovirus and Malaria Advisory Committee</article-title><source>Commun. Dis. Intell.</source><year>2016</year><volume>40</volume><fpage>E400</fpage><lpage>E436</lpage></element-citation></ref><ref id="B72-microorganisms-07-00133"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klapsing</surname><given-names>P.</given-names></name><name><surname>MacLean</surname><given-names>J.D.</given-names></name><name><surname>Glaze</surname><given-names>S.</given-names></name><name><surname>McClean</surname><given-names>K.L.</given-names></name><name><surname>Drebot</surname><given-names>M.A.</given-names></name><name><surname>Lanciotti</surname><given-names>R.S.</given-names></name><name><surname>Campbell</surname><given-names>G.L.</given-names></name></person-group><article-title>Ross River Virus Disease Reemergence, Fiji, 2003&#x02013;2004</article-title><source>Emerg. Infect. Dis.</source><year>2005</year><volume>11</volume><fpage>613</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.3201/eid1104.041070</pub-id><pub-id pub-id-type="pmid">15829203</pub-id></element-citation></ref><ref id="B73-microorganisms-07-00133"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aaskov</surname><given-names>J.G.</given-names></name><name><surname>Mataika</surname><given-names>J.U.</given-names></name><name><surname>Lawrence</surname><given-names>G.W.</given-names></name><name><surname>Rabukawaqa</surname><given-names>V.</given-names></name><name><surname>Tucker</surname><given-names>M.M.</given-names></name><name><surname>Miles</surname><given-names>J.A.R.</given-names></name></person-group><article-title>An Epidemic of Ross River Virus Infection in Fiji, 1979</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1981</year><volume>30</volume><fpage>1053</fpage><lpage>1059</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1981.30.1053</pub-id><pub-id pub-id-type="pmid">7283004</pub-id></element-citation></ref><ref id="B74-microorganisms-07-00133"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesh</surname><given-names>R.B.</given-names></name><name><surname>McLean</surname><given-names>R.G.</given-names></name><name><surname>Shroyer</surname><given-names>D.A.</given-names></name><name><surname>Calisher</surname><given-names>C.H.</given-names></name><name><surname>Rosen</surname><given-names>L.</given-names></name></person-group><article-title>Ross River virus (Togaviridae: Alphavirus) infection (epidemic polyarthritis) in American Samoa</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1981</year><volume>75</volume><fpage>426</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(81)90112-7</pub-id><pub-id pub-id-type="pmid">7324110</pub-id></element-citation></ref><ref id="B75-microorganisms-07-00133"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosen</surname><given-names>L.</given-names></name><name><surname>Gubler</surname><given-names>D.J.</given-names></name><name><surname>Bennett</surname><given-names>P.H.</given-names></name></person-group><article-title>EPIDEMIC POLYARTHRTTIS (ROSS RIVER) VIRUS INFECTION IN THE COOK ISLANDS</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1981</year><volume>30</volume><fpage>1294</fpage><lpage>1302</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1981.30.1294</pub-id><?supplied-pmid 7325286?><pub-id pub-id-type="pmid">7325286</pub-id></element-citation></ref><ref id="B76-microorganisms-07-00133"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halstead</surname><given-names>S.B.</given-names></name><name><surname>Udomsakdi</surname><given-names>S.</given-names></name></person-group><article-title>Vertebrate hosts of chikungunya virus</article-title><source>Bull. World Health Organ.</source><year>1966</year><volume>35</volume><fpage>89</fpage><?supplied-pmid 20604287?><pub-id pub-id-type="pmid">20604287</pub-id></element-citation></ref><ref id="B77-microorganisms-07-00133"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eastwood</surname><given-names>G.</given-names></name><name><surname>Sang</surname><given-names>R.C.</given-names></name><name><surname>Guerbois</surname><given-names>M.</given-names></name><name><surname>Taracha</surname><given-names>E.L.N.</given-names></name><name><surname>Weaver</surname><given-names>S.C.</given-names></name></person-group><article-title>Enzootic Circulation of Chikungunya Virus in East Africa: Serological Evidence in Non-human Kenyan Primates</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2017</year><volume>97</volume><fpage>1399</fpage><lpage>1404</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.17-0126</pub-id><?supplied-pmid 29016323?><pub-id pub-id-type="pmid">29016323</pub-id></element-citation></ref><ref id="B78-microorganisms-07-00133"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinbren</surname><given-names>M.</given-names></name><name><surname>Haddow</surname><given-names>A.</given-names></name><name><surname>Williams</surname><given-names>M.</given-names></name></person-group><article-title>The occurrence of chikungunya virus in Uganda I. Isolation from mosquitoes</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1958</year><volume>52</volume><fpage>253</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(58)90084-1</pub-id><pub-id pub-id-type="pmid">13556869</pub-id></element-citation></ref><ref id="B79-microorganisms-07-00133"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>V.R.</given-names></name><name><surname>Marshall</surname><given-names>J.D.</given-names></name><name><surname>Guilloud</surname><given-names>N.B.</given-names></name></person-group><article-title>The Presence of Antibody to Chikungunya and Other Serologically Related Viruses in the Sera of Sub-Human Primate Imports to the United States</article-title><source>J. Immunol.</source><year>1966</year><volume>98</volume><fpage>5</fpage></element-citation></ref><ref id="B80-microorganisms-07-00133"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntosh</surname><given-names>B.M.</given-names></name></person-group><article-title>Antibody against Chikungunya virus in wild primates in Southern Africa</article-title><source>S. Afr. J. Med. Sci.</source><year>1970</year><volume>35</volume><fpage>65</fpage><lpage>74</lpage><?supplied-pmid 4398581?><pub-id pub-id-type="pmid">4398581</pub-id></element-citation></ref><ref id="B81-microorganisms-07-00133"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pialoux</surname><given-names>G.</given-names></name><name><surname>Ga&#x000fc;z&#x000e8;re</surname><given-names>B.-A.</given-names></name><name><surname>Jaur&#x000e9;guiberry</surname><given-names>S.</given-names></name><name><surname>Strobel</surname><given-names>M.</given-names></name></person-group><article-title>Chikungunya, an epidemic arbovirosis</article-title><source>Lancet Infect. Dis.</source><year>2007</year><volume>7</volume><fpage>319</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(07)70107-X</pub-id><pub-id pub-id-type="pmid">17448935</pub-id></element-citation></ref><ref id="B82-microorganisms-07-00133"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lumsden</surname><given-names>W.H.</given-names></name></person-group><article-title>An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952&#x02013;1953 II. General description and epidemiology</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1955</year><volume>49</volume><fpage>33</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(55)90081-X</pub-id><pub-id pub-id-type="pmid">14373835</pub-id></element-citation></ref><ref id="B83-microorganisms-07-00133"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuffenecker</surname><given-names>I.</given-names></name><name><surname>Iteman</surname><given-names>I.</given-names></name><name><surname>Michault</surname><given-names>A.</given-names></name><name><surname>Murri</surname><given-names>S.</given-names></name><name><surname>Frangeul</surname><given-names>L.</given-names></name><name><surname>Vaney</surname><given-names>M.-C.</given-names></name><name><surname>Lavenir</surname><given-names>R.</given-names></name><name><surname>Pardigon</surname><given-names>N.</given-names></name><name><surname>Reynes</surname><given-names>J.-M.</given-names></name><name><surname>Pettinelli</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak</article-title><source>PLoS Med.</source><year>2006</year><volume>3</volume><elocation-id>e263</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0030263</pub-id><pub-id pub-id-type="pmid">16700631</pub-id></element-citation></ref><ref id="B84-microorganisms-07-00133"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vazeille</surname><given-names>M.</given-names></name><name><surname>Moutailler</surname><given-names>S.</given-names></name><name><surname>Coudrier</surname><given-names>D.</given-names></name><name><surname>Rousseaux</surname><given-names>C.</given-names></name><name><surname>Khun</surname><given-names>H.</given-names></name><name><surname>Huerre</surname><given-names>M.</given-names></name><name><surname>Thiria</surname><given-names>J.</given-names></name><name><surname>Dehecq</surname><given-names>J.-S.</given-names></name><name><surname>Fontenille</surname><given-names>D.</given-names></name><name><surname>Schuffenecker</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus</article-title><source>PLoS ONE</source><year>2007</year><volume>2</volume><elocation-id>e1168</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0001168</pub-id><?supplied-pmid 18000540?><pub-id pub-id-type="pmid">18000540</pub-id></element-citation></ref><ref id="B85-microorganisms-07-00133"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsetsarkin</surname><given-names>K.A.</given-names></name><name><surname>Vanlandingham</surname><given-names>D.L.</given-names></name><name><surname>McGee</surname><given-names>C.E.</given-names></name><name><surname>Higgs</surname><given-names>S.</given-names></name></person-group><article-title>A single mutation in chikungunya virus affects vector specificity and epidemic potential</article-title><source>PLoS Pathog.</source><year>2007</year><volume>3</volume><elocation-id>e201</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.0030201</pub-id><?supplied-pmid 18069894?><pub-id pub-id-type="pmid">18069894</pub-id></element-citation></ref><ref id="B86-microorganisms-07-00133"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kading</surname><given-names>R.C.</given-names></name><name><surname>Borland</surname><given-names>E.M.</given-names></name><name><surname>Cranfield</surname><given-names>M.</given-names></name><name><surname>Powers</surname><given-names>A.M.</given-names></name></person-group><article-title>Prevalence of antibodies to alphaviruses and flaviviruses in free-ranging game animals and nonhuman primates in the greater Congo basin</article-title><source>J. Wildl. Dis.</source><year>2013</year><volume>49</volume><fpage>587</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.7589/2012-08-212</pub-id><pub-id pub-id-type="pmid">23778608</pub-id></element-citation></ref><ref id="B87-microorganisms-07-00133"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbet</surname><given-names>P.S.</given-names></name><name><surname>Williams</surname><given-names>M.C.</given-names></name><name><surname>Gillett</surname><given-names>J.D.</given-names></name></person-group><article-title>O&#x02019;nyong&#x02019;nyong fever: An epidemic virus disease in East Africa. IV. Vector studies at epidemic sites</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1961</year><volume>55</volume><fpage>463</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(61)90095-5</pub-id><pub-id pub-id-type="pmid">13881254</pub-id></element-citation></ref><ref id="B88-microorganisms-07-00133"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>B.K.</given-names></name><name><surname>Gichogo</surname><given-names>A.</given-names></name><name><surname>Gitau</surname><given-names>G.</given-names></name><name><surname>Patel</surname><given-names>N.</given-names></name><name><surname>Ademba</surname><given-names>G.</given-names></name><name><surname>Kirui</surname><given-names>R.</given-names></name><name><surname>Highton</surname><given-names>R.B.</given-names></name><name><surname>Smith</surname><given-names>D.H.</given-names></name></person-group><article-title>Recovery of O&#x02019;nyong&#x02019;nyong virus from Anopheles funestus in Western Kenya</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1981</year><volume>75</volume><fpage>239</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(81)90325-4</pub-id><pub-id pub-id-type="pmid">6272457</pub-id></element-citation></ref><ref id="B89-microorganisms-07-00133"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutwama</surname><given-names>J.J.</given-names></name><name><surname>Kayondo</surname><given-names>J.</given-names></name><name><surname>Savage</surname><given-names>H.M.</given-names></name><name><surname>Burkot</surname><given-names>T.R.</given-names></name><name><surname>Miller</surname><given-names>B.R.</given-names></name></person-group><article-title>Epidemic O&#x02019;nyong&#x02019;nyong fever in southcentral Uganda, 1996-1997: Entomologic studies in Bbaale village, Rakai District</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1999</year><volume>61</volume><fpage>158</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1999.61.158</pub-id><pub-id pub-id-type="pmid">10432073</pub-id></element-citation></ref><ref id="B90-microorganisms-07-00133"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanlandingham</surname><given-names>D.L.</given-names></name><name><surname>Hong</surname><given-names>C.</given-names></name><name><surname>Klingler</surname><given-names>K.</given-names></name><name><surname>Tsetsarkin</surname><given-names>K.</given-names></name><name><surname>McElroy</surname><given-names>K.L.</given-names></name><name><surname>Powers</surname><given-names>A.M.</given-names></name><name><surname>Lehane</surname><given-names>M.J.</given-names></name><name><surname>Higgs</surname><given-names>S.</given-names></name></person-group><article-title>Differential infectivities of O&#x02019;nyong&#x02019;nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2005</year><volume>72</volume><fpage>616</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2005.72.616</pub-id><pub-id pub-id-type="pmid">15891138</pub-id></element-citation></ref><ref id="B91-microorganisms-07-00133"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoch</surname><given-names>A.L.</given-names></name><name><surname>Peterson</surname><given-names>N.E.</given-names></name><name><surname>LeDuc</surname><given-names>J.W.</given-names></name><name><surname>Pinheiro</surname><given-names>F.P.</given-names></name></person-group><article-title>An outbreak of Mayaro virus disease in Belterra, Brazil. III. Entomological and ecological studies</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1981</year><volume>30</volume><fpage>689</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1981.30.689</pub-id><pub-id pub-id-type="pmid">6266265</pub-id></element-citation></ref><ref id="B92-microorganisms-07-00133"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seymour</surname><given-names>C.</given-names></name><name><surname>Peralta</surname><given-names>P.H.</given-names></name><name><surname>Montgomery</surname><given-names>G.G.</given-names></name></person-group><article-title>Serologic evidence of natural togavirus infections in Panamanian sloths and other vertebrates</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1983</year><volume>32</volume><fpage>854</fpage><lpage>861</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1983.32.854</pub-id><?supplied-pmid 6309027?><pub-id pub-id-type="pmid">6309027</pub-id></element-citation></ref><ref id="B93-microorganisms-07-00133"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Thoisy</surname><given-names>B.</given-names></name><name><surname>Vogel</surname><given-names>I.</given-names></name><name><surname>Reynes</surname><given-names>J.M.</given-names></name><name><surname>Pouliquen</surname><given-names>J.F.</given-names></name><name><surname>Carme</surname><given-names>B.</given-names></name><name><surname>Kazanji</surname><given-names>M.</given-names></name><name><surname>Vi&#x000e9;</surname><given-names>J.C.</given-names></name></person-group><article-title>Health evaluation of translocated free-ranging primates in French Guiana</article-title><source>Am. J. Primatol.</source><year>2001</year><volume>54</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1002/ajp.1008</pub-id><pub-id pub-id-type="pmid">11329164</pub-id></element-citation></ref><ref id="B94-microorganisms-07-00133"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Thoisy</surname><given-names>B.</given-names></name><name><surname>Gardon</surname><given-names>J.</given-names></name><name><surname>Salas</surname><given-names>R.A.</given-names></name><name><surname>Morvan</surname><given-names>J.</given-names></name><name><surname>Kazanji</surname><given-names>M.</given-names></name></person-group><article-title>Mayaro virus in wild mammals, French Guiana</article-title><source>Emerg. Infect. Dis.</source><year>2003</year><volume>9</volume><fpage>1326</fpage><lpage>1329</lpage><pub-id pub-id-type="doi">10.3201/eid0910.030161</pub-id><?supplied-pmid 14609474?><pub-id pub-id-type="pmid">14609474</pub-id></element-citation></ref><ref id="B95-microorganisms-07-00133"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calisher</surname><given-names>C.H.</given-names></name><name><surname>Guti&#x000e9;rrez</surname><given-names>E.</given-names></name><name><surname>Maness</surname><given-names>K.S.</given-names></name><name><surname>Lord</surname><given-names>R.D.</given-names></name></person-group><article-title>Isolation of Mayaro virus from a migrating bird captured in Louisiana in 1967</article-title><source>Bull. Pan Am. Health Organ.</source><year>1974</year><volume>8</volume><fpage>243</fpage><lpage>248</lpage><?supplied-pmid 4418030?><pub-id pub-id-type="pmid">4418030</pub-id></element-citation></ref><ref id="B96-microorganisms-07-00133"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aitken</surname><given-names>T.H.</given-names></name><name><surname>Downs</surname><given-names>W.G.</given-names></name><name><surname>Anderson</surname><given-names>C.R.</given-names></name><name><surname>Spence</surname><given-names>L.</given-names></name><name><surname>Casals</surname><given-names>J.</given-names></name></person-group><article-title>Mayaro virus isolated from a Trinidadian mosquito, Mansonia venezuelensis</article-title><source>Science</source><year>1960</year><volume>131</volume><fpage>986</fpage><pub-id pub-id-type="doi">10.1126/science.131.3405.986</pub-id></element-citation></ref><ref id="B97-microorganisms-07-00133"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maia</surname><given-names>L.M.S.</given-names></name><name><surname>Bezerra</surname><given-names>M.C.F.</given-names></name><name><surname>Costa</surname><given-names>M.C.S.</given-names></name><name><surname>Souza</surname><given-names>E.M.</given-names></name><name><surname>Oliveira</surname><given-names>M.E.B.</given-names></name><name><surname>Ribeiro</surname><given-names>A.L.M.</given-names></name><name><surname>Miyazaki</surname><given-names>R.D.</given-names></name><name><surname>Slhessarenko</surname><given-names>R.D.</given-names></name></person-group><article-title>Natural vertical infection by dengue virus serotype 4, Zika virus and Mayaro virus in Aedes (Stegomyia) aegypti and Aedes (Stegomyia) albopictus</article-title><source>Med. Vet. Entomol.</source><year>2019</year><pub-id pub-id-type="doi">10.1111/mve.12369</pub-id></element-citation></ref><ref id="B98-microorganisms-07-00133"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>G.C.</given-names></name><name><surname>Francy</surname><given-names>D.B.</given-names></name></person-group><article-title>Laboratory studies of a Brazilian strain of Aedes albopictus as a potential vector of Mayaro and Oropouche viruses</article-title><source>J. Am. Mosq. Control Assoc.</source><year>1991</year><volume>7</volume><fpage>89</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">1646286</pub-id></element-citation></ref><ref id="B99-microorganisms-07-00133"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>K.C.</given-names></name><name><surname>Ziegler</surname><given-names>S.A.</given-names></name><name><surname>Thangamani</surname><given-names>S.</given-names></name><name><surname>Hausser</surname><given-names>N.L.</given-names></name><name><surname>Kochel</surname><given-names>T.J.</given-names></name><name><surname>Higgs</surname><given-names>S.</given-names></name><name><surname>Tesh</surname><given-names>R.B.</given-names></name></person-group><article-title>Experimental transmission of Mayaro virus by Aedes aegypti</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2011</year><volume>85</volume><fpage>750</fpage><lpage>757</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2011.11-0359</pub-id><?supplied-pmid 21976583?><pub-id pub-id-type="pmid">21976583</pub-id></element-citation></ref><ref id="B100-microorganisms-07-00133"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiggins</surname><given-names>K.</given-names></name><name><surname>Eastmond</surname><given-names>B.</given-names></name><name><surname>Alto</surname><given-names>B.W.</given-names></name></person-group><article-title>Transmission potential of Mayaro virus in Florida Aedes aegypti and Aedes albopictus mosquitoes</article-title><source>Med. Vet. Entomol.</source><year>2018</year><volume>32</volume><fpage>436</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1111/mve.12322</pub-id><?supplied-pmid 30006976?><pub-id pub-id-type="pmid">30006976</pub-id></element-citation></ref><ref id="B101-microorganisms-07-00133"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brustolin</surname><given-names>M.</given-names></name><name><surname>Pujhari</surname><given-names>S.</given-names></name><name><surname>Henderson</surname><given-names>C.A.</given-names></name><name><surname>Rasgon</surname><given-names>J.L.</given-names></name></person-group><article-title>Anopheles mosquitoes may drive invasion and transmission of Mayaro virus across geographically diverse regions</article-title><source>PLoS Negl. Trop. Dis.</source><year>2018</year><volume>12</volume><elocation-id>e0006895</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0006895</pub-id><?supplied-pmid 30403665?><pub-id pub-id-type="pmid">30403665</pub-id></element-citation></ref><ref id="B102-microorganisms-07-00133"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kantor</surname><given-names>A.M.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>A.</given-names></name><name><surname>Thompson</surname><given-names>D.C.</given-names></name><name><surname>Franz</surname><given-names>A.W.E.</given-names></name></person-group><article-title>Infection Pattern of Mayaro Virus in Aedes aegypti (Diptera: Culicidae) and Transmission Potential of the Virus in Mixed Infections With Chikungunya Virus</article-title><source>J. Med. Entomol.</source><year>2019</year><volume>56</volume><fpage>832</fpage><lpage>843</lpage><pub-id pub-id-type="doi">10.1093/jme/tjy241</pub-id><pub-id pub-id-type="pmid">30668762</pub-id></element-citation></ref><ref id="B103-microorganisms-07-00133"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>M.G.</given-names></name></person-group><article-title>Ecological and life history traits are associated with Ross River virus infection among sylvatic mammals in Australia</article-title><source>BMC Ecol.</source><year>2019</year><volume>19</volume><elocation-id>2</elocation-id><pub-id pub-id-type="doi">10.1186/s12898-019-0220-5</pub-id><pub-id pub-id-type="pmid">30646881</pub-id></element-citation></ref><ref id="B104-microorganisms-07-00133"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potter</surname><given-names>A.</given-names></name><name><surname>Johansen</surname><given-names>C.A.</given-names></name><name><surname>Fenwick</surname><given-names>S.</given-names></name><name><surname>Reid</surname><given-names>S.A.</given-names></name><name><surname>Lindsay</surname><given-names>M.D.A.</given-names></name></person-group><article-title>The seroprevalence and factors associated with Ross river virus infection in western grey kangaroos (Macropus fuliginosus) in Western Australia</article-title><source>Vector Borne Zoonotic Dis.</source><year>2014</year><volume>14</volume><fpage>740</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1089/vbz.2014.1617</pub-id><pub-id pub-id-type="pmid">25325318</pub-id></element-citation></ref><ref id="B105-microorganisms-07-00133"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flies</surname><given-names>E.J.</given-names></name><name><surname>Flies</surname><given-names>A.S.</given-names></name><name><surname>Fricker</surname><given-names>S.R.</given-names></name><name><surname>Weinstein</surname><given-names>P.</given-names></name><name><surname>Williams</surname><given-names>C.R.</given-names></name></person-group><article-title>Regional Comparison of Mosquito Bloodmeals in South Australia: Implications for Ross River Virus Ecology</article-title><source>J. Med. Entomol.</source><year>2016</year><volume>53</volume><fpage>902</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1093/jme/tjw035</pub-id><pub-id pub-id-type="pmid">27113100</pub-id></element-citation></ref><ref id="B106-microorganisms-07-00133"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koolhof</surname><given-names>I.S.</given-names></name><name><surname>Carver</surname><given-names>S.</given-names></name></person-group><article-title>Epidemic host community contribution to mosquito-borne disease transmission: Ross River virus</article-title><source>Epidemiol. Infect.</source><year>2017</year><volume>145</volume><fpage>656</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1017/S0950268816002739</pub-id><pub-id pub-id-type="pmid">27890043</pub-id></element-citation></ref><ref id="B107-microorganisms-07-00133"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephenson</surname><given-names>E.B.</given-names></name><name><surname>Peel</surname><given-names>A.J.</given-names></name><name><surname>Reid</surname><given-names>S.A.</given-names></name><name><surname>Jansen</surname><given-names>C.C.</given-names></name><name><surname>McCallum</surname><given-names>H.</given-names></name></person-group><article-title>The non-human reservoirs of Ross River virus: A systematic review of the evidence</article-title><source>Parasit. Vectors</source><year>2018</year><volume>11</volume><fpage>188</fpage><pub-id pub-id-type="doi">10.1186/s13071-018-2733-8</pub-id><pub-id pub-id-type="pmid">29554936</pub-id></element-citation></ref><ref id="B108-microorganisms-07-00133"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>C.</given-names></name><name><surname>Aubry</surname><given-names>M.</given-names></name><name><surname>Musso</surname><given-names>D.</given-names></name><name><surname>Teissier</surname><given-names>A.</given-names></name><name><surname>Paulous</surname><given-names>S.</given-names></name><name><surname>Despr&#x000e8;s</surname><given-names>P.</given-names></name><name><surname>de-Lamballerie</surname><given-names>X.</given-names></name><name><surname>Pastorino</surname><given-names>B.</given-names></name><name><surname>Cao-Lormeau</surname><given-names>V.-M.</given-names></name><name><surname>Weinstein</surname><given-names>P.</given-names></name></person-group><article-title>New evidence for endemic circulation of Ross River virus in the Pacific Islands and the potential for emergence</article-title><source>Int. J. Infect. Dis.</source><year>2017</year><volume>57</volume><fpage>73</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2017.01.041</pub-id><pub-id pub-id-type="pmid">28188934</pub-id></element-citation></ref><ref id="B109-microorganisms-07-00133"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gummow</surname><given-names>B.</given-names></name><name><surname>Tan</surname><given-names>R.</given-names></name><name><surname>Joice</surname><given-names>R.K.</given-names></name><name><surname>Burgess</surname><given-names>G.</given-names></name><name><surname>Picard</surname><given-names>J.</given-names></name></person-group><article-title>Seroprevalence and associated risk factors of mosquito-borne alphaviruses in horses in northern Queensland</article-title><source>Aust. Vet. J.</source><year>2018</year><volume>96</volume><fpage>243</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1111/avj.12711</pub-id><pub-id pub-id-type="pmid">29944744</pub-id></element-citation></ref><ref id="B110-microorganisms-07-00133"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacups</surname><given-names>S.P.</given-names></name><name><surname>Whelan</surname><given-names>P.I.</given-names></name><name><surname>Currie</surname><given-names>B.J.</given-names></name></person-group><article-title>Ross River Virus and Barmah Forest Virus Infections: A Review of History, Ecology, and Predictive Models, with Implications for Tropical Northern Australia</article-title><source>Vector Borne Zoonotic Dis.</source><year>2008</year><volume>8</volume><fpage>283</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1089/vbz.2007.0152</pub-id><pub-id pub-id-type="pmid">18279007</pub-id></element-citation></ref><ref id="B111-microorganisms-07-00133"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gratz</surname><given-names>N.G.</given-names></name></person-group><article-title>Critical review of the vector status of Aedes albopictus</article-title><source>Med. Vet. Entomol.</source><year>2004</year><volume>18</volume><fpage>215</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1111/j.0269-283X.2004.00513.x</pub-id><pub-id pub-id-type="pmid">15347388</pub-id></element-citation></ref><ref id="B112-microorganisms-07-00133"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasci</surname><given-names>R.S.</given-names></name><name><surname>Mitchell</surname><given-names>C.J.</given-names></name></person-group><article-title>Larval diet, adult size, and susceptibility of Aedes aegypti (Diptera: Culicidae) to infection with Ross River virus</article-title><source>J. Med. Entomol.</source><year>1994</year><volume>31</volume><fpage>123</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1093/jmedent/31.1.123</pub-id><pub-id pub-id-type="pmid">8158614</pub-id></element-citation></ref><ref id="B113-microorganisms-07-00133"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>C.J.</given-names></name><name><surname>Miller</surname><given-names>B.R.</given-names></name><name><surname>Gubler</surname><given-names>D.J.</given-names></name></person-group><article-title>Vector competence of Aedes albopictus from Houston, Texas, for dengue serotypes 1 to 4, yellow fever and Ross River viruses</article-title><source>J. Am. Mosq. Control Assoc.</source><year>1987</year><volume>3</volume><fpage>460</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">2849638</pub-id></element-citation></ref><ref id="B114-microorganisms-07-00133"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>C.J.</given-names></name><name><surname>Gubler</surname><given-names>D.J.</given-names></name></person-group><article-title>Vector competence of geographic strains of Aedes albopictus and Aedes polynesiensis and certain other Aedes (Stegomyia) mosquitoes for Ross River virus</article-title><source>J. Am. Mosq. Control Assoc.</source><year>1987</year><volume>3</volume><fpage>142</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">2849637</pub-id></element-citation></ref><ref id="B115-microorganisms-07-00133"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subissi</surname><given-names>L.</given-names></name><name><surname>Daudens-Vaysse</surname><given-names>E.</given-names></name><name><surname>Cassadou</surname><given-names>S.</given-names></name><name><surname>Ledrans</surname><given-names>M.</given-names></name><name><surname>Bompard</surname><given-names>P.</given-names></name><name><surname>Gustave</surname><given-names>J.</given-names></name><name><surname>Aubry</surname><given-names>M.</given-names></name><name><surname>Cao-Lormeau</surname><given-names>V.-M.</given-names></name><name><surname>Mallet</surname><given-names>H.-P.</given-names></name></person-group><article-title>Revising rates of asymptomatic Zika virus infection based on sentinel surveillance data from French Overseas Territories</article-title><source>Int. J. Infect. Dis.</source><year>2017</year><volume>65</volume><fpage>116</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2017.10.009</pub-id><pub-id pub-id-type="pmid">29081369</pub-id></element-citation></ref><ref id="B116-microorganisms-07-00133"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grange</surname><given-names>L.</given-names></name><name><surname>Simon-Loriere</surname><given-names>E.</given-names></name><name><surname>Sakuntabhai</surname><given-names>A.</given-names></name><name><surname>Gresh</surname><given-names>L.</given-names></name><name><surname>Paul</surname><given-names>R.</given-names></name><name><surname>Harris</surname><given-names>E.</given-names></name></person-group><article-title>Epidemiological Risk Factors Associated with High Global Frequency of Inapparent Dengue Virus Infections</article-title><source>Front. Immunol.</source><year>2014</year><volume>5</volume><fpage>280</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2014.00280</pub-id><pub-id pub-id-type="pmid">24966859</pub-id></element-citation></ref><ref id="B117-microorganisms-07-00133"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moro</surname><given-names>M.L.</given-names></name><name><surname>Gagliotti</surname><given-names>C.</given-names></name><name><surname>Silvi</surname><given-names>G.</given-names></name><name><surname>Angelini</surname><given-names>R.</given-names></name><name><surname>Sambri</surname><given-names>V.</given-names></name><name><surname>Rezza</surname><given-names>G.</given-names></name><name><surname>Massimiliani</surname><given-names>E.</given-names></name><name><surname>Mattivi</surname><given-names>A.</given-names></name><name><surname>Grilli</surname><given-names>E.</given-names></name><name><surname>Finarelli</surname><given-names>A.C.</given-names></name><etal/></person-group><article-title>Chikungunya virus in North-Eastern Italy: A seroprevalence survey</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2010</year><volume>82</volume><fpage>508</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2010.09-0322</pub-id><pub-id pub-id-type="pmid">20207883</pub-id></element-citation></ref><ref id="B118-microorganisms-07-00133"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouard</surname><given-names>C.</given-names></name><name><surname>Bernillon</surname><given-names>P.</given-names></name><name><surname>Quatresous</surname><given-names>I.</given-names></name><name><surname>Pillonel</surname><given-names>J.</given-names></name><name><surname>Assal</surname><given-names>A.</given-names></name><name><surname>De Valk</surname><given-names>H.</given-names></name><name><surname>Desenclos</surname><given-names>J.-C.</given-names></name></person-group><article-title>Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007</article-title><source>Transfusion</source><year>2008</year><volume>48</volume><fpage>1333</fpage><lpage>1341</lpage><pub-id pub-id-type="doi">10.1111/j.1537-2995.2008.01646.x</pub-id><pub-id pub-id-type="pmid">18298600</pub-id></element-citation></ref><ref id="B119-microorganisms-07-00133"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>F.</given-names></name><name><surname>Javelle</surname><given-names>E.</given-names></name><name><surname>Cabie</surname><given-names>A.</given-names></name><name><surname>Bouquillard</surname><given-names>E.</given-names></name><name><surname>Troisgros</surname><given-names>O.</given-names></name><name><surname>Gentile</surname><given-names>G.</given-names></name><name><surname>Leparc-Goffart</surname><given-names>I.</given-names></name><name><surname>Hoen</surname><given-names>B.</given-names></name><name><surname>Gandjbakhch</surname><given-names>F.</given-names></name><name><surname>Rene-Corail</surname><given-names>P.</given-names></name><etal/></person-group><article-title>French guidelines for the management of chikungunya (acute and persistent presentations). November 2014</article-title><source>M&#x000e9;decine Mal. Infect.</source><year>2015</year><volume>45</volume><fpage>243</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.medmal.2015.05.007</pub-id></element-citation></ref><ref id="B120-microorganisms-07-00133"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aubry</surname><given-names>M.</given-names></name><name><surname>Teissier</surname><given-names>A.</given-names></name><name><surname>Huart</surname><given-names>M.</given-names></name><name><surname>Merceron</surname><given-names>S.</given-names></name><name><surname>Vanhomwegen</surname><given-names>J.</given-names></name><name><surname>Mapotoeke</surname><given-names>M.</given-names></name><name><surname>Mariteragi-Helle</surname><given-names>T.</given-names></name><name><surname>Roche</surname><given-names>C.</given-names></name><name><surname>Vial</surname><given-names>A.-L.</given-names></name><name><surname>Teururai</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Seroprevalence of Dengue and Chikungunya Virus Antibodies, French Polynesia, 2014&#x02013;2015</article-title><source>Emerg. Infect. Dis.</source><year>2018</year><volume>24</volume><fpage>558</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.3201/eid2403.171149</pub-id><pub-id pub-id-type="pmid">29460745</pub-id></element-citation></ref><ref id="B121-microorganisms-07-00133"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>I.-K.</given-names></name><name><surname>Alera</surname><given-names>M.T.</given-names></name><name><surname>Lago</surname><given-names>C.B.</given-names></name><name><surname>Tac-An</surname><given-names>I.A.</given-names></name><name><surname>Villa</surname><given-names>D.</given-names></name><name><surname>Fernandez</surname><given-names>S.</given-names></name><name><surname>Thaisomboonsuk</surname><given-names>B.</given-names></name><name><surname>Klungthong</surname><given-names>C.</given-names></name><name><surname>Levy</surname><given-names>J.W.</given-names></name><name><surname>Velasco</surname><given-names>J.M.</given-names></name><etal/></person-group><article-title>High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines</article-title><source>PLoS Negl. Trop. Dis.</source><year>2015</year><volume>9</volume><elocation-id>e0003764</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0003764</pub-id><pub-id pub-id-type="pmid">25951202</pub-id></element-citation></ref><ref id="B122-microorganisms-07-00133"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shore</surname><given-names>H.</given-names></name></person-group><article-title>O&#x02019;nyong&#x02019;nyong fever: An epidemic virus disease in east africa. III. Some clinical and epidemiological observations in the northern province of uganda</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1961</year><volume>5</volume><fpage>361</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(61)90106-7</pub-id></element-citation></ref><ref id="B123-microorganisms-07-00133"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>M.C.</given-names></name><name><surname>Woodall</surname><given-names>J.P.</given-names></name><name><surname>Porterfield</surname><given-names>J.S.</given-names></name></person-group><article-title>O&#x02019;nyong&#x02019;nyong fever: An epidemic virus disease in East Africa. V Human antibody studies by plaque inhibition and other serological tests</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1962</year><volume>56</volume><fpage>166</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(62)90144-X</pub-id><pub-id pub-id-type="pmid">14038061</pub-id></element-citation></ref><ref id="B124-microorganisms-07-00133"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>M.C.</given-names></name><name><surname>Woodall</surname><given-names>J.P.</given-names></name><name><surname>Gillett</surname><given-names>J.D.</given-names></name></person-group><article-title>O&#x02019;nyong&#x02019;nyong fever: An epidemic virus disease in east africa. VII. Virus isolations from man and serological studies up to july 1961</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1965</year><volume>59</volume><fpage>186</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(65)90080-5</pub-id><pub-id pub-id-type="pmid">14297194</pub-id></element-citation></ref><ref id="B125-microorganisms-07-00133"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkes</surname><given-names>R.A.</given-names></name><name><surname>Boughton</surname><given-names>C.R.</given-names></name><name><surname>Naim</surname><given-names>H.M.</given-names></name><name><surname>Stallman</surname><given-names>N.D.</given-names></name></person-group><article-title>A major outbreak of epidemic polyarthritis in New South Wales during the summer of 1983/1984</article-title><source>Med. J. Aust.</source><year>1985</year><volume>143</volume><fpage>330</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">4046944</pub-id></element-citation></ref><ref id="B126-microorganisms-07-00133"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harley</surname><given-names>D.</given-names></name><name><surname>Sleigh</surname><given-names>A.</given-names></name><name><surname>Ritchie</surname><given-names>S.</given-names></name></person-group><article-title>Ross River Virus Transmission, Infection, and Disease: A Cross-Disciplinary Review</article-title><source>Clin. Microbiol. Rev.</source><year>2001</year><volume>14</volume><fpage>909</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1128/CMR.14.4.909-932.2001</pub-id><pub-id pub-id-type="pmid">11585790</pub-id></element-citation></ref><ref id="B127-microorganisms-07-00133"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shanks</surname><given-names>G.D.</given-names></name></person-group><article-title>Could Ross River Virus Be the Next Zika?</article-title><source>J. Travel Med.</source><year>2019</year><pub-id pub-id-type="doi">10.1093/jtm/taz003</pub-id></element-citation></ref><ref id="B128-microorganisms-07-00133"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borgherini</surname><given-names>G.</given-names></name><name><surname>Poubeau</surname><given-names>P.</given-names></name><name><surname>Staikowsky</surname><given-names>F.</given-names></name><name><surname>Lory</surname><given-names>M.</given-names></name><name><surname>Moullec</surname><given-names>N.L.</given-names></name><name><surname>Becquart</surname><given-names>J.P.</given-names></name><name><surname>Wengling</surname><given-names>C.</given-names></name><name><surname>Michault</surname><given-names>A.</given-names></name><name><surname>Paganin</surname><given-names>F.</given-names></name></person-group><article-title>Outbreak of Chikungunya on Reunion Island: Early Clinical and Laboratory Features in 157 Adult Patients</article-title><source>Clin. Infect. Dis.</source><year>2007</year><volume>44</volume><fpage>1401</fpage><lpage>1407</lpage><pub-id pub-id-type="doi">10.1086/517537</pub-id><pub-id pub-id-type="pmid">17479933</pub-id></element-citation></ref><ref id="B129-microorganisms-07-00133"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiruvengadam</surname><given-names>K.V.</given-names></name><name><surname>Kalyanasundaram</surname><given-names>V.</given-names></name><name><surname>Rajgopal</surname><given-names>J.</given-names></name></person-group><article-title>Clinical and pathological studies on chikungunya fever in Madras city</article-title><source>Indian J. Med. Res.</source><year>1965</year><volume>53</volume><fpage>729</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">5830407</pub-id></element-citation></ref><ref id="B130-microorganisms-07-00133"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couturier</surname><given-names>E.</given-names></name><name><surname>Guillemin</surname><given-names>F.</given-names></name><name><surname>Mura</surname><given-names>M.</given-names></name><name><surname>L&#x000e9;on</surname><given-names>L.</given-names></name><name><surname>Virion</surname><given-names>J.-M.</given-names></name><name><surname>Letort</surname><given-names>M.-J.</given-names></name><name><surname>De Valk</surname><given-names>H.</given-names></name><name><surname>Simon</surname><given-names>F.</given-names></name><name><surname>Vaillant</surname><given-names>V.</given-names></name></person-group><article-title>Impaired quality of life after chikungunya virus infection: A 2-year follow-up study</article-title><source>Rheumatology</source><year>2012</year><volume>51</volume><fpage>1315</fpage><lpage>1322</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/kes015</pub-id><pub-id pub-id-type="pmid">22427407</pub-id></element-citation></ref><ref id="B131-microorganisms-07-00133"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manimunda</surname><given-names>S.P.</given-names></name><name><surname>Vijayachari</surname><given-names>P.</given-names></name><name><surname>Uppoor</surname><given-names>R.</given-names></name><name><surname>Sugunan</surname><given-names>A.P.</given-names></name><name><surname>Singh</surname><given-names>S.S.</given-names></name><name><surname>Rai</surname><given-names>S.K.</given-names></name><name><surname>Sudeep</surname><given-names>A.B.</given-names></name><name><surname>Muruganandam</surname><given-names>N.</given-names></name><name><surname>Chaitanya</surname><given-names>I.K.</given-names></name><name><surname>Guruprasad</surname><given-names>D.R.</given-names></name></person-group><article-title>Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>2010</year><volume>104</volume><fpage>392</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1016/j.trstmh.2010.01.011</pub-id><pub-id pub-id-type="pmid">20171708</pub-id></element-citation></ref><ref id="B132-microorganisms-07-00133"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staikowsky</surname><given-names>F.</given-names></name><name><surname>Talarmin</surname><given-names>F.</given-names></name><name><surname>Grivard</surname><given-names>P.</given-names></name><name><surname>Souab</surname><given-names>A.</given-names></name><name><surname>Schuffenecker</surname><given-names>I.</given-names></name><name><surname>Roux</surname><given-names>K.L.</given-names></name><name><surname>Lecuit</surname><given-names>M.</given-names></name><name><surname>Michault</surname><given-names>A.</given-names></name></person-group><article-title>Prospective Study of Chikungunya Virus Acute Infection in the Island of La R&#x000e9;union during the 2005&#x02013;2006 Outbreak</article-title><source>PLoS ONE</source><year>2009</year><volume>4</volume><elocation-id>e7603</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0007603</pub-id><pub-id pub-id-type="pmid">19893613</pub-id></element-citation></ref><ref id="B133-microorganisms-07-00133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiberville</surname><given-names>S.-D.</given-names></name><name><surname>Boisson</surname><given-names>V.</given-names></name><name><surname>Gaudart</surname><given-names>J.</given-names></name><name><surname>Simon</surname><given-names>F.</given-names></name><name><surname>Flahault</surname><given-names>A.</given-names></name><name><surname>de Lamballerie</surname><given-names>X.</given-names></name></person-group><article-title>Chikungunya fever: A clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean</article-title><source>PLoS Negl. Trop. Dis.</source><year>2013</year><volume>7</volume><elocation-id>e2004</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0002004</pub-id><?supplied-pmid 23350006?><pub-id pub-id-type="pmid">23350006</pub-id></element-citation></ref><ref id="B134-microorganisms-07-00133"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perti</surname><given-names>T.</given-names></name><name><surname>Lucero-Obusan</surname><given-names>C.A.</given-names></name><name><surname>Schirmer</surname><given-names>P.L.</given-names></name><name><surname>Winters</surname><given-names>M.A.</given-names></name><name><surname>Holodniy</surname><given-names>M.</given-names></name></person-group><article-title>Chikungunya Fever Cases Identified in the Veterans Health Administration System, 2014</article-title><source>PLoS Negl. Trop. Dis.</source><year>2016</year><volume>10</volume><elocation-id>e0004630</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0004630</pub-id><pub-id pub-id-type="pmid">27144588</pub-id></element-citation></ref><ref id="B135-microorganisms-07-00133"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>J.K.</given-names></name><name><surname>Chatterjee</surname><given-names>S.N.</given-names></name><name><surname>Chakravarty</surname><given-names>S.K.</given-names></name></person-group><article-title>Three-year study of mosquito-borne haemorrhagic fever in Calcutta</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1967</year><volume>61</volume><fpage>725</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(67)90142-3</pub-id><pub-id pub-id-type="pmid">4383288</pub-id></element-citation></ref><ref id="B136-microorganisms-07-00133"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deller</surname><given-names>J.J.</given-names></name><name><surname>Russell</surname><given-names>P.K.</given-names></name></person-group><article-title>An analysis of fevers of unknown origin in American soldiers in Vietnam</article-title><source>Ann. Intern. Med.</source><year>1967</year><volume>66</volume><fpage>1129</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-66-6-1129</pub-id><pub-id pub-id-type="pmid">5338939</pub-id></element-citation></ref><ref id="B137-microorganisms-07-00133"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayakumar</surname><given-names>K.P.</given-names></name><name><surname>Anish</surname><given-names>T.S.N.</given-names></name><name><surname>George</surname><given-names>B.</given-names></name><name><surname>Lawrence</surname><given-names>T.</given-names></name><name><surname>Muthukkutty</surname><given-names>S.C.</given-names></name><name><surname>Ramachandran</surname><given-names>R.</given-names></name></person-group><article-title>Clinical profile of chikungunya patients during the epidemic of 2007 in Kerala, India</article-title><source>J. Glob. Infect. Dis.</source><year>2011</year><volume>3</volume><fpage>221</fpage><?supplied-pmid 21887052?><pub-id pub-id-type="pmid">21887052</pub-id></element-citation></ref><ref id="B138-microorganisms-07-00133"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zingman</surname><given-names>M.A.</given-names></name><name><surname>Paulino</surname><given-names>A.T.</given-names></name><name><surname>Payano</surname><given-names>M.P.</given-names></name></person-group><article-title>Clinical manifestations of chikungunya among university professors and staff in Santo Domingo, the Dominican Republic</article-title><source>Rev. Panam. Salud P&#x000fa;blica</source><year>2017</year><volume>41</volume><fpage>e64</fpage><?supplied-pmid 28902277?><pub-id pub-id-type="pmid">28902277</pub-id></element-citation></ref><ref id="B139-microorganisms-07-00133"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huits</surname><given-names>R.</given-names></name><name><surname>de Kort</surname><given-names>J.</given-names></name><name><surname>van Den Berg</surname><given-names>R.</given-names></name><name><surname>Chong</surname><given-names>L.</given-names></name><name><surname>Tsoumanis</surname><given-names>A.</given-names></name><name><surname>Eggermont</surname><given-names>K.</given-names></name><name><surname>Bartholomeeusen</surname><given-names>K.</given-names></name><name><surname>Ari&#x000eb;n</surname><given-names>K.K.</given-names></name><name><surname>Jacobs</surname><given-names>J.</given-names></name><name><surname>van Esbroeck</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Chikungunya virus infection in Aruba: Diagnosis, clinical features and predictors of post-chikungunya chronic polyarthralgia</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><elocation-id>e0196630</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0196630</pub-id><pub-id pub-id-type="pmid">29709007</pub-id></element-citation></ref><ref id="B140-microorganisms-07-00133"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>A.C.</given-names></name><name><surname>Fleming</surname><given-names>J.</given-names></name><name><surname>Solomon</surname><given-names>L.</given-names></name></person-group><article-title>Chikungunya viral arthropathy: A clinical description</article-title><source>J. Rheumatol.</source><year>1980</year><volume>7</volume><fpage>231</fpage><lpage>236</lpage><?supplied-pmid 7373626?><pub-id pub-id-type="pmid">7373626</pub-id></element-citation></ref><ref id="B141-microorganisms-07-00133"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiwanuka</surname><given-names>N.</given-names></name><name><surname>Sanders</surname><given-names>E.J.</given-names></name><name><surname>Rwaguma</surname><given-names>E.B.</given-names></name><name><surname>Kawamata</surname><given-names>J.</given-names></name><name><surname>Ssengooba</surname><given-names>F.P.</given-names></name><name><surname>Najjemba</surname><given-names>R.</given-names></name><name><surname>Were</surname><given-names>W.A.</given-names></name><name><surname>Lamunu</surname><given-names>M.</given-names></name><name><surname>Bagambisa</surname><given-names>G.</given-names></name><name><surname>Burkot</surname><given-names>T.R.</given-names></name><etal/></person-group><article-title>O&#x02019;nyong&#x02019;nyong Fever in South-Central Uganda, 1996&#x02013;1997: Clinical Features and Validation of a Clinical Case Definition for Surveillance Purposes</article-title><source>Clin. Infect. Dis.</source><year>1999</year><volume>29</volume><fpage>1243</fpage><lpage>1250</lpage><pub-id pub-id-type="doi">10.1086/313462</pub-id><?supplied-pmid 10524970?><pub-id pub-id-type="pmid">10524970</pub-id></element-citation></ref><ref id="B142-microorganisms-07-00133"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mour&#x000e3;o</surname><given-names>M.P.G.</given-names></name><name><surname>Bastos</surname><given-names>M.D.S.</given-names></name><name><surname>de Figueiredo</surname><given-names>R.P.</given-names></name><name><surname>Gimaque</surname><given-names>J.B.L.</given-names></name><name><surname>dos Santos Galusso</surname><given-names>E.</given-names></name><name><surname>Kramer</surname><given-names>V.M.</given-names></name><name><surname>de Oliveira</surname><given-names>C.M.C.</given-names></name><name><surname>Naveca</surname><given-names>F.G.</given-names></name><name><surname>Figueiredo</surname><given-names>L.T.M.</given-names></name></person-group><article-title>Mayaro fever in the city of Manaus, Brazil, 2007&#x02013;2008</article-title><source>Vector Borne Zoonotic Dis.</source><year>2012</year><volume>12</volume><fpage>42</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">21923266</pub-id></element-citation></ref><ref id="B143-microorganisms-07-00133"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halsey</surname><given-names>E.S.</given-names></name><name><surname>Siles</surname><given-names>C.</given-names></name><name><surname>Guevara</surname><given-names>C.</given-names></name><name><surname>Vilcarromero</surname><given-names>S.</given-names></name><name><surname>Jhonston</surname><given-names>E.J.</given-names></name><name><surname>Ramal</surname><given-names>C.</given-names></name><name><surname>Aguilar</surname><given-names>P.V.</given-names></name><name><surname>Ampuero</surname><given-names>J.S.</given-names></name></person-group><article-title>Mayaro virus infection, Amazon Basin region, Peru, 2010-2013</article-title><source>Emerg. Infect. Dis.</source><year>2013</year><volume>19</volume><fpage>1839</fpage><lpage>1842</lpage><pub-id pub-id-type="doi">10.3201/eid1911.130777</pub-id><pub-id pub-id-type="pmid">24210165</pub-id></element-citation></ref><ref id="B144-microorganisms-07-00133"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>C.J.D.S.P.</given-names></name><name><surname>Silva</surname><given-names>D.J.F.D.</given-names></name><name><surname>Barreto</surname><given-names>E.S.</given-names></name><name><surname>Siqueira</surname><given-names>C.E.H.</given-names></name><name><surname>Colombo</surname><given-names>T.E.</given-names></name><name><surname>Ozanic</surname><given-names>K.</given-names></name><name><surname>Schmidt</surname><given-names>D.J.</given-names></name><name><surname>Drumond</surname><given-names>B.P.</given-names></name><name><surname>Mondini</surname><given-names>A.</given-names></name><name><surname>Nogueira</surname><given-names>M.L.</given-names></name><etal/></person-group><article-title>Detection of Mayaro virus infections during a dengue outbreak in Mato Grosso, Brazil</article-title><source>Acta Trop.</source><year>2015</year><volume>147</volume><fpage>12</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.actatropica.2015.03.020</pub-id><?supplied-pmid 25817238?><pub-id pub-id-type="pmid">25817238</pub-id></element-citation></ref><ref id="B145-microorganisms-07-00133"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Costa</surname><given-names>V.G.</given-names></name><name><surname>de Rezende F&#x000e9;res</surname><given-names>V.C.</given-names></name><name><surname>Saivish</surname><given-names>M.V.</given-names></name><name><surname>de Lima Gimaque</surname><given-names>J.B.</given-names></name><name><surname>Moreli</surname><given-names>M.L.</given-names></name></person-group><article-title>Silent emergence of Mayaro and Oropouche viruses in humans in Central Brazil</article-title><source>Int. J. Infect. Dis.</source><year>2017</year><volume>62</volume><fpage>84</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2017.07.016</pub-id><?supplied-pmid 28739422?><pub-id pub-id-type="pmid">28739422</pub-id></element-citation></ref><ref id="B146-microorganisms-07-00133"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Condon</surname><given-names>R.J.</given-names></name><name><surname>Rouse</surname><given-names>I.L.</given-names></name></person-group><article-title>Acute symptoms and sequelae of Ross River virus infection in South-Western Australia: A follow-up study</article-title><source>Clin. Diagn. Virol.</source><year>1995</year><volume>3</volume><fpage>273</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/S0928-0197(94)00043-3</pub-id><pub-id pub-id-type="pmid">15566808</pub-id></element-citation></ref><ref id="B147-microorganisms-07-00133"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westley-Wise</surname><given-names>V.J.</given-names></name><name><surname>Beard</surname><given-names>J.R.</given-names></name><name><surname>Sladden</surname><given-names>T.J.</given-names></name><name><surname>Dunn</surname><given-names>T.M.</given-names></name><name><surname>Simpson</surname><given-names>J.</given-names></name></person-group><article-title>Ross River virus infection on the North Coast of New South Wales</article-title><source>Aust. N. Z. J. Public Health</source><year>1996</year><volume>20</volume><fpage>87</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1111/j.1467-842X.1996.tb01343.x</pub-id><?supplied-pmid 8799074?><pub-id pub-id-type="pmid">8799074</pub-id></element-citation></ref><ref id="B148-microorganisms-07-00133"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mylonas</surname><given-names>A.D.</given-names></name><name><surname>Brown</surname><given-names>A.M.</given-names></name><name><surname>Carthew</surname><given-names>T.L.</given-names></name><name><surname>McGrath</surname><given-names>B.</given-names></name><name><surname>Purdie</surname><given-names>D.M.</given-names></name><name><surname>Pandeya</surname><given-names>N.</given-names></name><name><surname>Vecchio</surname><given-names>P.C.</given-names></name><name><surname>Collins</surname><given-names>L.G.</given-names></name><name><surname>Gardner</surname><given-names>I.D.</given-names></name><name><surname>de Looze</surname><given-names>F.J.</given-names></name><etal/></person-group><article-title>Natural history of Ross River virus-induced epidemic polyarthritis</article-title><source>Med. J. Aust.</source><year>2002</year><volume>177</volume><fpage>356</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">12358577</pub-id></element-citation></ref><ref id="B149-microorganisms-07-00133"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harley</surname><given-names>D.</given-names></name><name><surname>Bossingham</surname><given-names>D.</given-names></name><name><surname>Purdie</surname><given-names>D.M.</given-names></name><name><surname>Pandeya</surname><given-names>N.</given-names></name><name><surname>Sleigh</surname><given-names>A.C.</given-names></name></person-group><article-title>Ross River virus disease in tropical Queensland: Evolution of rheumatic manifestations in an inception cohort followed for six months</article-title><source>Med. J. Aust.</source><year>2002</year><volume>177</volume><fpage>352</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">12358576</pub-id></element-citation></ref><ref id="B150-microorganisms-07-00133"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Economopoulou</surname><given-names>A.</given-names></name><name><surname>Dominguez</surname><given-names>M.</given-names></name><name><surname>Helynck</surname><given-names>B.</given-names></name><name><surname>Sissoko</surname><given-names>D.</given-names></name><name><surname>Wichmann</surname><given-names>O.</given-names></name><name><surname>Quenel</surname><given-names>P.</given-names></name><name><surname>Germonneau</surname><given-names>P.</given-names></name><name><surname>Quatresous</surname><given-names>I.</given-names></name></person-group><article-title>Atypical Chikungunya virus infections: Clinical manifestations, mortality and risk factors for severe disease during the 2005&#x02013;2006 outbreak on R&#x000e9;union</article-title><source>Epidemiol. Infect.</source><year>2009</year><volume>137</volume><fpage>534</fpage><pub-id pub-id-type="doi">10.1017/S0950268808001167</pub-id><pub-id pub-id-type="pmid">18694529</pub-id></element-citation></ref><ref id="B151-microorganisms-07-00133"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazaud</surname><given-names>R.</given-names></name><name><surname>Sala&#x000fc;n</surname><given-names>J.J.</given-names></name><name><surname>Montabone</surname><given-names>H.</given-names></name><name><surname>Goube</surname><given-names>P.</given-names></name><name><surname>Bazillio</surname><given-names>R.</given-names></name></person-group><article-title>[Acute neurologic and sensorial disorders in dengue and Chikungunya fever]</article-title><source>Bull. Soc. Pathol. Exot. Fil.</source><year>1971</year><volume>64</volume><fpage>22</fpage><lpage>30</lpage></element-citation></ref><ref id="B152-microorganisms-07-00133"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oehler</surname><given-names>E.</given-names></name><name><surname>Fournier</surname><given-names>E.</given-names></name><name><surname>Leparc-Goffart</surname><given-names>I.</given-names></name><name><surname>Larre</surname><given-names>P.</given-names></name><name><surname>Cubizolle</surname><given-names>S.</given-names></name><name><surname>Sookhareea</surname><given-names>C.</given-names></name><name><surname>Last&#x000e8;re</surname><given-names>S.</given-names></name><name><surname>Ghawche</surname><given-names>F.</given-names></name></person-group><article-title>Increase in cases of Guillain-Barr&#x000e9; syndrome during a Chikungunya outbreak, French Polynesia, 2014 to 2015</article-title><source>Eurosurveillance</source><year>2015</year><volume>20</volume><fpage>30079</fpage><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2015.20.48.30079</pub-id><pub-id pub-id-type="pmid">26690898</pub-id></element-citation></ref><ref id="B153-microorganisms-07-00133"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohite</surname><given-names>A.A.</given-names></name><name><surname>Agius-Fernandez</surname><given-names>A.</given-names></name></person-group><article-title>Chikungunya fever presenting with acute optic neuropathy</article-title><source>BMJ Case Rep.</source><year>2015</year><volume>2015</volume><fpage>bcr2015210081</fpage><pub-id pub-id-type="doi">10.1136/bcr-2015-210081</pub-id></element-citation></ref><ref id="B154-microorganisms-07-00133"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maiti</surname><given-names>C.R.</given-names></name><name><surname>Mukherjee</surname><given-names>A.K.</given-names></name><name><surname>Bose</surname><given-names>B.</given-names></name><name><surname>Saha</surname><given-names>G.L.</given-names></name></person-group><article-title>Myopericarditis following chikungunya virus infection</article-title><source>J. Indian Med. Assoc.</source><year>1978</year><volume>70</volume><fpage>256</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">712084</pub-id></element-citation></ref><ref id="B155-microorganisms-07-00133"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obeyesekere</surname><given-names>I.</given-names></name><name><surname>Hermon</surname><given-names>Y.</given-names></name></person-group><article-title>Arbovirus heart disease: Myocarditis and cardiomyopathy following dengue and chikungunya fever&#x02014;A follow-up study</article-title><source>Am. Heart J.</source><year>1973</year><volume>85</volume><fpage>186</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/0002-8703(73)90459-6</pub-id><pub-id pub-id-type="pmid">4688831</pub-id></element-citation></ref><ref id="B156-microorganisms-07-00133"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorl&#x000e9;ans</surname><given-names>F.</given-names></name><name><surname>Hoen</surname><given-names>B.</given-names></name><name><surname>Najioullah</surname><given-names>F.</given-names></name><name><surname>Herrmann-Storck</surname><given-names>C.</given-names></name><name><surname>Schepers</surname><given-names>K.M.</given-names></name><name><surname>Abel</surname><given-names>S.</given-names></name><name><surname>Lamaury</surname><given-names>I.</given-names></name><name><surname>Fagour</surname><given-names>L.</given-names></name><name><surname>C&#x000e9;saire</surname><given-names>R.</given-names></name><name><surname>Guyomard</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Outbreak of Chikungunya in the French Caribbean Islands of Martinique and Guadeloupe: Findings from a Hospital-Based Surveillance System (2013-2015)</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2018</year><volume>98</volume><fpage>1819</fpage><lpage>1825</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.16-0719</pub-id><pub-id pub-id-type="pmid">29692295</pub-id></element-citation></ref><ref id="B157-microorganisms-07-00133"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans-Gilbert</surname><given-names>T.</given-names></name></person-group><article-title>Chikungunya and Neonatal Immunity: Fatal Vertically Transmitted Chikungunya Infection</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2017</year><volume>96</volume><fpage>913</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.16-0491</pub-id><pub-id pub-id-type="pmid">28167590</pub-id></element-citation></ref><ref id="B158-microorganisms-07-00133"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraser</surname><given-names>J.R.</given-names></name><name><surname>Cunningham</surname><given-names>A.L.</given-names></name><name><surname>Muller</surname><given-names>H.K.</given-names></name><name><surname>Sinclair</surname><given-names>R.A.</given-names></name><name><surname>Standish</surname><given-names>H.G.</given-names></name></person-group><article-title>Glomerulonephritis in the acute phase of Ross River virus disease (epidemic polyarthritis)</article-title><source>Clin. Nephrol.</source><year>1988</year><volume>29</volume><fpage>149</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">2834127</pub-id></element-citation></ref><ref id="B159-microorganisms-07-00133"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scrimgeour</surname><given-names>E.M.</given-names></name><name><surname>Aaskov</surname><given-names>J.G.</given-names></name><name><surname>Matz</surname><given-names>L.R.</given-names></name></person-group><article-title>Ross River virus arthritis in Papua New Guinea</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1987</year><volume>81</volume><fpage>833</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(87)90045-9</pub-id><pub-id pub-id-type="pmid">2835834</pub-id></element-citation></ref><ref id="B160-microorganisms-07-00133"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scrimgeour</surname><given-names>E.M.</given-names></name></person-group><article-title>Suspected Ross River virus encephalitis in Papua New Guinea</article-title><source>Aust. N. Z. J. Med.</source><year>1999</year><volume>29</volume><fpage>559</fpage><pub-id pub-id-type="doi">10.1111/j.1445-5994.1999.tb00759.x</pub-id><pub-id pub-id-type="pmid">10868536</pub-id></element-citation></ref><ref id="B161-microorganisms-07-00133"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucas</surname><given-names>R.E.</given-names></name><name><surname>Qiao</surname><given-names>M.</given-names></name></person-group><article-title>A case of encephalitis in central Australia due to Ross River virus?</article-title><source>Aust. N. Z. J. Med.</source><year>1999</year><volume>29</volume><fpage>268</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1111/j.1445-5994.1999.tb00695.x</pub-id><pub-id pub-id-type="pmid">10342029</pub-id></element-citation></ref><ref id="B162-microorganisms-07-00133"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallian</surname><given-names>P.</given-names></name><name><surname>Leparc-Goffart</surname><given-names>I.</given-names></name><name><surname>Richard</surname><given-names>P.</given-names></name><name><surname>Maire</surname><given-names>F.</given-names></name><name><surname>Flusin</surname><given-names>O.</given-names></name><name><surname>Djoudi</surname><given-names>R.</given-names></name><name><surname>Chiaroni</surname><given-names>J.</given-names></name><name><surname>Charrel</surname><given-names>R.</given-names></name><name><surname>Tiberghien</surname><given-names>P.</given-names></name><name><surname>de Lamballerie</surname><given-names>X.</given-names></name></person-group><article-title>Epidemiology of Chikungunya Virus Outbreaks in Guadeloupe and Martinique, 2014: An Observational Study in Volunteer Blood Donors</article-title><source>PLoS Negl. Trop. Dis.</source><year>2017</year><volume>11</volume><elocation-id>e0005254</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0005254</pub-id><pub-id pub-id-type="pmid">28081120</pub-id></element-citation></ref><ref id="B163-microorganisms-07-00133"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robin</surname><given-names>S.</given-names></name><name><surname>Ramful</surname><given-names>D.</given-names></name><name><surname>Zettor</surname><given-names>J.</given-names></name><name><surname>Benhamou</surname><given-names>L.</given-names></name><name><surname>Jaffar-Bandjee</surname><given-names>M.-C.</given-names></name><name><surname>Rivi&#x000e8;re</surname><given-names>J.-P.</given-names></name><name><surname>Marichy</surname><given-names>J.</given-names></name><name><surname>Ezzedine</surname><given-names>K.</given-names></name><name><surname>Alessandri</surname><given-names>J.-L.</given-names></name></person-group><article-title>Severe bullous skin lesions associated with Chikungunya virus infection in small infants</article-title><source>Eur. J. Pediatr.</source><year>2010</year><volume>169</volume><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1007/s00431-009-0986-0</pub-id><pub-id pub-id-type="pmid">19401826</pub-id></element-citation></ref><ref id="B164-microorganisms-07-00133"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>T.</given-names></name><name><surname>Sanke</surname><given-names>S.</given-names></name><name><surname>Ahmed</surname><given-names>R.</given-names></name><name><surname>Chander</surname><given-names>R.</given-names></name><name><surname>Basu</surname><given-names>S.</given-names></name></person-group><article-title>Stevens-Johnson syndrome and toxic epidermal necrolysis-like cutaneous presentation of chikungunya fever: A case series</article-title><source>Pediatr. Dermatol.</source><year>2018</year><volume>35</volume><fpage>392</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1111/pde.13450</pub-id><pub-id pub-id-type="pmid">29573443</pub-id></element-citation></ref><ref id="B165-microorganisms-07-00133"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jadhav</surname><given-names>M.</given-names></name><name><surname>Namboodripad</surname><given-names>M.</given-names></name><name><surname>Carman</surname><given-names>R.H.</given-names></name><name><surname>Carey</surname><given-names>D.E.</given-names></name><name><surname>Myers</surname><given-names>R.M.</given-names></name></person-group><article-title>Chikungunya disease in infants and children in Vellore: A report of clinical and haematological features of virologically proved cases</article-title><source>Indian J. Med. Res.</source><year>1965</year><volume>53</volume><fpage>764</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">5830895</pub-id></element-citation></ref><ref id="B166-microorganisms-07-00133"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Ranitz</surname><given-names>C.M.</given-names></name><name><surname>Myers</surname><given-names>R.M.</given-names></name><name><surname>Varkey</surname><given-names>M.J.</given-names></name><name><surname>Isaac</surname><given-names>Z.H.</given-names></name><name><surname>Carey</surname><given-names>D.E.</given-names></name></person-group><article-title>Clinical impressions of chikungunya in Vellore gained from study of adult patients</article-title><source>Indian J. Med. Res.</source><year>1965</year><volume>53</volume><fpage>756</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">5830409</pub-id></element-citation></ref><ref id="B167-microorganisms-07-00133"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godaert</surname><given-names>L.</given-names></name><name><surname>Bartholet</surname><given-names>S.</given-names></name><name><surname>Dorl&#x000e9;ans</surname><given-names>F.</given-names></name><name><surname>Najioullah</surname><given-names>F.</given-names></name><name><surname>Colas</surname><given-names>S.</given-names></name><name><surname>Fanon</surname><given-names>J.-L.</given-names></name><name><surname>Cabi&#x000e9;</surname><given-names>A.</given-names></name><name><surname>C&#x000e9;saire</surname><given-names>R.</given-names></name><name><surname>Dram&#x000e9;</surname><given-names>M.</given-names></name></person-group><article-title>Prognostic factors of inhospital death in elderly patients: A time-to-event analysis of a cohort study in Martinique (French West Indies)</article-title><source>BMJ Open</source><year>2018</year><volume>8</volume><fpage>e018838</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2017-018838</pub-id></element-citation></ref><ref id="B168-microorganisms-07-00133"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraser</surname><given-names>J.R.</given-names></name><name><surname>Cunningham</surname><given-names>A.L.</given-names></name></person-group><article-title>Incubation time of epidemic polyarthritis</article-title><source>Med. J. Aust.</source><year>1980</year><volume>1</volume><fpage>550</fpage><lpage>551</lpage><pub-id pub-id-type="pmid">6104774</pub-id></element-citation></ref><ref id="B169-microorganisms-07-00133"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mudge</surname><given-names>P.R.</given-names></name></person-group><article-title>A survey of epidemic polyarthritis in the Riverland area, 1976</article-title><source>Med. J. Aust.</source><year>1977</year><volume>1</volume><fpage>649</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">875818</pub-id></element-citation></ref><ref id="B170-microorganisms-07-00133"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tappe</surname><given-names>D.</given-names></name><name><surname>Schmidt-Chanasit</surname><given-names>J.</given-names></name><name><surname>Ries</surname><given-names>A.</given-names></name><name><surname>Ziegler</surname><given-names>U.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>A.</given-names></name><name><surname>Stich</surname><given-names>A.</given-names></name></person-group><article-title>Ross River virus infection in a traveller returning from northern Australia</article-title><source>Med. Microbiol. Immunol.</source><year>2009</year><volume>198</volume><fpage>271</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1007/s00430-009-0122-9</pub-id><pub-id pub-id-type="pmid">19727811</pub-id></element-citation></ref><ref id="B171-microorganisms-07-00133"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paix&#x000e3;o</surname><given-names>E.S.</given-names></name><name><surname>Rodrigues</surname><given-names>L.C.</given-names></name><name><surname>Costa</surname><given-names>M.D.C.N.</given-names></name><name><surname>Itaparica</surname><given-names>M.</given-names></name><name><surname>Barreto</surname><given-names>F.</given-names></name><name><surname>G&#x000e9;rardin</surname><given-names>P.</given-names></name><name><surname>Teixeira</surname><given-names>M.G.</given-names></name></person-group><article-title>Chikungunya chronic disease: A systematic review and meta-analysis</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>2018</year><volume>112</volume><fpage>301</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">30007303</pub-id></element-citation></ref><ref id="B172-microorganisms-07-00133"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouquillard</surname><given-names>E.</given-names></name><name><surname>Fianu</surname><given-names>A.</given-names></name><name><surname>Bangil</surname><given-names>M.</given-names></name><name><surname>Charlette</surname><given-names>N.</given-names></name><name><surname>Rib&#x000e9;ra</surname><given-names>A.</given-names></name><name><surname>Michault</surname><given-names>A.</given-names></name><name><surname>Favier</surname><given-names>F.</given-names></name><name><surname>Simon</surname><given-names>F.</given-names></name><name><surname>Flipo</surname><given-names>R.-M.</given-names></name></person-group><article-title>Rheumatic manifestations associated with Chikungunya virus infection: A study of 307 patients with 32-month follow-up (RHUMATOCHIK study)</article-title><source>Jt. Bone Spine Rev. Rhum.</source><year>2018</year><volume>85</volume><fpage>207</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1016/j.jbspin.2017.01.014</pub-id></element-citation></ref><ref id="B173-microorganisms-07-00133"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schilte</surname><given-names>C.</given-names></name><name><surname>Staikowsky</surname><given-names>F.</given-names></name><name><surname>Staikovsky</surname><given-names>F.</given-names></name><name><surname>Couderc</surname><given-names>T.</given-names></name><name><surname>Madec</surname><given-names>Y.</given-names></name><name><surname>Carpentier</surname><given-names>F.</given-names></name><name><surname>Kassab</surname><given-names>S.</given-names></name><name><surname>Albert</surname><given-names>M.L.</given-names></name><name><surname>Lecuit</surname><given-names>M.</given-names></name><name><surname>Michault</surname><given-names>A.</given-names></name></person-group><article-title>Chikungunya virus-associated long-term arthralgia: A 36-month prospective longitudinal study</article-title><source>PLoS Negl. Trop. Dis.</source><year>2013</year><volume>7</volume><elocation-id>e2137</elocation-id><pub-id pub-id-type="doi">10.1371/annotation/850ee20f-2641-46ac-b0c6-ef4ae79b6de6</pub-id><pub-id pub-id-type="pmid">23556021</pub-id></element-citation></ref><ref id="B174-microorganisms-07-00133"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouquillard</surname><given-names>&#x000c9;.</given-names></name><name><surname>Combe</surname><given-names>B.</given-names></name></person-group><article-title>A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years</article-title><source>Joint Bone Spine</source><year>2009</year><volume>76</volume><fpage>654</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1016/j.jbspin.2009.08.005</pub-id><pub-id pub-id-type="pmid">19945329</pub-id></element-citation></ref><ref id="B175-microorganisms-07-00133"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>A.Y.</given-names></name><name><surname>Martins</surname><given-names>K.A.O.</given-names></name><name><surname>Encinales</surname><given-names>L.</given-names></name><name><surname>Reid</surname><given-names>S.P.</given-names></name><name><surname>Acu&#x000f1;a</surname><given-names>M.</given-names></name><name><surname>Encinales</surname><given-names>C.</given-names></name><name><surname>Matranga</surname><given-names>C.B.</given-names></name><name><surname>Pacheco</surname><given-names>N.</given-names></name><name><surname>Cure</surname><given-names>C.</given-names></name><name><surname>Shukla</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Chikungunya Arthritis Mechanisms in the Americas: A Cross-Sectional Analysis of Chikungunya Arthritis Patients Twenty-Two Months After Infection Demonstrating No Detectable Viral Persistence in Synovial Fluid</article-title><source>Arthritis Rheumatol.</source><year>2018</year><volume>70</volume><fpage>585</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1002/art.40383</pub-id><pub-id pub-id-type="pmid">29266856</pub-id></element-citation></ref><ref id="B176-microorganisms-07-00133"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javelle</surname><given-names>E.</given-names></name><name><surname>Ribera</surname><given-names>A.</given-names></name><name><surname>Degasne</surname><given-names>I.</given-names></name><name><surname>Ga&#x000fc;z&#x000e8;re</surname><given-names>B.-A.</given-names></name><name><surname>Marimoutou</surname><given-names>C.</given-names></name><name><surname>Simon</surname><given-names>F.</given-names></name></person-group><article-title>Specific Management of Post-Chikungunya Rheumatic Disorders: A Retrospective Study of 159 Cases in Reunion Island from 2006&#x02013;2012</article-title><source>PLoS Negl. Trop. Dis.</source><year>2015</year><volume>9</volume><elocation-id>e0003603</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0003603</pub-id><pub-id pub-id-type="pmid">25760632</pub-id></element-citation></ref><ref id="B177-microorganisms-07-00133"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>S.F.</given-names></name><name><surname>Patel</surname><given-names>P.R.</given-names></name><name><surname>Herold</surname><given-names>T.J.S.</given-names></name></person-group><article-title>Recurrent arthralgias in a patient with previous Mayaro fever infection</article-title><source>South. Med. J.</source><year>2005</year><volume>98</volume><fpage>484</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1097/01.SMJ.0000145879.14102.F4</pub-id><pub-id pub-id-type="pmid">15898531</pub-id></element-citation></ref><ref id="B178-microorganisms-07-00133"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theilacker</surname><given-names>C.</given-names></name><name><surname>Held</surname><given-names>J.</given-names></name><name><surname>Allering</surname><given-names>L.</given-names></name><name><surname>Emmerich</surname><given-names>P.</given-names></name><name><surname>Schmidt-Chanasit</surname><given-names>J.</given-names></name><name><surname>Kern</surname><given-names>W.V.</given-names></name><name><surname>Panning</surname><given-names>M.</given-names></name></person-group><article-title>Prolonged polyarthralgia in a German traveller with Mayaro virus infection without inflammatory correlates</article-title><source>BMC Infect. Dis.</source><year>2013</year><volume>13</volume><elocation-id>369</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-13-369</pub-id><pub-id pub-id-type="pmid">23927600</pub-id></element-citation></ref><ref id="B179-microorganisms-07-00133"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Receveur</surname><given-names>M.C.</given-names></name><name><surname>Grandadam</surname><given-names>M.</given-names></name><name><surname>Pistone</surname><given-names>T.</given-names></name><name><surname>Malvy</surname><given-names>D.</given-names></name></person-group><article-title>Infection with Mayaro virus in a French traveller returning from the Amazon region, Brazil, January, 2010</article-title><source>Eurosurveillance</source><year>2010</year><volume>15</volume><pub-id pub-id-type="doi">10.2807/ese.15.18.19563-en</pub-id></element-citation></ref><ref id="B180-microorganisms-07-00133"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassing</surname><given-names>R.-J.</given-names></name><name><surname>Leparc-Goffart</surname><given-names>I.</given-names></name><name><surname>Blank</surname><given-names>S.N.</given-names></name><name><surname>Thevarayan</surname><given-names>S.</given-names></name><name><surname>Tolou</surname><given-names>H.</given-names></name><name><surname>van Doornum</surname><given-names>G.</given-names></name><name><surname>van Genderen</surname><given-names>P.J.</given-names></name></person-group><article-title>Imported Mayaro virus infection in the Netherlands</article-title><source>J. Infect.</source><year>2010</year><volume>61</volume><fpage>343</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2010.06.009</pub-id><pub-id pub-id-type="pmid">20600300</pub-id></element-citation></ref><ref id="B181-microorganisms-07-00133"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tappe</surname><given-names>D.</given-names></name><name><surname>P&#x000e9;rez-Gir&#x000f3;n</surname><given-names>J.V.</given-names></name><name><surname>Just-N&#x000fc;bling</surname><given-names>G.</given-names></name><name><surname>Schuster</surname><given-names>G.</given-names></name><name><surname>G&#x000f3;mez-Medina</surname><given-names>S.</given-names></name><name><surname>G&#x000fc;nther</surname><given-names>S.</given-names></name><name><surname>Mu&#x000f1;oz-Fontela</surname><given-names>C.</given-names></name><name><surname>Schmidt-Chanasit</surname><given-names>J.</given-names></name></person-group><article-title>Sustained Elevated Cytokine Levels during Recovery Phase of Mayaro Virus Infection</article-title><source>Emerg. Infect. Dis.</source><year>2016</year><volume>22</volume><fpage>750</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.3201/eid2204.151502</pub-id><pub-id pub-id-type="pmid">26981875</pub-id></element-citation></ref><ref id="B182-microorganisms-07-00133"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Foo</surname><given-names>S.-S.</given-names></name><name><surname>Rulli</surname><given-names>N.E.</given-names></name><name><surname>Taylor</surname><given-names>A.</given-names></name><name><surname>Sheng</surname><given-names>K.-C.</given-names></name><name><surname>Herrero</surname><given-names>L.J.</given-names></name><name><surname>Herring</surname><given-names>B.L.</given-names></name><name><surname>Lidbury</surname><given-names>B.A.</given-names></name><name><surname>Li</surname><given-names>R.W.</given-names></name><name><surname>Walsh</surname><given-names>N.C.</given-names></name><etal/></person-group><article-title>Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>6040</fpage><lpage>6045</lpage><pub-id pub-id-type="doi">10.1073/pnas.1318859111</pub-id><?supplied-pmid 24733914?><pub-id pub-id-type="pmid">24733914</pub-id></element-citation></ref><ref id="B183-microorganisms-07-00133"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>E.X.Y.</given-names></name><name><surname>Supramaniam</surname><given-names>A.</given-names></name><name><surname>Lui</surname><given-names>H.</given-names></name><name><surname>Coles</surname><given-names>P.</given-names></name><name><surname>Lee</surname><given-names>W.S.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Rudd</surname><given-names>P.A.</given-names></name><name><surname>Herrero</surname><given-names>L.J.</given-names></name></person-group><article-title>Chondrocytes Contribute to Alphaviral Disease Pathogenesis as a Source of Virus Replication and Soluble Factor Production</article-title><source>Viruses</source><year>2018</year><volume>10</volume><elocation-id>86</elocation-id><pub-id pub-id-type="doi">10.3390/v10020086</pub-id><?supplied-pmid 29462879?><pub-id pub-id-type="pmid">29462879</pub-id></element-citation></ref><ref id="B184-microorganisms-07-00133"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panning</surname><given-names>M.</given-names></name><name><surname>Grywna</surname><given-names>K.</given-names></name><name><surname>van Esbroeck</surname><given-names>M.</given-names></name><name><surname>Emmerich</surname><given-names>P.</given-names></name><name><surname>Drosten</surname><given-names>C.</given-names></name></person-group><article-title>Chikungunya Fever in Travelers Returning to Europe from the Indian Ocean Region, 2006</article-title><source>Emerg. Infect. Dis.</source><year>2008</year><volume>14</volume><fpage>416</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.3201/eid1403.070906</pub-id><?supplied-pmid 18325256?><pub-id pub-id-type="pmid">18325256</pub-id></element-citation></ref><ref id="B185-microorganisms-07-00133"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appassakij</surname><given-names>H.</given-names></name><name><surname>Khuntikij</surname><given-names>P.</given-names></name><name><surname>Kemapunmanus</surname><given-names>M.</given-names></name><name><surname>Wutthanarungsan</surname><given-names>R.</given-names></name><name><surname>Silpapojakul</surname><given-names>K.</given-names></name></person-group><article-title>Viremic profiles in asymptomatic and symptomatic chikungunya fever: A blood transfusion threat?</article-title><source>Transfusion</source><year>2013</year><volume>53</volume><fpage>2567</fpage><lpage>2574</lpage><pub-id pub-id-type="doi">10.1111/j.1537-2995.2012.03960.x</pub-id><?supplied-pmid 23176378?><pub-id pub-id-type="pmid">23176378</pub-id></element-citation></ref><ref id="B186-microorganisms-07-00133"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acosta-Ampudia</surname><given-names>Y.</given-names></name><name><surname>Monsalve</surname><given-names>D.M.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>Y.</given-names></name><name><surname>Pacheco</surname><given-names>Y.</given-names></name><name><surname>Anaya</surname><given-names>J.-M.</given-names></name><name><surname>Ram&#x000ed;rez-Santana</surname><given-names>C.</given-names></name></person-group><article-title>Mayaro: An emerging viral threat?</article-title><source>Emerg. Microbes Infect.</source><year>2018</year><volume>7</volume><fpage>163</fpage><pub-id pub-id-type="doi">10.1038/s41426-018-0163-5</pub-id><pub-id pub-id-type="pmid">30254258</pub-id></element-citation></ref><ref id="B187-microorganisms-07-00133"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibney</surname><given-names>K.B.</given-names></name><name><surname>Fischer</surname><given-names>M.</given-names></name><name><surname>Prince</surname><given-names>H.E.</given-names></name><name><surname>Kramer</surname><given-names>L.D.</given-names></name><name><surname>St. George</surname><given-names>K.</given-names></name><name><surname>Kosoy</surname><given-names>O.L.</given-names></name><name><surname>Laven</surname><given-names>J.J.</given-names></name><name><surname>Staples</surname><given-names>J.E.</given-names></name></person-group><article-title>Chikungunya Fever in the United States: A Fifteen Year Review of Cases</article-title><source>Clin. Infect. Dis.</source><year>2011</year><volume>52</volume><fpage>e121</fpage><lpage>e126</lpage><pub-id pub-id-type="doi">10.1093/cid/ciq214</pub-id><?supplied-pmid 21242326?><pub-id pub-id-type="pmid">21242326</pub-id></element-citation></ref><ref id="B188-microorganisms-07-00133"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telles</surname><given-names>J.-N.</given-names></name><name><surname>Le Roux</surname><given-names>K.</given-names></name><name><surname>Grivard</surname><given-names>P.</given-names></name><name><surname>Vernet</surname><given-names>G.</given-names></name><name><surname>Michault</surname><given-names>A.</given-names></name></person-group><article-title>Evaluation of real-time nucleic acid sequence-based amplification for detection of Chikungunya virus in clinical samples</article-title><source>J. Med. Microbiol.</source><year>2009</year><volume>58</volume><fpage>1168</fpage><lpage>1172</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.010736-0</pub-id><pub-id pub-id-type="pmid">19528148</pub-id></element-citation></ref><ref id="B189-microorganisms-07-00133"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waggoner</surname><given-names>J.</given-names></name><name><surname>Heath</surname><given-names>C.J.</given-names></name><name><surname>Ndenga</surname><given-names>B.</given-names></name><name><surname>Mutuku</surname><given-names>F.</given-names></name><name><surname>Sahoo</surname><given-names>M.K.</given-names></name><name><surname>Mohamed-Hadley</surname><given-names>A.</given-names></name><name><surname>Vulule</surname><given-names>J.</given-names></name><name><surname>Mukoko</surname><given-names>D.</given-names></name><name><surname>Desiree LaBeaud</surname><given-names>A.</given-names></name><name><surname>Pinsky</surname><given-names>B.A.</given-names></name></person-group><article-title>Development of a Real-Time Reverse Transcription Polymerase Chain Reaction for O&#x02019;nyong&#x02019;nyong Virus and Evaluation with Clinical and Mosquito Specimens from Kenya</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2017</year><volume>97</volume><fpage>121</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.17-0027</pub-id><pub-id pub-id-type="pmid">28719301</pub-id></element-citation></ref><ref id="B190-microorganisms-07-00133"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waggoner</surname><given-names>J.J.</given-names></name><name><surname>Rojas</surname><given-names>A.</given-names></name><name><surname>Mohamed-Hadley</surname><given-names>A.</given-names></name><name><surname>de Guill&#x000e9;n</surname><given-names>Y.A.</given-names></name><name><surname>Pinsky</surname><given-names>B.A.</given-names></name></person-group><article-title>Real-time RT-PCR for Mayaro virus detection in plasma and urine</article-title><source>J. Clin. Virol.</source><year>2018</year><volume>98</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2017.11.006</pub-id><pub-id pub-id-type="pmid">29172075</pub-id></element-citation></ref><ref id="B191-microorganisms-07-00133"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozza</surname><given-names>F.A.</given-names></name><name><surname>Moreira-Soto</surname><given-names>A.</given-names></name><name><surname>Rockstroh</surname><given-names>A.</given-names></name><name><surname>Fischer</surname><given-names>C.</given-names></name><name><surname>Nascimento</surname><given-names>A.D.</given-names></name><name><surname>Calheiros</surname><given-names>A.S.</given-names></name><name><surname>Drosten</surname><given-names>C.</given-names></name><name><surname>Bozza</surname><given-names>P.T.</given-names></name><name><surname>Souza</surname><given-names>T.M.L.</given-names></name><name><surname>Ulbert</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Differential Shedding and Antibody Kinetics of Zika and Chikungunya Viruses, Brazil</article-title><source>Emerg. Infect. Dis.</source><year>2019</year><volume>25</volume><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.3201/eid2502.180166</pub-id><pub-id pub-id-type="pmid">30666934</pub-id></element-citation></ref><ref id="B192-microorganisms-07-00133"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malvy</surname><given-names>D.</given-names></name><name><surname>Ezzedine</surname><given-names>K.</given-names></name><name><surname>Mamani-Matsuda</surname><given-names>M.</given-names></name><name><surname>Autran</surname><given-names>B.</given-names></name><name><surname>Tolou</surname><given-names>H.</given-names></name><name><surname>Receveur</surname><given-names>M.-C.</given-names></name><name><surname>Pistone</surname><given-names>T.</given-names></name><name><surname>Rambert</surname><given-names>J.</given-names></name><name><surname>Moynet</surname><given-names>D.</given-names></name><name><surname>Mossalayi</surname><given-names>D.</given-names></name></person-group><article-title>Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies</article-title><source>BMC Infect. Dis.</source><year>2009</year><volume>9</volume><elocation-id>200</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-9-200</pub-id><pub-id pub-id-type="pmid">20003320</pub-id></element-citation></ref><ref id="B193-microorganisms-07-00133"><label>193.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Azami</surname><given-names>N.A.M.</given-names></name><name><surname>Moi</surname><given-names>M.L.</given-names></name><name><surname>Takasaki</surname><given-names>T.</given-names></name></person-group><source>Neutralization Assay for Chikungunya Virus Infection: Plaque Reduction Neutralization Test</source><publisher-name>Humana Press</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2016</year><fpage>273</fpage><lpage>282</lpage></element-citation></ref><ref id="B194-microorganisms-07-00133"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henss</surname><given-names>L.</given-names></name><name><surname>Yue</surname><given-names>C.</given-names></name><name><surname>Kandler</surname><given-names>J.</given-names></name><name><surname>Faddy</surname><given-names>H.M.</given-names></name><name><surname>Simmons</surname><given-names>G.</given-names></name><name><surname>Panning</surname><given-names>M.</given-names></name><name><surname>Lewis-Ximenez</surname><given-names>L.L.</given-names></name><name><surname>Baylis</surname><given-names>S.A.</given-names></name><name><surname>Schnierle</surname><given-names>B.S.</given-names></name></person-group><article-title>Establishment of an Alphavirus-Specific Neutralization Assay to Distinguish Infections with Different Members of the Semliki Forest complex</article-title><source>Viruses</source><year>2019</year><volume>11</volume><elocation-id>82</elocation-id><pub-id pub-id-type="doi">10.3390/v11010082</pub-id></element-citation></ref><ref id="B195-microorganisms-07-00133"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>L.J.</given-names></name><name><surname>Selvey</surname><given-names>L.A.</given-names></name><name><surname>Jardine</surname><given-names>A.</given-names></name><name><surname>Johansen</surname><given-names>C.A.</given-names></name><name><surname>Lindsay</surname><given-names>M.D.A.</given-names></name></person-group><article-title>Mosquito and Virus Surveillance as a Predictor of Human Ross River Virus Infection in South-West Western Australia: How Useful Is It?</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2018</year><volume>99</volume><fpage>1066</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.18-0459</pub-id><pub-id pub-id-type="pmid">30182918</pub-id></element-citation></ref><ref id="B196-microorganisms-07-00133"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curren</surname><given-names>E.J.</given-names></name><name><surname>Lehman</surname><given-names>J.</given-names></name><name><surname>Kolsin</surname><given-names>J.</given-names></name><name><surname>Walker</surname><given-names>W.L.</given-names></name><name><surname>Martin</surname><given-names>S.W.</given-names></name><name><surname>Staples</surname><given-names>J.E.</given-names></name><name><surname>Hills</surname><given-names>S.L.</given-names></name><name><surname>Gould</surname><given-names>C.V.</given-names></name><name><surname>Rabe</surname><given-names>I.B.</given-names></name><name><surname>Fischer</surname><given-names>M.</given-names></name><etal/></person-group><article-title>West Nile Virus and Other Nationally Notifiable Arboviral Diseases&#x02014;United States, 2017</article-title><source>MMWR Morb. Mortal. Wkly. Rep.</source><year>2018</year><volume>67</volume><fpage>1137</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6741a1</pub-id><pub-id pub-id-type="pmid">30335737</pub-id></element-citation></ref><ref id="B197-microorganisms-07-00133"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>N.M.D.</given-names></name><name><surname>Teixeira</surname><given-names>R.A.G.</given-names></name><name><surname>Cardoso</surname><given-names>C.G.</given-names></name><name><surname>Siqueira Junior</surname><given-names>J.B.</given-names></name><name><surname>Coelho</surname><given-names>G.E.</given-names></name><name><surname>Oliveira</surname><given-names>E.S.F.</given-names></name></person-group><article-title>Chikungunya surveillance in Brazil: Challenges in the context of Public Health</article-title><source>Epidemiol. Servi&#x000e7;os Sa&#x000fa;de</source><year>2018</year><volume>27</volume><fpage>e2017127</fpage></element-citation></ref><ref id="B198-microorganisms-07-00133"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trentini</surname><given-names>F.</given-names></name><name><surname>Poletti</surname><given-names>P.</given-names></name><name><surname>Baldacchino</surname><given-names>F.</given-names></name><name><surname>Drago</surname><given-names>A.</given-names></name><name><surname>Montarsi</surname><given-names>F.</given-names></name><name><surname>Capelli</surname><given-names>G.</given-names></name><name><surname>Rizzoli</surname><given-names>A.</given-names></name><name><surname>Ros&#x000e0;</surname><given-names>R.</given-names></name><name><surname>Rizzo</surname><given-names>C.</given-names></name><name><surname>Merler</surname><given-names>S.</given-names></name><etal/></person-group><article-title>The containment of potential outbreaks triggered by imported Chikungunya cases in Italy: A cost utility epidemiological assessment of vector control measures</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>9034</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-27443-9</pub-id><pub-id pub-id-type="pmid">29899520</pub-id></element-citation></ref><ref id="B199-microorganisms-07-00133"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitar</surname><given-names>D.</given-names></name><name><surname>Che</surname><given-names>D.</given-names></name><name><surname>Capek</surname><given-names>I.</given-names></name><name><surname>de Valk</surname><given-names>H.</given-names></name><name><surname>Saura</surname><given-names>C.</given-names></name></person-group><article-title>[Public health surveillance and assessment of emerging infectious threats: Method and criteria for risk analysis]</article-title><source>Med. Mal. Infect.</source><year>2011</year><volume>41</volume><fpage>53</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.medmal.2010.12.006</pub-id><pub-id pub-id-type="pmid">21251782</pub-id></element-citation></ref><ref id="B200-microorganisms-07-00133"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hierlihy</surname><given-names>C.</given-names></name><name><surname>Waddell</surname><given-names>L.</given-names></name><name><surname>Young</surname><given-names>I.</given-names></name><name><surname>Greig</surname><given-names>J.</given-names></name><name><surname>Corrin</surname><given-names>T.</given-names></name><name><surname>Mascarenhas</surname><given-names>M.</given-names></name></person-group><article-title>A systematic review of individual and community mitigation measures for prevention and control of chikungunya virus</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><elocation-id>e0212054</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0212054</pub-id><pub-id pub-id-type="pmid">30811438</pub-id></element-citation></ref><ref id="B201-microorganisms-07-00133"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurucz</surname><given-names>N.</given-names></name><name><surname>Jacups</surname><given-names>S.</given-names></name><name><surname>Carter</surname><given-names>J.M.</given-names></name></person-group><article-title>Determining Culex annulirostris larval densities and control efforts across a coastal wetland, Northern Territory, Australia</article-title><source>J. Vector Ecol.</source><year>2016</year><volume>41</volume><fpage>271</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1111/jvec.12222</pub-id><pub-id pub-id-type="pmid">27860005</pub-id></element-citation></ref><ref id="B202-microorganisms-07-00133"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staples</surname><given-names>K.</given-names></name><name><surname>Oosthuizen</surname><given-names>J.</given-names></name><name><surname>Lund</surname><given-names>M.</given-names></name></person-group><article-title>Effectiveness of S-Methoprene Briquets and Application Method for Mosquito Control in Urban Road Gullies/Catch Basins/Gully Pots in a Mediterranean Climate: Implications for Ross River Virus Transmission</article-title><source>J. Am. Mosq. Control Assoc.</source><year>2016</year><volume>32</volume><fpage>203</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.2987/16-6563.1</pub-id><pub-id pub-id-type="pmid">27802404</pub-id></element-citation></ref><ref id="B203-microorganisms-07-00133"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flies</surname><given-names>E.J.</given-names></name><name><surname>Williams</surname><given-names>C.R.</given-names></name><name><surname>Weinstein</surname><given-names>P.</given-names></name><name><surname>Anderson</surname><given-names>S.J.</given-names></name></person-group><article-title>Improving public health intervention for mosquito-borne disease: The value of geovisualization using source of infection and LandScan data</article-title><source>Epidemiol. Infect.</source><year>2016</year><volume>144</volume><fpage>3108</fpage><lpage>3119</lpage><pub-id pub-id-type="doi">10.1017/S0950268816001357</pub-id><pub-id pub-id-type="pmid">27334542</pub-id></element-citation></ref><ref id="B204-microorganisms-07-00133"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erasmus</surname><given-names>J.H.</given-names></name><name><surname>Rossi</surname><given-names>S.L.</given-names></name><name><surname>Weaver</surname><given-names>S.C.</given-names></name></person-group><article-title>Development of Vaccines for Chikungunya Fever</article-title><source>J. Infect. Dis.</source><year>2016</year><volume>214</volume><fpage>S488</fpage><lpage>S496</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiw271</pub-id><pub-id pub-id-type="pmid">27920179</pub-id></element-citation></ref><ref id="B205-microorganisms-07-00133"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edelman</surname><given-names>R.</given-names></name><name><surname>Tacket</surname><given-names>C.O.</given-names></name><name><surname>Wasserman</surname><given-names>S.S.</given-names></name><name><surname>Bodison</surname><given-names>S.A.</given-names></name><name><surname>Perry</surname><given-names>J.A.</given-names></name><name><surname>Perry</surname><given-names>J.G.</given-names></name></person-group><article-title>Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2000</year><volume>62</volume><fpage>681</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2000.62.681</pub-id><pub-id pub-id-type="pmid">11304054</pub-id></element-citation></ref><ref id="B206-microorganisms-07-00133"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>E.</given-names></name><name><surname>Volkova</surname><given-names>E.</given-names></name><name><surname>Adams</surname><given-names>A.P.</given-names></name><name><surname>Forrester</surname><given-names>N.</given-names></name><name><surname>Xiao</surname><given-names>S.-Y.</given-names></name><name><surname>Frolov</surname><given-names>I.</given-names></name><name><surname>Weaver</surname><given-names>S.C.</given-names></name></person-group><article-title>Chimeric alphavirus vaccine candidates for chikungunya</article-title><source>Vaccine</source><year>2008</year><volume>26</volume><fpage>5030</fpage><lpage>5039</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2008.07.054</pub-id><pub-id pub-id-type="pmid">18692107</pub-id></element-citation></ref><ref id="B207-microorganisms-07-00133"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandler</surname><given-names>S.</given-names></name><name><surname>Ruffi&#x000e9;</surname><given-names>C.</given-names></name><name><surname>Combredet</surname><given-names>C.</given-names></name><name><surname>Brault</surname><given-names>J.-B.</given-names></name><name><surname>Najburg</surname><given-names>V.</given-names></name><name><surname>Prevost</surname><given-names>M.-C.</given-names></name><name><surname>Habel</surname><given-names>A.</given-names></name><name><surname>Tauber</surname><given-names>E.</given-names></name><name><surname>Despr&#x000e8;s</surname><given-names>P.</given-names></name><name><surname>Tangy</surname><given-names>F.</given-names></name></person-group><article-title>A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus</article-title><source>Vaccine</source><year>2013</year><volume>31</volume><fpage>3718</fpage><lpage>3725</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2013.05.086</pub-id><pub-id pub-id-type="pmid">23742993</pub-id></element-citation></ref><ref id="B208-microorganisms-07-00133"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramsauer</surname><given-names>K.</given-names></name><name><surname>Schwameis</surname><given-names>M.</given-names></name><name><surname>Firbas</surname><given-names>C.</given-names></name><name><surname>M&#x000fc;llner</surname><given-names>M.</given-names></name><name><surname>Putnak</surname><given-names>R.J.</given-names></name><name><surname>Thomas</surname><given-names>S.J.</given-names></name><name><surname>Despr&#x000e8;s</surname><given-names>P.</given-names></name><name><surname>Tauber</surname><given-names>E.</given-names></name><name><surname>Jilma</surname><given-names>B.</given-names></name><name><surname>Tangy</surname><given-names>F.</given-names></name></person-group><article-title>Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: A randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial</article-title><source>Lancet Infect. Dis.</source><year>2015</year><volume>15</volume><fpage>519</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(15)70043-5</pub-id><pub-id pub-id-type="pmid">25739878</pub-id></element-citation></ref><ref id="B209-microorganisms-07-00133"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reisinger</surname><given-names>E.C.</given-names></name><name><surname>Tschismarov</surname><given-names>R.</given-names></name><name><surname>Beubler</surname><given-names>E.</given-names></name><name><surname>Wiedermann</surname><given-names>U.</given-names></name><name><surname>Firbas</surname><given-names>C.</given-names></name><name><surname>Loebermann</surname><given-names>M.</given-names></name><name><surname>Pfeiffer</surname><given-names>A.</given-names></name><name><surname>Muellner</surname><given-names>M.</given-names></name><name><surname>Tauber</surname><given-names>E.</given-names></name><name><surname>Ramsauer</surname><given-names>K.</given-names></name></person-group><article-title>Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: A double-blind, randomised, placebo-controlled and active-controlled phase 2 trial</article-title><source>Lancet</source><year>2018</year><volume>392</volume><fpage>2718</fpage><lpage>2727</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(18)32488-7</pub-id><pub-id pub-id-type="pmid">30409443</pub-id></element-citation></ref><ref id="B210-microorganisms-07-00133"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>E.</given-names></name><name><surname>Seymour</surname><given-names>R.</given-names></name><name><surname>Weaver</surname><given-names>S.C.</given-names></name><name><surname>Rose</surname><given-names>J.K.</given-names></name></person-group><article-title>A chimeric vesiculo/alphavirus is an effective alphavirus vaccine</article-title><source>J. Virol.</source><year>2013</year><volume>87</volume><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1128/JVI.01860-12</pub-id><pub-id pub-id-type="pmid">23077320</pub-id></element-citation></ref><ref id="B211-microorganisms-07-00133"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>A.</given-names></name><name><surname>Aguilar</surname><given-names>P.V.</given-names></name><name><surname>Bopp</surname><given-names>N.E.</given-names></name><name><surname>Yarovinsky</surname><given-names>T.O.</given-names></name><name><surname>Weaver</surname><given-names>S.C.</given-names></name><name><surname>Rose</surname><given-names>J.K.</given-names></name></person-group><article-title>A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections</article-title><source>Vaccine</source><year>2018</year><volume>36</volume><fpage>3894</fpage><lpage>3900</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2018.05.095</pub-id><pub-id pub-id-type="pmid">29807712</pub-id></element-citation></ref><ref id="B212-microorganisms-07-00133"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>V.R.</given-names></name><name><surname>Eckels</surname><given-names>K.H.</given-names></name><name><surname>Hampton</surname><given-names>C.</given-names></name></person-group><article-title>Production and Evaluation of a Formalin-Killed Chikungunya Vaccine</article-title><source>J. Immunol.</source><year>1971</year><volume>107</volume><fpage>6</fpage></element-citation></ref><ref id="B213-microorganisms-07-00133"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>M.</given-names></name><name><surname>Parida</surname><given-names>M.</given-names></name><name><surname>Santhosh</surname><given-names>S.R.</given-names></name><name><surname>Khan</surname><given-names>M.</given-names></name><name><surname>Dash</surname><given-names>P.K.</given-names></name><name><surname>Rao</surname><given-names>P.V.L.</given-names></name></person-group><article-title>Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus</article-title><source>Vaccine</source><year>2009</year><volume>27</volume><fpage>2513</fpage><lpage>2522</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2009.02.062</pub-id><pub-id pub-id-type="pmid">19368794</pub-id></element-citation></ref><ref id="B214-microorganisms-07-00133"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akahata</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>Z.-Y.</given-names></name><name><surname>Andersen</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name><name><surname>Holdaway</surname><given-names>H.A.</given-names></name><name><surname>Kong</surname><given-names>W.-P.</given-names></name><name><surname>Lewis</surname><given-names>M.G.</given-names></name><name><surname>Higgs</surname><given-names>S.</given-names></name><name><surname>Rossmann</surname><given-names>M.G.</given-names></name><name><surname>Rao</surname><given-names>S.</given-names></name><etal/></person-group><article-title>A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection</article-title><source>Nat. Med.</source><year>2010</year><volume>16</volume><fpage>334</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1038/nm.2105</pub-id><pub-id pub-id-type="pmid">20111039</pub-id></element-citation></ref><ref id="B215-microorganisms-07-00133"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metz</surname><given-names>S.W.</given-names></name><name><surname>Martina</surname><given-names>B.E.</given-names></name><name><surname>van den Doel</surname><given-names>P.</given-names></name><name><surname>Geertsema</surname><given-names>C.</given-names></name><name><surname>Osterhaus</surname><given-names>A.D.</given-names></name><name><surname>Vlak</surname><given-names>J.M.</given-names></name><name><surname>Pijlman</surname><given-names>G.P.</given-names></name></person-group><article-title>Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits</article-title><source>Vaccine</source><year>2013</year><volume>31</volume><fpage>6092</fpage><lpage>6096</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2013.09.045</pub-id><pub-id pub-id-type="pmid">24099875</pub-id></element-citation></ref><ref id="B216-microorganisms-07-00133"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metz</surname><given-names>S.W.</given-names></name><name><surname>Gardner</surname><given-names>J.</given-names></name><name><surname>Geertsema</surname><given-names>C.</given-names></name><name><surname>Le</surname><given-names>T.T.</given-names></name><name><surname>Goh</surname><given-names>L.</given-names></name><name><surname>Vlak</surname><given-names>J.M.</given-names></name><name><surname>Suhrbier</surname><given-names>A.</given-names></name><name><surname>Pijlman</surname><given-names>G.P.</given-names></name></person-group><article-title>Effective Chikungunya Virus-like Particle Vaccine Produced in Insect Cells</article-title><source>PLoS Negl. Trop. Dis.</source><year>2013</year><volume>7</volume><elocation-id>e2124</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0002124</pub-id><pub-id pub-id-type="pmid">23516657</pub-id></element-citation></ref><ref id="B217-microorganisms-07-00133"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallilankaraman</surname><given-names>K.</given-names></name><name><surname>Shedlock</surname><given-names>D.J.</given-names></name><name><surname>Bao</surname><given-names>H.</given-names></name><name><surname>Kawalekar</surname><given-names>O.U.</given-names></name><name><surname>Fagone</surname><given-names>P.</given-names></name><name><surname>Ramanathan</surname><given-names>A.A.</given-names></name><name><surname>Ferraro</surname><given-names>B.</given-names></name><name><surname>Stabenow</surname><given-names>J.</given-names></name><name><surname>Vijayachari</surname><given-names>P.</given-names></name><name><surname>Sundaram</surname><given-names>S.G.</given-names></name><etal/></person-group><article-title>A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates</article-title><source>PLoS Negl. Trop. Dis.</source><year>2011</year><volume>5</volume><elocation-id>e928</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0000928</pub-id><pub-id pub-id-type="pmid">21264351</pub-id></element-citation></ref><ref id="B218-microorganisms-07-00133"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tretyakova</surname><given-names>I.</given-names></name><name><surname>Hearn</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>E.</given-names></name><name><surname>Weaver</surname><given-names>S.</given-names></name><name><surname>Pushko</surname><given-names>P.</given-names></name></person-group><article-title>DNA Vaccine Initiates Replication of Live Attenuated Chikungunya Virus In Vitro and Elicits Protective Immune Response in Mice</article-title><source>J. Infect. Dis.</source><year>2014</year><volume>209</volume><fpage>1882</fpage><lpage>1890</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiu114</pub-id><pub-id pub-id-type="pmid">24585894</pub-id></element-citation></ref><ref id="B219-microorganisms-07-00133"><label>219.</label><element-citation publication-type="web"><article-title>A Phase 1, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of VAL-181388 in Healthy Adults in a Non Endemic Chikungunya Region&#x02014;ICH GCP&#x02014;Clinical Trials Registry</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://ichgcp.net/clinical-trials-registry/NCT03325075">https://ichgcp.net/clinical-trials-registry/NCT03325075</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-04-02">(accessed on 2 April 2019)</date-in-citation></element-citation></ref><ref id="B220-microorganisms-07-00133"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>M.</given-names></name><name><surname>Dhanwani</surname><given-names>R.</given-names></name><name><surname>Rao</surname><given-names>P.V.L.</given-names></name><name><surname>Parida</surname><given-names>M.</given-names></name></person-group><article-title>Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in mice</article-title><source>Virus Res.</source><year>2012</year><volume>167</volume><fpage>236</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2012.05.004</pub-id><pub-id pub-id-type="pmid">22610133</pub-id></element-citation></ref><ref id="B221-microorganisms-07-00133"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>L.-J.</given-names></name><name><surname>Dowd</surname><given-names>K.A.</given-names></name><name><surname>Mendoza</surname><given-names>F.H.</given-names></name><name><surname>Saunders</surname><given-names>J.G.</given-names></name><name><surname>Sitar</surname><given-names>S.</given-names></name><name><surname>Plummer</surname><given-names>S.H.</given-names></name><name><surname>Yamshchikov</surname><given-names>G.</given-names></name><name><surname>Sarwar</surname><given-names>U.N.</given-names></name><name><surname>Hu</surname><given-names>Z.</given-names></name><name><surname>Enama</surname><given-names>M.E.</given-names></name><etal/></person-group><article-title>Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: A phase 1 dose-escalation trial</article-title><source>Lancet</source><year>2014</year><volume>384</volume><fpage>2046</fpage><lpage>2052</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(14)61185-5</pub-id><pub-id pub-id-type="pmid">25132507</pub-id></element-citation></ref><ref id="B222-microorganisms-07-00133"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeZure</surname><given-names>A.D.</given-names></name><name><surname>Berkowitz</surname><given-names>N.M.</given-names></name><name><surname>Graham</surname><given-names>B.S.</given-names></name><name><surname>Ledgerwood</surname><given-names>J.E.</given-names></name></person-group><article-title>Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus</article-title><source>J. Infect. Dis.</source><year>2016</year><volume>214</volume><fpage>S497</fpage><lpage>S499</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiw352</pub-id><pub-id pub-id-type="pmid">27920180</pub-id></element-citation></ref><ref id="B223-microorganisms-07-00133"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goo</surname><given-names>L.</given-names></name><name><surname>Dowd</surname><given-names>K.A.</given-names></name><name><surname>Lin</surname><given-names>T.-Y.</given-names></name><name><surname>Mascola</surname><given-names>J.R.</given-names></name><name><surname>Graham</surname><given-names>B.S.</given-names></name><name><surname>Ledgerwood</surname><given-names>J.E.</given-names></name><name><surname>Pierson</surname><given-names>T.C.</given-names></name></person-group><article-title>A Virus-Like Particle Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All Chikungunya Virus Genotypes</article-title><source>J. Infect. Dis.</source><year>2016</year><volume>214</volume><fpage>1487</fpage><lpage>1491</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiw431</pub-id><pub-id pub-id-type="pmid">27655868</pub-id></element-citation></ref><ref id="B224-microorganisms-07-00133"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerswald</surname><given-names>H.</given-names></name><name><surname>Boussioux</surname><given-names>C.</given-names></name><name><surname>In</surname><given-names>S.</given-names></name><name><surname>Mao</surname><given-names>S.</given-names></name><name><surname>Ong</surname><given-names>S.</given-names></name><name><surname>Huy</surname><given-names>R.</given-names></name><name><surname>Leang</surname><given-names>R.</given-names></name><name><surname>Chan</surname><given-names>M.</given-names></name><name><surname>Duong</surname><given-names>V.</given-names></name><name><surname>Ly</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community</article-title><source>Emerg. Microbes Infect.</source><year>2018</year><volume>7</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1038/s41426-017-0010-0</pub-id><pub-id pub-id-type="pmid">29410416</pub-id></element-citation></ref><ref id="B225-microorganisms-07-00133"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powers</surname><given-names>A.M.</given-names></name></person-group><article-title>Licensed chikungunya virus vaccine: A possibility?</article-title><source>Lancet</source><year>2018</year><volume>392</volume><fpage>2660</fpage><lpage>2661</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(18)32809-5</pub-id><pub-id pub-id-type="pmid">30409444</pub-id></element-citation></ref><ref id="B226-microorganisms-07-00133"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langsjoen</surname><given-names>R.M.</given-names></name><name><surname>Haller</surname><given-names>S.L.</given-names></name><name><surname>Roy</surname><given-names>C.J.</given-names></name><name><surname>Vinet-Oliphant</surname><given-names>H.</given-names></name><name><surname>Bergren</surname><given-names>N.A.</given-names></name><name><surname>Erasmus</surname><given-names>J.H.</given-names></name><name><surname>Livengood</surname><given-names>J.A.</given-names></name><name><surname>Powell</surname><given-names>T.D.</given-names></name><name><surname>Weaver</surname><given-names>S.C.</given-names></name><name><surname>Rossi</surname><given-names>S.L.</given-names></name></person-group><article-title>Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models</article-title><source>mBio</source><year>2018</year><volume>9</volume><fpage>e02449-17</fpage><pub-id pub-id-type="doi">10.1128/mBio.02449-17</pub-id><pub-id pub-id-type="pmid">29511072</pub-id></element-citation></ref><ref id="B227-microorganisms-07-00133"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Partidos</surname><given-names>C.D.</given-names></name><name><surname>Paykel</surname><given-names>J.</given-names></name><name><surname>Weger</surname><given-names>J.</given-names></name><name><surname>Borland</surname><given-names>E.M.</given-names></name><name><surname>Powers</surname><given-names>A.M.</given-names></name><name><surname>Seymour</surname><given-names>R.</given-names></name><name><surname>Weaver</surname><given-names>S.C.</given-names></name><name><surname>Stinchcomb</surname><given-names>D.T.</given-names></name><name><surname>Osorio</surname><given-names>J.E.</given-names></name></person-group><article-title>Cross-protective immunity against O&#x02019;nyong&#x02019;nyong virus afforded by a novel recombinant chikungunya vaccine</article-title><source>Vaccine</source><year>2012</year><volume>30</volume><fpage>4638</fpage><lpage>4643</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2012.04.099</pub-id><pub-id pub-id-type="pmid">22583812</pub-id></element-citation></ref><ref id="B228-microorganisms-07-00133"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>D.M.</given-names></name><name><surname>Cole</surname><given-names>F.E.</given-names></name><name><surname>McManus</surname><given-names>A.T.</given-names></name><name><surname>Pedersen</surname><given-names>C.E.</given-names></name></person-group><article-title>Inactivated Mayaro vaccine produced in human diploid cell cultures</article-title><source>Mil. Med.</source><year>1976</year><volume>141</volume><fpage>163</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1093/milmed/141.3.163</pub-id><pub-id pub-id-type="pmid">815839</pub-id></element-citation></ref><ref id="B229-microorganisms-07-00133"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weise</surname><given-names>W.J.</given-names></name><name><surname>Hermance</surname><given-names>M.E.</given-names></name><name><surname>Forrester</surname><given-names>N.</given-names></name><name><surname>Adams</surname><given-names>A.P.</given-names></name><name><surname>Langsjoen</surname><given-names>R.</given-names></name><name><surname>Gorchakov</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>E.</given-names></name><name><surname>Alcorn</surname><given-names>M.D.H.</given-names></name><name><surname>Tsetsarkin</surname><given-names>K.</given-names></name><name><surname>Weaver</surname><given-names>S.C.</given-names></name></person-group><article-title>A novel live-attenuated vaccine candidate for mayaro Fever</article-title><source>PLoS Negl. Trop. Dis.</source><year>2014</year><volume>8</volume><elocation-id>e2969</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0002969</pub-id><pub-id pub-id-type="pmid">25101995</pub-id></element-citation></ref><ref id="B230-microorganisms-07-00133"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>H.</given-names></name><name><surname>Kudchodkar</surname><given-names>S.B.</given-names></name><name><surname>Reuschel</surname><given-names>E.L.</given-names></name><name><surname>Asija</surname><given-names>K.</given-names></name><name><surname>Borole</surname><given-names>P.</given-names></name><name><surname>Ho</surname><given-names>M.</given-names></name><name><surname>Wojtak</surname><given-names>K.</given-names></name><name><surname>Reed</surname><given-names>C.</given-names></name><name><surname>Ramos</surname><given-names>S.</given-names></name><name><surname>Bopp</surname><given-names>N.E.</given-names></name><etal/></person-group><article-title>Protective immunity by an engineered DNA vaccine for Mayaro virus</article-title><source>PLoS Negl. Trop. Dis.</source><year>2019</year><volume>13</volume><elocation-id>e0007042</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0007042</pub-id><pub-id pub-id-type="pmid">30730897</pub-id></element-citation></ref><ref id="B231-microorganisms-07-00133"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Aaskov</surname><given-names>J.G.</given-names></name></person-group><article-title>Development of a candidate vaccine against Ross River virus infection</article-title><source>Vaccine</source><year>1994</year><volume>12</volume><fpage>1118</fpage><lpage>1124</lpage><pub-id pub-id-type="doi">10.1016/0264-410X(94)90182-1</pub-id><pub-id pub-id-type="pmid">7998422</pub-id></element-citation></ref><ref id="B232-microorganisms-07-00133"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aaskov</surname><given-names>J.</given-names></name><name><surname>Williams</surname><given-names>L.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name></person-group><article-title>A candidate Ross River virus vaccine: Preclinical evaluation</article-title><source>Vaccine</source><year>1997</year><volume>15</volume><fpage>1396</fpage><lpage>1404</lpage><pub-id pub-id-type="doi">10.1016/S0264-410X(97)00051-0</pub-id><pub-id pub-id-type="pmid">9302751</pub-id></element-citation></ref><ref id="B233-microorganisms-07-00133"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kistner</surname><given-names>O.</given-names></name><name><surname>Barrett</surname><given-names>N.</given-names></name><name><surname>Br&#x000fc;hmann</surname><given-names>A.</given-names></name><name><surname>Reiter</surname><given-names>M.</given-names></name><name><surname>Mundt</surname><given-names>W.</given-names></name><name><surname>Savidis-Dacho</surname><given-names>H.</given-names></name><name><surname>Schober-Bendixen</surname><given-names>S.</given-names></name><name><surname>Dorner</surname><given-names>F.</given-names></name><name><surname>Aaskov</surname><given-names>J.</given-names></name></person-group><article-title>The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans</article-title><source>Vaccine</source><year>2007</year><volume>25</volume><fpage>4845</fpage><lpage>4852</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2007.01.103</pub-id><pub-id pub-id-type="pmid">17509734</pub-id></element-citation></ref><ref id="B234-microorganisms-07-00133"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzer</surname><given-names>G.W.</given-names></name><name><surname>Coulibaly</surname><given-names>S.</given-names></name><name><surname>Aichinger</surname><given-names>G.</given-names></name><name><surname>Savidis-Dacho</surname><given-names>H.</given-names></name><name><surname>Mayrhofer</surname><given-names>J.</given-names></name><name><surname>Brunner</surname><given-names>S.</given-names></name><name><surname>Schmid</surname><given-names>K.</given-names></name><name><surname>Kistner</surname><given-names>O.</given-names></name><name><surname>Aaskov</surname><given-names>J.G.</given-names></name><name><surname>Falkner</surname><given-names>F.G.</given-names></name><etal/></person-group><article-title>Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection</article-title><source>Vaccine</source><year>2011</year><volume>29</volume><fpage>4132</fpage><lpage>4141</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2011.03.089</pub-id><pub-id pub-id-type="pmid">21477673</pub-id></element-citation></ref><ref id="B235-microorganisms-07-00133"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aichinger</surname><given-names>G.</given-names></name><name><surname>Ehrlich</surname><given-names>H.J.</given-names></name><name><surname>Aaskov</surname><given-names>J.G.</given-names></name><name><surname>Fritsch</surname><given-names>S.</given-names></name><name><surname>Thomasser</surname><given-names>C.</given-names></name><name><surname>Draxler</surname><given-names>W.</given-names></name><name><surname>Wolzt</surname><given-names>M.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M.</given-names></name><name><surname>Pinl</surname><given-names>F.</given-names></name><name><surname>Van Damme</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: A randomized trial</article-title><source>Vaccine</source><year>2011</year><volume>29</volume><fpage>9376</fpage><lpage>9384</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2011.09.125</pub-id><pub-id pub-id-type="pmid">22001875</pub-id></element-citation></ref><ref id="B236-microorganisms-07-00133"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wressnigg</surname><given-names>N.</given-names></name><name><surname>van der Velden</surname><given-names>M.V.W.</given-names></name><name><surname>Portsmouth</surname><given-names>D.</given-names></name><name><surname>Draxler</surname><given-names>W.</given-names></name><name><surname>O&#x02019;Rourke</surname><given-names>M.</given-names></name><name><surname>Richmond</surname><given-names>P.</given-names></name><name><surname>Hall</surname><given-names>S.</given-names></name><name><surname>McBride</surname><given-names>W.J.H.</given-names></name><name><surname>Redfern</surname><given-names>A.</given-names></name><name><surname>Aaskov</surname><given-names>J.</given-names></name><etal/></person-group><article-title>An Inactivated Ross River Virus Vaccine Is Well Tolerated and Immunogenic in an Adult Population in a Randomized Phase 3 Trial</article-title><source>Clin. Vaccine Immunol.</source><year>2015</year><volume>22</volume><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1128/CVI.00546-14</pub-id><pub-id pub-id-type="pmid">25540268</pub-id></element-citation></ref><ref id="B237-microorganisms-07-00133"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezza</surname><given-names>G.</given-names></name><name><surname>Weaver</surname><given-names>S.C.</given-names></name></person-group><article-title>Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development</article-title><source>PLoS Negl. Trop. Dis.</source><year>2019</year><volume>13</volume><elocation-id>e0006919</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0006919</pub-id><pub-id pub-id-type="pmid">30653504</pub-id></element-citation></ref><ref id="B238-microorganisms-07-00133"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suhrbier</surname><given-names>A.</given-names></name><name><surname>La Linn</surname><given-names>M.</given-names></name></person-group><article-title>Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses</article-title><source>Curr. Opin. Rheumatol.</source><year>2004</year><volume>16</volume><fpage>374</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1097/01.bor.0000130537.76808.26</pub-id><pub-id pub-id-type="pmid">15201600</pub-id></element-citation></ref><ref id="B239-microorganisms-07-00133"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padmakumar</surname><given-names>B.</given-names></name><name><surname>Jayan</surname><given-names>J.B.</given-names></name><name><surname>Menon</surname><given-names>R.M.</given-names></name><name><surname>Krishnankutty</surname><given-names>B.</given-names></name><name><surname>Payippallil</surname><given-names>R.</given-names></name><name><surname>Nisha</surname><given-names>R.</given-names></name></person-group><article-title>Comparative evaluation of four therapeutic regimes in chikungunya arthritis: A prospective randomized parallel-group study</article-title><source>Indian J. Rheumatol.</source><year>2009</year><volume>4</volume><fpage>94</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/S0973-3698(10)60189-6</pub-id></element-citation></ref><ref id="B240-microorganisms-07-00133"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>S.</given-names></name><name><surname>Taylor</surname><given-names>A.</given-names></name><name><surname>Zaid</surname><given-names>A.</given-names></name><name><surname>Freitas</surname><given-names>J.</given-names></name><name><surname>Herrero</surname><given-names>L.J.</given-names></name><name><surname>Rao</surname><given-names>S.</given-names></name><name><surname>Suhrbier</surname><given-names>A.</given-names></name><name><surname>Forwood</surname><given-names>M.R.</given-names></name><name><surname>Bucala</surname><given-names>R.</given-names></name><name><surname>Mahalingam</surname><given-names>S.</given-names></name></person-group><article-title>Inhibition of IL-1&#x003b2; signaling by anakinra shows a critical role for bone loss in experimental arthritogenic alphavirus infections</article-title><source>Arthritis Rheumatol.</source><year>2019</year><pub-id pub-id-type="doi">10.1002/art.40856</pub-id></element-citation></ref><ref id="B241-microorganisms-07-00133"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Foo</surname><given-names>S.-S.</given-names></name><name><surname>Taylor</surname><given-names>A.</given-names></name><name><surname>Lulla</surname><given-names>A.</given-names></name><name><surname>Merits</surname><given-names>A.</given-names></name><name><surname>Hueston</surname><given-names>L.</given-names></name><name><surname>Forwood</surname><given-names>M.R.</given-names></name><name><surname>Walsh</surname><given-names>N.C.</given-names></name><name><surname>Sims</surname><given-names>N.A.</given-names></name><name><surname>Herrero</surname><given-names>L.J.</given-names></name><etal/></person-group><article-title>Bindarit, an Inhibitor of Monocyte Chemotactic Protein Synthesis, Protects against Bone Loss Induced by Chikungunya Virus Infection</article-title><source>J. Virol.</source><year>2015</year><volume>89</volume><fpage>581</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1128/JVI.02034-14</pub-id><pub-id pub-id-type="pmid">25339772</pub-id></element-citation></ref><ref id="B242-microorganisms-07-00133"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rulli</surname><given-names>N.E.</given-names></name><name><surname>Guglielmotti</surname><given-names>A.</given-names></name><name><surname>Mangano</surname><given-names>G.</given-names></name><name><surname>Rolph</surname><given-names>M.S.</given-names></name><name><surname>Apicella</surname><given-names>C.</given-names></name><name><surname>Zaid</surname><given-names>A.</given-names></name><name><surname>Suhrbier</surname><given-names>A.</given-names></name><name><surname>Mahalingam</surname><given-names>S.</given-names></name></person-group><article-title>Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins</article-title><source>Arthritis Rheum.</source><year>2009</year><volume>60</volume><fpage>2513</fpage><lpage>2523</lpage><pub-id pub-id-type="doi">10.1002/art.24682</pub-id><pub-id pub-id-type="pmid">19644852</pub-id></element-citation></ref><ref id="B243-microorganisms-07-00133"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ching</surname><given-names>K.-C.</given-names></name><name><surname>Kam</surname><given-names>Y.-W.</given-names></name><name><surname>Merits</surname><given-names>A.</given-names></name><name><surname>Ng</surname><given-names>L.F.P.</given-names></name><name><surname>Chai</surname><given-names>C.L.L.</given-names></name></person-group><article-title>Trisubstituted Thieno[3,2-<italic>b</italic>]pyrrole 5-Carboxamides as Potent Inhibitors of Alphaviruses</article-title><source>J. Med. Chem.</source><year>2015</year><volume>58</volume><fpage>9196</fpage><lpage>9213</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b01047</pub-id><pub-id pub-id-type="pmid">26540338</pub-id></element-citation></ref><ref id="B244-microorganisms-07-00133"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byler</surname><given-names>K.G.</given-names></name><name><surname>Collins</surname><given-names>J.T.</given-names></name><name><surname>Ogungbe</surname><given-names>I.V.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name></person-group><article-title>Alphavirus protease inhibitors from natural sources: A homology modeling and molecular docking investigation</article-title><source>Comput. Biol. Chem.</source><year>2016</year><volume>64</volume><fpage>163</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.compbiolchem.2016.06.005</pub-id><pub-id pub-id-type="pmid">27387412</pub-id></element-citation></ref><ref id="B245-microorganisms-07-00133"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gall</surname><given-names>B.</given-names></name><name><surname>Pryke</surname><given-names>K.</given-names></name><name><surname>Abraham</surname><given-names>J.</given-names></name><name><surname>Mizuno</surname><given-names>N.</given-names></name><name><surname>Botto</surname><given-names>S.</given-names></name><name><surname>Sali</surname><given-names>T.M.</given-names></name><name><surname>Broeckel</surname><given-names>R.</given-names></name><name><surname>Haese</surname><given-names>N.</given-names></name><name><surname>Nilsen</surname><given-names>A.</given-names></name><name><surname>Placzek</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway</article-title><source>J. Virol.</source><year>2018</year><volume>92</volume><fpage>e01913-17</fpage><pub-id pub-id-type="doi">10.1128/JVI.01913-17</pub-id><pub-id pub-id-type="pmid">29263267</pub-id></element-citation></ref><ref id="B246-microorganisms-07-00133"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neris</surname><given-names>R.L.S.</given-names></name><name><surname>Figueiredo</surname><given-names>C.M.</given-names></name><name><surname>Higa</surname><given-names>L.M.</given-names></name><name><surname>Araujo</surname><given-names>D.F.</given-names></name><name><surname>Carvalho</surname><given-names>C.A.M.</given-names></name><name><surname>Ver&#x000e7;oza</surname><given-names>B.R.F.</given-names></name><name><surname>Silva</surname><given-names>M.O.L.</given-names></name><name><surname>Carneiro</surname><given-names>F.A.</given-names></name><name><surname>Tanuri</surname><given-names>A.</given-names></name><name><surname>Gomes</surname><given-names>A.M.O.</given-names></name><etal/></person-group><article-title>Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>9805</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-27855-7</pub-id><pub-id pub-id-type="pmid">29955082</pub-id></element-citation></ref><ref id="B247-microorganisms-07-00133"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>S.M.</given-names></name><name><surname>Mudgal</surname><given-names>P.P.</given-names></name><name><surname>N</surname><given-names>S.</given-names></name><name><surname>Arunkumar</surname><given-names>G.</given-names></name></person-group><article-title>Spectrum of candidate molecules against Chikungunya virus&#x02014;An insight into the antiviral screening platforms</article-title><source>Expert Rev. Anti-Infect. Ther.</source><year>2019</year><volume>17</volume><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1080/14787210.2019.1595591</pub-id><pub-id pub-id-type="pmid">30449226</pub-id></element-citation></ref><ref id="B248-microorganisms-07-00133"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Lamballerie</surname><given-names>X.</given-names></name><name><surname>Boisson</surname><given-names>V.</given-names></name><name><surname>Reynier</surname><given-names>J.-C.</given-names></name><name><surname>Enault</surname><given-names>S.</given-names></name><name><surname>Charrel</surname><given-names>R.N.</given-names></name><name><surname>Flahault</surname><given-names>A.</given-names></name><name><surname>Roques</surname><given-names>P.</given-names></name><name><surname>Le Grand</surname><given-names>R.</given-names></name></person-group><article-title>On chikungunya acute infection and chloroquine treatment</article-title><source>Vector Borne Zoonotic Dis.</source><year>2008</year><volume>8</volume><fpage>837</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1089/vbz.2008.0049</pub-id><pub-id pub-id-type="pmid">18620511</pub-id></element-citation></ref><ref id="B249-microorganisms-07-00133"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roques</surname><given-names>P.</given-names></name><name><surname>Thiberville</surname><given-names>S.-D.</given-names></name><name><surname>Dupuis-Maguiraga</surname><given-names>L.</given-names></name><name><surname>Lum</surname><given-names>F.-M.</given-names></name><name><surname>Labadie</surname><given-names>K.</given-names></name><name><surname>Martinon</surname><given-names>F.</given-names></name><name><surname>Gras</surname><given-names>G.</given-names></name><name><surname>Lebon</surname><given-names>P.</given-names></name><name><surname>Ng</surname><given-names>L.F.P.</given-names></name><name><surname>de Lamballerie</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection</article-title><source>Viruses</source><year>2018</year><volume>10</volume><elocation-id>268</elocation-id><pub-id pub-id-type="doi">10.3390/v10050268</pub-id></element-citation></ref><ref id="B250-microorganisms-07-00133"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravichandran</surname><given-names>R.</given-names></name><name><surname>Manian</surname><given-names>M.</given-names></name></person-group><article-title>Ribavirin therapy for Chikungunya arthritis</article-title><source>J. Infect. Dev. Ctries.</source><year>2008</year><volume>2</volume><fpage>140</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.3855/T2.2.140</pub-id><pub-id pub-id-type="pmid">19738340</pub-id></element-citation></ref><ref id="B251-microorganisms-07-00133"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrero</surname><given-names>L.J.</given-names></name><name><surname>Foo</surname><given-names>S.-S.</given-names></name><name><surname>Sheng</surname><given-names>K.-C.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Forwood</surname><given-names>M.R.</given-names></name><name><surname>Bucala</surname><given-names>R.</given-names></name><name><surname>Mahalingam</surname><given-names>S.</given-names></name></person-group><article-title>Pentosan Polysulfate: A Novel Glycosaminoglycan-Like Molecule for Effective Treatment of Alphavirus-Induced Cartilage Destruction and Inflammatory Disease</article-title><source>J. Virol.</source><year>2015</year><volume>89</volume><fpage>8063</fpage><lpage>8076</lpage><pub-id pub-id-type="doi">10.1128/JVI.00224-15</pub-id><pub-id pub-id-type="pmid">26018160</pub-id></element-citation></ref><ref id="B252-microorganisms-07-00133"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couderc</surname><given-names>T.</given-names></name><name><surname>Khandoudi</surname><given-names>N.</given-names></name><name><surname>Grandadam</surname><given-names>M.</given-names></name><name><surname>Visse</surname><given-names>C.</given-names></name><name><surname>Gangneux</surname><given-names>N.</given-names></name><name><surname>Bagot</surname><given-names>S.</given-names></name><name><surname>Prost</surname><given-names>J.-F.</given-names></name><name><surname>Lecuit</surname><given-names>M.</given-names></name></person-group><article-title>Prophylaxis and therapy for Chikungunya virus infection</article-title><source>J. Infect. Dis.</source><year>2009</year><volume>200</volume><fpage>516</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1086/600381</pub-id><pub-id pub-id-type="pmid">19572805</pub-id></element-citation></ref><ref id="B253-microorganisms-07-00133"><label>253.</label><element-citation publication-type="gov"><article-title>Prevention of Chikungunya Infection in Neonates: Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins&#x02014;ICH GCP&#x02014;Clinical Trials Registry</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02230163">https://clinicaltrials.gov/ct2/show/NCT02230163</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-04-04">(accessed on 4 April 2019)</date-in-citation></element-citation></ref><ref id="B254-microorganisms-07-00133"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezza</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Weaver</surname><given-names>S.C.</given-names></name></person-group><article-title>O&#x02019;nyong&#x02019;nyong fever: A neglected mosquito-borne viral disease</article-title><source>Pathog. Glob. Health</source><year>2017</year><volume>111</volume><fpage>271</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1080/20477724.2017.1355431</pub-id><pub-id pub-id-type="pmid">28829253</pub-id></element-citation></ref><ref id="B255-microorganisms-07-00133"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>I.M.</given-names></name><name><surname>Arden</surname><given-names>K.E.</given-names></name></person-group><article-title>Mayaro virus: A forest virus primed for a trip to the city?</article-title><source>Microbes Infect.</source><year>2016</year><volume>18</volume><fpage>724</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2016.10.007</pub-id><pub-id pub-id-type="pmid">27989728</pub-id></element-citation></ref><ref id="B256-microorganisms-07-00133"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>D.L.A.</given-names></name><name><surname>Fonseca</surname><given-names>B.A.L.</given-names></name></person-group><article-title>da Will Mayaro virus be responsible for the next outbreak of an arthropod-borne virus in Brazil?</article-title><source>Braz. J. Infect. Dis.</source><year>2017</year><volume>21</volume><fpage>540</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1016/j.bjid.2017.06.002</pub-id><pub-id pub-id-type="pmid">28688628</pub-id></element-citation></ref><ref id="B257-microorganisms-07-00133"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Tharmarajah</surname><given-names>K.</given-names></name><name><surname>Taylor</surname><given-names>A.</given-names></name></person-group><article-title>Ross River virus disease clinical presentation, pathogenesis and current therapeutic strategies</article-title><source>Microbes Infect.</source><year>2017</year><volume>19</volume><fpage>496</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2017.07.001</pub-id><pub-id pub-id-type="pmid">28754345</pub-id></element-citation></ref><ref id="B258-microorganisms-07-00133"><label>258.</label><element-citation publication-type="web"><article-title>Walter Reed Biosystematics Unit</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.wrbu.org/index.html">http://www.wrbu.org/index.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-04-05">(accessed on 5 April 2019)</date-in-citation></element-citation></ref><ref id="B259-microorganisms-07-00133"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>M.G.</given-names></name><name><surname>Webb</surname><given-names>C.</given-names></name></person-group><article-title>Hydrological features and the ecological niches of mammalian hosts delineate elevated risk for Ross River virus epidemics in anthropogenic landscapes in Australia</article-title><source>Parasit. Vectors</source><year>2018</year><volume>11</volume><fpage>192</fpage><pub-id pub-id-type="doi">10.1186/s13071-018-2776-x</pub-id><pub-id pub-id-type="pmid">29554980</pub-id></element-citation></ref><ref id="B260-microorganisms-07-00133"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname><given-names>J.S.</given-names></name><name><surname>Lindsay</surname><given-names>M.D.A.</given-names></name><name><surname>Smith</surname><given-names>D.W.</given-names></name><name><surname>Imrie</surname><given-names>A.</given-names></name></person-group><article-title>The ecology and epidemiology of Ross River and Murray Valley encephalitis viruses in Western Australia: Examples of One Health in Action</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>2017</year><volume>111</volume><fpage>248</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1093/trstmh/trx045</pub-id><pub-id pub-id-type="pmid">29044370</pub-id></element-citation></ref><ref id="B261-microorganisms-07-00133"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koolhof</surname><given-names>I.S.</given-names></name><name><surname>Bettiol</surname><given-names>S.</given-names></name><name><surname>Carver</surname><given-names>S.</given-names></name></person-group><article-title>Fine-temporal forecasting of outbreak probability and severity: Ross River virus in Western Australia</article-title><source>Epidemiol. Infect.</source><year>2017</year><volume>145</volume><fpage>2949</fpage><lpage>2960</lpage><pub-id pub-id-type="doi">10.1017/S095026881700190X</pub-id><pub-id pub-id-type="pmid">28868994</pub-id></element-citation></ref><ref id="B262-microorganisms-07-00133"><label>262.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shocket</surname><given-names>M.S.</given-names></name><name><surname>Ryan</surname><given-names>S.J.</given-names></name><name><surname>Mordecai</surname><given-names>E.A.</given-names></name></person-group><article-title>Temperature explains broad patterns of Ross River virus transmission</article-title><source>eLife</source><year>2018</year><volume>7</volume><fpage>e37762</fpage><pub-id pub-id-type="doi">10.7554/eLife.37762</pub-id><pub-id pub-id-type="pmid">30152328</pub-id></element-citation></ref><ref id="B263-microorganisms-07-00133"><label>263.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>C.</given-names></name><name><surname>Azevedo</surname><given-names>T.S.</given-names></name><name><surname>Virginio</surname><given-names>F.</given-names></name><name><surname>Aguiar</surname><given-names>B.S.</given-names></name><name><surname>Chiaravalloti-Neto</surname><given-names>F.</given-names></name><name><surname>Suesdek</surname><given-names>L.</given-names></name></person-group><article-title>Impact of environmental factors on neglected emerging arboviral diseases</article-title><source>PLoS Negl. Trop. Dis.</source><year>2017</year><volume>11</volume><elocation-id>e0005959</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0005959</pub-id><pub-id pub-id-type="pmid">28953892</pub-id></element-citation></ref><ref id="B264-microorganisms-07-00133"><label>264.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manrubia</surname><given-names>S.C.</given-names></name><name><surname>Escarm&#x000ed;s</surname><given-names>C.</given-names></name><name><surname>Domingo</surname><given-names>E.</given-names></name><name><surname>L&#x000e1;zaro</surname><given-names>E.</given-names></name></person-group><article-title>High mutation rates, bottlenecks, and robustness of RNA viral quasispecies</article-title><source>Gene</source><year>2005</year><volume>347</volume><fpage>273</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2004.12.033</pub-id><pub-id pub-id-type="pmid">15777632</pub-id></element-citation></ref><ref id="B265-microorganisms-07-00133"><label>265.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stapleford</surname><given-names>K.A.</given-names></name><name><surname>Moratorio</surname><given-names>G.</given-names></name><name><surname>Henningsson</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Matheus</surname><given-names>S.</given-names></name><name><surname>Enfissi</surname><given-names>A.</given-names></name><name><surname>Weissglas-Volkov</surname><given-names>D.</given-names></name><name><surname>Isakov</surname><given-names>O.</given-names></name><name><surname>Blanc</surname><given-names>H.</given-names></name><name><surname>Mounce</surname><given-names>B.C.</given-names></name><etal/></person-group><article-title>Whole-Genome Sequencing Analysis from the Chikungunya Virus Caribbean Outbreak Reveals Novel Evolutionary Genomic Elements</article-title><source>PLoS Negl. Trop. Dis.</source><year>2016</year><volume>10</volume><elocation-id>e0004402</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0004402</pub-id><pub-id pub-id-type="pmid">26807575</pub-id></element-citation></ref><ref id="B266-microorganisms-07-00133"><label>266.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Kim</surname><given-names>A.S.</given-names></name><name><surname>Fox</surname><given-names>J.M.</given-names></name><name><surname>Nair</surname><given-names>S.</given-names></name><name><surname>Basore</surname><given-names>K.</given-names></name><name><surname>Klimstra</surname><given-names>W.B.</given-names></name><name><surname>Rimkunas</surname><given-names>R.</given-names></name><name><surname>Fong</surname><given-names>R.H.</given-names></name><name><surname>Lin</surname><given-names>H.</given-names></name><name><surname>Poddar</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Mxra8 is a receptor for multiple arthritogenic alphaviruses</article-title><source>Nature</source><year>2018</year><volume>557</volume><fpage>570</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0121-3</pub-id><pub-id pub-id-type="pmid">29769725</pub-id></element-citation></ref><ref id="B267-microorganisms-07-00133"><label>267.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bessaud</surname><given-names>M.</given-names></name><name><surname>Peyrefitte</surname><given-names>C.N.</given-names></name><name><surname>Pastorino</surname><given-names>B.A.M.</given-names></name><name><surname>Gravier</surname><given-names>P.</given-names></name><name><surname>Tock</surname><given-names>F.</given-names></name><name><surname>Boete</surname><given-names>F.</given-names></name><name><surname>Tolou</surname><given-names>H.J.</given-names></name><name><surname>Grandadam</surname><given-names>M.</given-names></name></person-group><article-title>O&#x02019;nyong&#x02019;nyong Virus, Chad</article-title><source>Emerg. Infect. Dis.</source><year>2006</year><volume>12</volume><fpage>1248</fpage><lpage>1250</lpage><pub-id pub-id-type="doi">10.3201/eid1208.060199</pub-id><pub-id pub-id-type="pmid">16965706</pub-id></element-citation></ref><ref id="B268-microorganisms-07-00133"><label>268.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuchi</surname><given-names>N.</given-names></name><name><surname>Heinen</surname><given-names>L.B.D.S.</given-names></name><name><surname>Santos</surname><given-names>M.A.M.D.</given-names></name><name><surname>Pereira</surname><given-names>F.C.</given-names></name><name><surname>Slhessarenko</surname><given-names>R.D.</given-names></name></person-group><article-title>Molecular detection of Mayaro virus during a dengue outbreak in the state of Mato Grosso, Central-West Brazil</article-title><source>Mem. Inst. Oswaldo Cruz</source><year>2014</year><volume>109</volume><fpage>820</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1590/0074-0276140108</pub-id><pub-id pub-id-type="pmid">25141284</pub-id></element-citation></ref><ref id="B269-microorganisms-07-00133"><label>269.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Souza Costa</surname><given-names>M.C.</given-names></name><name><surname>Siqueira Maia</surname><given-names>L.M.</given-names></name><name><surname>Costa de Souza</surname><given-names>V.</given-names></name><name><surname>Gonzaga</surname><given-names>A.M.</given-names></name><name><surname>Correa de Azevedo</surname><given-names>V.</given-names></name><name><surname>Ramos Martins</surname><given-names>L.</given-names></name><name><surname>Chavez Pavoni</surname><given-names>J.H.</given-names></name><name><surname>Gomes Naveca</surname><given-names>F.</given-names></name><name><surname>Dezengrini Slhessarenko</surname><given-names>R.</given-names></name></person-group><article-title>Arbovirus investigation in patients from Mato Grosso during Zika and Chikungunya virus introdution in Brazil, 2015-2016</article-title><source>Acta Trop.</source><year>2019</year><volume>190</volume><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.actatropica.2018.12.019</pub-id><pub-id pub-id-type="pmid">30552880</pub-id></element-citation></ref><ref id="B270-microorganisms-07-00133"><label>270.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Ochieng</surname><given-names>C.</given-names></name><name><surname>Wiersma</surname><given-names>S.</given-names></name><name><surname>Str&#x000f6;her</surname><given-names>U.</given-names></name><name><surname>Towner</surname><given-names>J.S.</given-names></name><name><surname>Whitmer</surname><given-names>S.</given-names></name><name><surname>Nichol</surname><given-names>S.T.</given-names></name><name><surname>Moore</surname><given-names>C.C.</given-names></name><name><surname>Kersh</surname><given-names>G.J.</given-names></name><name><surname>Kato</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Development of a TaqMan Array Card for Acute-Febrile-Illness Outbreak Investigation and Surveillance of Emerging Pathogens, Including Ebola Virus</article-title><source>J. Clin. Microbiol.</source><year>2016</year><volume>54</volume><fpage>49</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1128/JCM.02257-15</pub-id><pub-id pub-id-type="pmid">26491176</pub-id></element-citation></ref><ref id="B271-microorganisms-07-00133"><label>271.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>D.R.</given-names></name><name><surname>Lee</surname><given-names>J.S.</given-names></name><name><surname>Jahrling</surname><given-names>J.</given-names></name><name><surname>Kulesh</surname><given-names>D.A.</given-names></name><name><surname>Turell</surname><given-names>M.J.</given-names></name><name><surname>Groebner</surname><given-names>J.L.</given-names></name><name><surname>O&#x02019;Guinn</surname><given-names>M.L.</given-names></name></person-group><article-title>Development of field-based real-time reverse transcription-polymerase chain reaction assays for detection of Chikungunya and O&#x02019;nyong&#x02019;nyong viruses in mosquitoes</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2009</year><volume>81</volume><fpage>679</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2009.09-0138</pub-id><pub-id pub-id-type="pmid">19815886</pub-id></element-citation></ref><ref id="B272-microorganisms-07-00133"><label>272.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inglis</surname><given-names>T.J.J.</given-names></name><name><surname>Bradbury</surname><given-names>R.S.</given-names></name><name><surname>McInnes</surname><given-names>R.L.</given-names></name><name><surname>Frances</surname><given-names>S.P.</given-names></name><name><surname>Merritt</surname><given-names>A.J.</given-names></name><name><surname>Levy</surname><given-names>A.</given-names></name><name><surname>Nicholson</surname><given-names>J.</given-names></name><name><surname>Neville</surname><given-names>P.J.</given-names></name><name><surname>Lindsay</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>D.W.</given-names></name></person-group><article-title>Deployable Molecular Detection of Arboviruses in the Australian Outback</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2016</year><volume>95</volume><fpage>633</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.15-0878</pub-id><pub-id pub-id-type="pmid">27402516</pub-id></element-citation></ref><ref id="B273-microorganisms-07-00133"><label>273.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batovska</surname><given-names>J.</given-names></name><name><surname>Lynch</surname><given-names>S.E.</given-names></name><name><surname>Rodoni</surname><given-names>B.C.</given-names></name><name><surname>Sawbridge</surname><given-names>T.I.</given-names></name><name><surname>Cogan</surname><given-names>N.O.</given-names></name></person-group><article-title>Metagenomic arbovirus detection using MinION nanopore sequencing</article-title><source>J. Virol. Methods</source><year>2017</year><volume>249</volume><fpage>79</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2017.08.019</pub-id><pub-id pub-id-type="pmid">28855093</pub-id></element-citation></ref><ref id="B274-microorganisms-07-00133"><label>274.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calisher</surname><given-names>C.H.</given-names></name><name><surname>el-Kafrawi</surname><given-names>A.O.</given-names></name><name><surname>Al-Deen Mahmud</surname><given-names>M.I.</given-names></name><name><surname>Travassos da Rosa</surname><given-names>A.P.</given-names></name><name><surname>Bartz</surname><given-names>C.R.</given-names></name><name><surname>Brummer-Korvenkontio</surname><given-names>M.</given-names></name><name><surname>Haksohusodo</surname><given-names>S.</given-names></name><name><surname>Suharyono</surname><given-names>W.</given-names></name></person-group><article-title>Complex-specific immunoglobulin M antibody patterns in humans infected with alphaviruses</article-title><source>J. Clin. Microbiol.</source><year>1986</year><volume>23</volume><fpage>155</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">3009526</pub-id></element-citation></ref><ref id="B275-microorganisms-07-00133"><label>275.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Z.S.</given-names></name><name><surname>Jia</surname><given-names>L.L.</given-names></name><name><surname>Qu</surname><given-names>X.S.</given-names></name><name><surname>Zhang</surname><given-names>Y.H.</given-names></name></person-group><article-title>Application of enzyme immunoassay on infected cells (EIA-IC) for arboviruses</article-title><source>Acta Virol.</source><year>1986</year><volume>30</volume><fpage>487</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">2881468</pub-id></element-citation></ref><ref id="B276-microorganisms-07-00133"><label>276.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greiser-Wilke</surname><given-names>I.M.</given-names></name><name><surname>Moennig</surname><given-names>V.</given-names></name><name><surname>Kaaden</surname><given-names>O.R.</given-names></name><name><surname>Shope</surname><given-names>R.E.</given-names></name></person-group><article-title>Detection of alphaviruses in a genus-specific antigen capture enzyme immunoassay using monoclonal antibodies</article-title><source>J. Clin. Microbiol.</source><year>1991</year><volume>29</volume><fpage>131</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">1847149</pub-id></element-citation></ref><ref id="B277-microorganisms-07-00133"><label>277.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>J.S.</given-names></name><name><surname>Parida</surname><given-names>M.</given-names></name><name><surname>Lakshmana Rao</surname><given-names>P.V.</given-names></name></person-group><article-title>Development &#x00026; evaluation of biotinylated DNA probe for clinical diagnosis of chikungunya infection in patients&#x02019; acute phase serum &#x00026; CSF samples</article-title><source>Indian J. Med. Res.</source><year>2013</year><volume>138</volume><fpage>117</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">24056565</pub-id></element-citation></ref><ref id="B278-microorganisms-07-00133"><label>278.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuekprakhon</surname><given-names>A.</given-names></name><name><surname>Puiprom</surname><given-names>O.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>Michiels</surname><given-names>J.</given-names></name><name><surname>Bartholomeeusen</surname><given-names>K.</given-names></name><name><surname>Nakayama</surname><given-names>E.E.</given-names></name><name><surname>Meno</surname><given-names>M.K.</given-names></name><name><surname>Phadungsombat</surname><given-names>J.</given-names></name><name><surname>Huits</surname><given-names>R.</given-names></name><name><surname>Ari&#x000eb;n</surname><given-names>K.K.</given-names></name><etal/></person-group><article-title>Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><elocation-id>e0208851</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0208851</pub-id><pub-id pub-id-type="pmid">30557365</pub-id></element-citation></ref><ref id="B279-microorganisms-07-00133"><label>279.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>J.M.</given-names></name><name><surname>Long</surname><given-names>F.</given-names></name><name><surname>Edeling</surname><given-names>M.A.</given-names></name><name><surname>Lin</surname><given-names>H.</given-names></name><name><surname>van Duijl-Richter</surname><given-names>M.K.S.</given-names></name><name><surname>Fong</surname><given-names>R.H.</given-names></name><name><surname>Kahle</surname><given-names>K.M.</given-names></name><name><surname>Smit</surname><given-names>J.M.</given-names></name><name><surname>Jin</surname><given-names>J.</given-names></name><name><surname>Simmons</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress</article-title><source>Cell</source><year>2015</year><volume>163</volume><fpage>1095</fpage><lpage>1107</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.10.050</pub-id><pub-id pub-id-type="pmid">26553503</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="microorganisms-07-00133-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Timeline after arthritogenic alphavirus infection. After infection by a bite from an infected mosquito, an incubation period of 3&#x02013;8 days takes place. Viremia starts before the onset of symptoms and lasts only a few days, leaving a very short window for direct diagnosis by RT-PCR or virus isolation. If the infection is symptomatic (&#x0003e;60% of cases), the patient presents with brutal onset of fever associated with polyarthralgia and other general symptoms, and after a few days, a delayed rash often appears. Lymphadenopathy is particularly frequent in ONNV infection. General blood tests during the acute phase can show lymphopenia, thrombopenia, hypocalcemia and mild rhabdomyolysis (with cytolysis and increased creatinine kinase). Polyarthralgia with or without arthritis and asthenia might be prolonged during the sub-acute phase (2 weeks to 3 months) or as chronic symptoms, sometimes as post-infectious chronic inflammatory rheumatism mimicking rheumatoid arthritis. Indirect diagnosis by serology requires two blood samples separated by at least 12 days to show appearance and/or disappearance of IgM (that may stay positive for over 6 months) and appearance of IgG.</p></caption><graphic xlink:href="microorganisms-07-00133-g001"/></fig><fig id="microorganisms-07-00133-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Number of publications for each virus reported in PubMed through the years. CHIKV publications were rare before 2006 (under 10 per year), except during the South-East Asia epidemic in the late 1960s, when it reached around 20 publications per year. Since the La Reunion outbreak, and followed by the Caribbean epidemic, attention has increased tremendously, and publications now number around 500 per year. While Ross River virus has 10&#x02013;20 publications a year since 1979, MAYV and ONNV had less than 10 publications a year until 2015, and only MAYV has slightly exceeded this number since then.</p></caption><graphic xlink:href="microorganisms-07-00133-g002"/></fig><table-wrap id="microorganisms-07-00133-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">microorganisms-07-00133-t001_Table 1</object-id><label>Table 1</label><caption><p>Arthritogenic alphavirus general characteristics. CHIKV, chikungunya virus; ONNV, O&#x02019;nyong&#x02019;nyong virus; MAYV, Mayaro virus; RRV, Ross River virus.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CHIKV</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ONNV</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MAYV</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RRV</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Other Name</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uruma virus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Igbo-Ora virus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Epidemic polyarthritis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Location of circulation</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endemic: Africa, Asia (South-East and India), Pacific Islands, Central and South America.<break/>Sporadically: Mediterranean Europe, USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sub-Saharan Africa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Central and South America</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Australia, South Pacific Island, Papua New Guinea</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Cycle</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enzootic cycle and urban cycle during epidemic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enzootic cycle and urban cycle during epidemic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enzootic cycle </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enzootic cycle and urban cycle during epidemic</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Vertebrate host</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-human primate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mostly unknown (possibly forest buffalo, monkeys, duikers)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-human primate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marsupials mainly, horses, cattle</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Invertebrate vector</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Aedes</italic> sp. (enzootic cycle: <italic>africanus</italic>, <italic>furcifer-taylori</italic>, <italic>luteocephalus</italic>, <italic>dalzieli;</italic> urban cycle: <italic>aegypti</italic> and <italic>albopictus</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Anopheles funestus</italic> and more rarely <italic>Anopheles gambiae</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Haemagogus</italic> sp., <italic>Mansonia</italic> sp., and <italic>Psophora</italic> sp. [<xref rid="B5-microorganisms-07-00133" ref-type="bibr">5</xref>,<xref rid="B6-microorganisms-07-00133" ref-type="bibr">6</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Aedes vigilax</italic> and <italic>Culex annulirostris</italic> mainly,<break/><italic>Aedes notoscriptus</italic>, <italic>Aedes funereus</italic>, <italic>Aedes camptorhynchus</italic>, <italic>Ochlerotatus camptorhynchus</italic></td></tr></tbody></table></table-wrap><table-wrap id="microorganisms-07-00133-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">microorganisms-07-00133-t002_Table 2</object-id><label>Table 2</label><caption><p>Arthritogenic alphavirus acute infection symptoms, range of frequency reported in the listed studies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CHIKV Median</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Min</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Max</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ONNV Median</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Min</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Max</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MAYV Median</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Min</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Max</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RRV Median</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Min</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Max</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>% of symptomatic cases</bold>
</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">18&#x02013;97 [<xref rid="B30-microorganisms-07-00133" ref-type="bibr">30</xref>,<xref rid="B117-microorganisms-07-00133" ref-type="bibr">117</xref>,<xref rid="B118-microorganisms-07-00133" ref-type="bibr">118</xref>,<xref rid="B119-microorganisms-07-00133" ref-type="bibr">119</xref>,<xref rid="B121-microorganisms-07-00133" ref-type="bibr">121</xref>]</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">64&#x02013;86 [<xref rid="B42-microorganisms-07-00133" ref-type="bibr">42</xref>,<xref rid="B122-microorganisms-07-00133" ref-type="bibr">122</xref>,<xref rid="B123-microorganisms-07-00133" ref-type="bibr">123</xref>,<xref rid="B124-microorganisms-07-00133" ref-type="bibr">124</xref>]</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">64&#x02013;80 [<xref rid="B48-microorganisms-07-00133" ref-type="bibr">48</xref>,<xref rid="B56-microorganisms-07-00133" ref-type="bibr">56</xref>]</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">25&#x02013;76 [<xref rid="B73-microorganisms-07-00133" ref-type="bibr">73</xref>,<xref rid="B125-microorganisms-07-00133" ref-type="bibr">125</xref>,<xref rid="B126-microorganisms-07-00133" ref-type="bibr">126</xref>,<xref rid="B127-microorganisms-07-00133" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Incubation time</bold>
</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">2,5 days (2&#x02013;12)</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Approximately 8 days</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">&#x0003c;7 days</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">8 days (3&#x02013;21)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Symptoms</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Arthralgia</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">69</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94.35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">98</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Joint Stiffness</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">84.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">78.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">89</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Fever</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Asthenia</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">92.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Anorexia</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">75</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Myalgia</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">59</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">71</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">71</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">71</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">78.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">61.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">66.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Headache</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">84.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">74</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Gastrointestinal Symptom</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">63</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Post Orbital Pain</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Skin Rash</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">84</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">59.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Nausea</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">69</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">69</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Pruritus</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Swollen Joints</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Vomiting</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Diarrhea</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Conjunctival Hyperemia</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Abdominal Pain</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Lymphadenopathy</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Number of study/total number of patients [references]</bold>
</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">18/4502 [<xref rid="B21-microorganisms-07-00133" ref-type="bibr">21</xref>,<xref rid="B25-microorganisms-07-00133" ref-type="bibr">25</xref>,<xref rid="B32-microorganisms-07-00133" ref-type="bibr">32</xref>,<xref rid="B117-microorganisms-07-00133" ref-type="bibr">117</xref>,<xref rid="B128-microorganisms-07-00133" ref-type="bibr">128</xref>,<xref rid="B129-microorganisms-07-00133" ref-type="bibr">129</xref>,<xref rid="B130-microorganisms-07-00133" ref-type="bibr">130</xref>,<xref rid="B131-microorganisms-07-00133" ref-type="bibr">131</xref>,<xref rid="B132-microorganisms-07-00133" ref-type="bibr">132</xref>,<xref rid="B133-microorganisms-07-00133" ref-type="bibr">133</xref>,<xref rid="B134-microorganisms-07-00133" ref-type="bibr">134</xref>,<xref rid="B135-microorganisms-07-00133" ref-type="bibr">135</xref>,<xref rid="B136-microorganisms-07-00133" ref-type="bibr">136</xref>,<xref rid="B137-microorganisms-07-00133" ref-type="bibr">137</xref>,<xref rid="B138-microorganisms-07-00133" ref-type="bibr">138</xref>,<xref rid="B139-microorganisms-07-00133" ref-type="bibr">139</xref>,<xref rid="B140-microorganisms-07-00133" ref-type="bibr">140</xref>]</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">3/891 [<xref rid="B44-microorganisms-07-00133" ref-type="bibr">44</xref>,<xref rid="B122-microorganisms-07-00133" ref-type="bibr">122</xref>,<xref rid="B141-microorganisms-07-00133" ref-type="bibr">141</xref>]</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">9/179 [<xref rid="B47-microorganisms-07-00133" ref-type="bibr">47</xref>,<xref rid="B49-microorganisms-07-00133" ref-type="bibr">49</xref>,<xref rid="B50-microorganisms-07-00133" ref-type="bibr">50</xref>,<xref rid="B51-microorganisms-07-00133" ref-type="bibr">51</xref>,<xref rid="B56-microorganisms-07-00133" ref-type="bibr">56</xref>,<xref rid="B142-microorganisms-07-00133" ref-type="bibr">142</xref>,<xref rid="B143-microorganisms-07-00133" ref-type="bibr">143</xref>,<xref rid="B144-microorganisms-07-00133" ref-type="bibr">144</xref>,<xref rid="B145-microorganisms-07-00133" ref-type="bibr">145</xref>]</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">5/626 [<xref rid="B125-microorganisms-07-00133" ref-type="bibr">125</xref>,<xref rid="B146-microorganisms-07-00133" ref-type="bibr">146</xref>,<xref rid="B147-microorganisms-07-00133" ref-type="bibr">147</xref>,<xref rid="B148-microorganisms-07-00133" ref-type="bibr">148</xref>,<xref rid="B149-microorganisms-07-00133" ref-type="bibr">149</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Severe forms</bold>
</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Meningo-encephalopathy [<xref rid="B150-microorganisms-07-00133" ref-type="bibr">150</xref>,<xref rid="B151-microorganisms-07-00133" ref-type="bibr">151</xref>], Guillain-Barr&#x000e9; syndrome [<xref rid="B152-microorganisms-07-00133" ref-type="bibr">152</xref>], acute optic neuropathy [<xref rid="B153-microorganisms-07-00133" ref-type="bibr">153</xref>], Myo-pericarditis [<xref rid="B150-microorganisms-07-00133" ref-type="bibr">150</xref>,<xref rid="B154-microorganisms-07-00133" ref-type="bibr">154</xref>,<xref rid="B155-microorganisms-07-00133" ref-type="bibr">155</xref>], shock [<xref rid="B150-microorganisms-07-00133" ref-type="bibr">150</xref>], neonatal infection [<xref rid="B156-microorganisms-07-00133" ref-type="bibr">156</xref>,<xref rid="B157-microorganisms-07-00133" ref-type="bibr">157</xref>]</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">unknown</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">unknown</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Glomerulonephritis [<xref rid="B158-microorganisms-07-00133" ref-type="bibr">158</xref>], encephalitis [<xref rid="B159-microorganisms-07-00133" ref-type="bibr">159</xref>,<xref rid="B160-microorganisms-07-00133" ref-type="bibr">160</xref>,<xref rid="B161-microorganisms-07-00133" ref-type="bibr">161</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>